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LC-ESI Liquid chromatography - electrospray ionization 
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MCS  Multiple cloning site 
MeJA  Methyl jasmonate 
MEP  2-C-methyl-D-erythritol 4-phosphate 
MKB1  Makibishi 1, RMA-like E3 ubiquitin ligase 
ML257 Maesa lanceolata β-amyrin 28-oxidase 
ML593 Maesa lanceolata putative β-amyrin 21-hydroxylase 
MtGEA Medicago truncatula gene expression atlas 
MVA  Mevalonic acid 
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OSC  Oxidosqualene cyclase 
qRT-PCR Quantitative reverse transcriptase polymerase chain reaction 
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UGT  UDP-dependent glycosyltransferase 
UGT73F3 UDP- dependent glycosyltransferase 
UGT73K1 UDP- dependent glycosyltransferase 
WHO  World Health Organization 








Plants are a rich source of natural products with diverse structures and biological 
activities beneficial to humans. This has led to their application as flavors and fragrances, 
colorants and therapeutics. Terpenoids or isoprenoids constitute the largest class of plant 
natural products with over 25,000 characterized structures. This dissertation focuses on 
the building blocks of triterpenoid saponins that structurally consist of 30 carbon atoms 
arranged in four or five ring structures with several attached oxygens and sugar moieties. 
The triterpenoids have been valued in traditional herbal medicine for their healing power 
and general health promoting activities. Despite their potential therapeutic applications, 
triterpenoids have not been widely employed in modern medicine, owing to the usually 
very low amounts in which they are produced in their natural source, the plants 
themselves. Engineering plants and cell cultures for the enhanced production of 
triterpenoids has been limited. Therefore, first and foremost a heterologous microbial 
Saccharomyces cerevisiae based yeast platform was established for the production of 
high amounts of the triterpene saponin building blocks, resulting in 36.2 mg/L β-amyrin 
and 46.3 mg/L lupeol producing yeast strains. Besides the establishment of a production 
host, the yeast strains also facilitated the identifica on and characterization of novel 
genes encoding enzymes catalyzing saponin biosynthesis from the medicinal plants 
Bupleurum falcatum and Maesa lanceolata, and the establishment of a combinatorial 
biosynthetic platform in yeast to generate novel triterpene sapogenins. Furthermore, to 
increase the productivity and simplify the purificat on pipeline of triterpene sapogenins, a 
methyl β-cyclodextrin based culturing approach was established to promote their release 
from yeast cells into the growth medium. Finally, b down regulating the expression of a 
Medicago truncatula saponin regulatory gene that targets specific isoforms of 3-hydroxy-
3-methylglutaryl-CoA reductase, the rate controlling enzyme of the mevalonate pathway, 
monoglycosylated saponin building blocks could be accumulated in transgenic hairy 
roots, thereby serving as a plant based production system. In conclusion, two in vivo 




conventional yeast S. cerevisiae, for the synthesis of glycosylated and unglycosylated 











From time immemorial plant-derived natural products have played a significant role in 
curing diseases and promoting general human health. The production of these high-value, 
biologically active natural products is hindered by the unfeasibility of total chemical 
synthesis due to their structural complexity whereas, the plants themselves most often 
cannot provide a sustainable supply. An alternative route of obtaining these compounds is 
by engineering plant cultures or heterologous microbial hosts like Escherichia coli and 
Saccharomyces cerevisiae. The growing knowledge of plant secondary metabolism, 
together with the advances in engineering tools, facilit tes translating plant-based 
biosynthetic routes into such microorganisms for the production of natural products. 
The main objective of this PhD was to address the lack of a robust microbial production 
system for triterpenoid saponins and hence, to develop an S. cerevisiae based production 
platform for saponin building blocks (or sapogenins). Such a yeast based system could 
serve several purposes, which include (a) the charaterization of novel genes involved in 
triterpene saponin biosynthesis, (b) the engineering of a production host for the targeted 
synthesis of a desired sapogenin and (c) the generation of new-to-nature sapogenins using 
combinatorial biosynthesis to widen the spectrum of lead molecules with biological 
activities for pharmaceutical applications. 
Saponins and its building blocks have been primarily valued as therapeutics owing to 
their adjuvant, anti-angiogenic, anti-inflammatory, anti-cancer, anit-viral, anti-bacterial 
and general health promoting activities in both tradi ional and modern medicine. The 
amphipathic nature of saponins also render them biologically active as surfactants that 
can enhance the penetration of macromolecules, like proteins, through cell membranes. 
Additionally, the surface active properties of saponins has been exploited in beverages, 
soaps and shampoos to produce stable foams. Saponins have also found applications in 
animal feed as anti-parasitics and fecal odor reductants. Next to these applications, the 
plants themselves produce saponins as defense compounds to overcome pathogen and 
pest attacks, thereby also highlighting their pesticidal activities. The multiple applications 




be harvested only in limited amounts from the plants. Therefore, the development of a 
yeast based production platform allows creating a source for the sustainable supply of 
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Terpenoids, also called isoprenoids, constitute a large and diverse class of natural 
products that serve many functions in nature. More than half of the over 40,000 
discovered terpenoid structures are synthesized by plants, where they can function as 
primary metabolites involved in growth and development, or as secondary metabolites 
involved in the interaction of the plant with its environment. Several plant terpenoids are 
economically important molecules that are used as pharmaceuticals, flavors and 
fragrances, colorants, pesticides and elastomers. Two of the major challenges 
encountered for the commercialization of plant-derived (terpenoid) compounds is their 
low production or accumulation in planta and the continuous demand of the 
(pharmaceutical) industry for novel molecules with new or superior biological activities. 
In this review, we highlight several methods to enhance and diversify the production of 
plant terpenoids, with a foresight into triterpenoid engineering. Higher yields or a cheaper 
production of valuable terpenoids may be obtained by metabolic engineering of plants or 
by heterologous production of the compounds in other plants or microbes. Alternatively, 
novel compounds can be generated by applying combinator al biosynthesis or directed 
enzyme evolution approaches. Ultimately, synthetic biology may lead to the production 
of high amounts of plant terpenoids in i  vitro systems or custom-designed artificial 
biological systems. 









Plants synthesize and accumulate a wide range of small molecules or natural products 
that are involved in fundamental physiological and ecological processes. Some of these 
natural products have therapeutic potential that has been exploited by humans for 
thousands of years in the form of traditional herbal medicine. In recent years, with our 
growing understanding of their biosynthesis, regulation and functioning, plant-derived 
natural products have emerged as high-value therapeutics, flavors and fragrances, 
colorants and health-promoting agents. Based on their structure and biosynthetic origin, 
plant natural products can be classified in different groups, such as the terpenoids, 
alkaloids and phenolic compounds (Croteau et al., 2000). This review focuses on the 
terpenoids, of which over 25,000 compounds have been characterized from plants, 
making them the largest class of plant natural products. The terpenoids or isoprenoids 
comprise structurally diverse compounds that are associated with primary as well as 
secondary metabolism. Gibberellin, abscisic acid anbrassinosteroid phytohormones, 
phytosterols and carotenoid pigments are primary metabolic terpenoids involved in basic 
functions such as regulation of plant growth and development, photosynthesis, membrane 
permeability and fluidity (Bohlmann & Keeling, 2008; Vranová et al., 2012). However, 
the majority of the plant terpenoids are secondary metabolites that play a crucial role in 
the interaction of the plant with its environment, for instance by serving as pollinator 
attractants, herbivore repellents, anti-feedants, toxins or antibiotics (Gershenzon & 
Dudareva, 2007). 
The structural variety and inherent biological activities of many plant terpenoids have 
rendered them widely applicable. With an annual production of 107 tons, natural rubber is 
undoubtedly the most abundant terpenoid produced, which serves as biological material 
in the non-food industry. Its unique properties in terms of resilience, abrasion and impact 
resistance, make natural rubber the preferred material fo  the production of heavy-duty 
tires and vibration dampers. Furthermore, latex products for medical applications, such as 
surgical gloves, are often based on natural rubber (van Beilen & Poirier, 2007). Other 
examples of plant terpenoids with significant economical value include menthol, a 
monoterpenoid extracted from peppermint and used in the flavor and fragrance industry; 




abietic acid, a diterpenoid isolated from conifer rosin that is used in lacquers, varnishes 
and soap; and the anti-malarial and anti-cancer drugs artemisinin and taxol, respectively 
(Bohlmann & Keeling, 2008). 
A major hurdle in the commercialization of plant terp noids is that they often accumulate 
in very low concentrations in planta, thereby hindering their purification in large amounts 
from the natural source. For instance, the diterpenoid taxol is harvested from the inner 
bark of the yew tree where it corresponds to only ~0.001-0.05% of the dry weight. Taxol 
can also be produced semi-synthetically from taxol precursors, baccatin III and 10-
deacetylbaccatin III, which can reach concentrations f ~0.3% of the dry weight in 
certain Taxus species. As such, the production cost of taxol is high and the supply from 
natural sources cannot fulfill the growing demand for the compound (Expósito et al., 
2009). 
When extraction of a natural product from its naturl source is not sufficient, several 
alternative approaches can be explored, including (a) plant breeding and genetic 
engineering to generate cultivars or transgenics acumulating higher levels of the desired 
compounds, (b) developing scalable plant cell or root cultures, and (c) engineering 
microbial hosts to produce the compound (Kirby & Keasling, 2009). Commercially 
viable production systems have already been establihed for some terpenoids, which is 
reflected in the emergence of companies like Phyton Biotech 
(http://www.phytonbiotech.com/), a global provider of chemotherapeutics including 
paclitaxel extracted from Taxus cell cultures and Amyris (http://www.amyris.com/) that 
uses a synthetic biology platform for the production of artemisinin in yeast. 
The pharmaceutical industry is in constant search for novel molecules, primarily due to 
the discovery of new drug targets, the emergence of new diseases and, in the case of 
infectious diseases, the growing resistance of microbes against the currently marketed 
antibiotics (Pollier et al., 2011; Winter & Tang, 2012). Additionally, the business model 
of pharmaceutical companies is under threat, as leading blockbuster drugs will soon lose 
patent protection and become available for market competition, which often leads to 
lower market prices, thereby rendering the production of the drug non-profitable to the 




original developer. As traditional pharmacological screening of medicinal plants is time-
consuming and expensive, and the output of combinatorial chemistry libraries is low in 
terms of new drugs, alternative approaches to generate new molecules or scaffolds are 
required (Koehn & Carter, 2005; Welsch et al., 2010; Carter, 2011). Combinatorial 
biosynthesis accelerates the process of natural evolution and multiplies the natural 
diversity by generating novel enzyme-substrate combinations that result in the production 
of novel compounds (Kirschning et al., 2007; Pollier et al., 2011). By integrating 
emerging technologies such as synthetic biology anddirected enzyme evolution, 
combinatorial biosynthesis can be rationally applied to custom design new compounds. 
In this review, we summarize the current status of terpenoid engineering in plants and 
microbial hosts, thereby highlighting the latest approaches available for enhancing 
compound production and increasing structural divers ty. We discuss the booming trend 
of synthetic biology in the perspective of terpenoid production and give a futuristic view 
into the engineering of triterpenoids, the least engineered class of terpenoids with 
pharmaceutical potential. 
 
Classification and biosynthesis of plant terpenoids 
All terpenes are derived from the repetitive fusion of isoprene (C5H8) units and have the 
molecular formula (C5H8)n, where ‘n’ stands for the number of linked isoprene units. 
These isoprene units are linked most commonly in a ‘he d-to-tail’ fashion, but products 
with ‘head-to-head’ and ‘head-to-middle’ fusions also occur (Fig. 1). The terpenes 
resulting from the fusion of isoprene units undergo various modifications, like carbon 
rearrangements or oxidations, to result in the formation of a plethora of different 
terpenoid structures. 





Figure 1. Linking of isoprene units for the generation of terpenes. 
 
The terpenoids are classified by the number of isoprene units they comprise (Croteau et 
al., 2000). The C5H8 ‘hemiterpenes’ are the smallest terpenoids consisti g of a single 
isoprene unit. The volatile isoprene is a hemiterpene, and oxygenated derivatives, such as 
prenol, angelic acid and isovaleric acid, are hemitrpenoids found in plants. The C10H16 
terpenes consist of two isoprene units and are calld ‘monoterpenes’. They form the base 
unit from which terpene nomenclature is derived andconsist of a-, mono- and bicyclic 
compounds. The monoterpenes comprise volatiles, such as like linalool, menthol, thymol 
and camphor, that are used as flavors and fragrances (Schwab et al., 2008). The C15H24 
‘sesquiterpenes’ are a-, mono-, bi- or tricyclic compounds derived from the fusion of 
three isoprene units. Sesquiterpenes can also acquire a lactone ring resulting in the 
formation of sesquiterpene lactones, such as artemisinin. The ‘diterpenes’ are C20H32 
compounds derived from the fusion of four isoprene u its. The plant hormone gibberellin 
and the anti-cancer agent taxol belong to this class of terpenoids (Croteau et al., 2000). 
Although rare in plants, the ‘sesterterpenes’ with the molecular formula C25H40 are 
derived from five isoprene units. To date, they have been identified in only two medicinal 
plant genera, Salvia (Moghaddam et al., 2010) and Leucosceptrum (Choudhary et al., 
2004). The ‘triterpenes’ are composed of six isoprene units and are formed by the ‘head-
to-head’ joining of two C15 chains, in which the isoprene units are joined ‘head-to-tail’. 
The resulting C30H48 compounds constitute a large class of molecules, including 
phytosterols, brassinosteroids and saponins. The ‘tetraterpenes’ consist of the well known 
carotenoids with the molecular formula C40H64 and are composed of eight isoprene units. 




They serve as light absorbing accessory pigments in pla ts and have been exploited as 
natural colorants and food additives for their beneficial effects on human health (Rao & 
Rao, 2007). The ‘polyterpenes’ contain more than eight soprene units. The tail of the 
electron carrier ubiquinone or coenzyme Q10 and rubber are polyterpenes. Finally, the 
‘meroterpenes’ include members from the terpenoid in ole alkaloids (TIAs) and 
cytokinins that have mixed origins, but are partially derived from terpenes (Croteau et al., 
2000). In bacteria, a relatively new family of terpnes made up of seven isoprene units 
has been encountered, denominated sesquarterpenes (Sato et al., 2011), but such 
compounds have not been detected in plants yet. 
Despite their enormous structural diversity, terpenoids share a common biosynthetic 
origin and follow similar synthesis routes. The biosynthesis begins with the generation of 
isopentenyl pyrophosphate (IPP), the principal precursor. This is followed by consecutive 
condensation of IPP units to form prenylated pyrophos ates, the immediate precursors 
of the different terpenoid classes. Specific terpenoid synthases (often cyclases) (Chen et 
al., 2011) modify these precursors to terpenoid skeletons, which are subsequently 
decorated by various enzymatic modifications to generate the structural and functional 
diversity of terpenoids. 
In higher plants, the biosynthesis of the central intermediate IPP occurs through two 
distinct pathways, the mevalonate (MVA)/3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) 
reductase pathway and the 2-C-methyl-D-erythritol 4-phosphate (MEP)/1-deoxy-D-
xylulose 5-phosphate (DOXP)/non-mevalonate pathway (Rodríguez-Concepción & 
Boronat, 2002). A clear compartmentalization for the generation of IPP and the synthesis 
of terpenoids exists in plants (Lange et al., 2000). The IPP generated from the MVA 
pathway in the cytosol, peroxisome and endoplasmic reti ulum (ER) is used for the 
biosynthesis of sesqui- and triterpenes (Sapir-Mir et al., 2008; Clastre et al., 2011), 
whereas the plastidic MEP pathway synthesizes IPP for the generation of hemi-, mono-, 
di- and tetraterpenes. Additionally, parts of the isoprenoid pathway have also been 
detected in the mitochondria (Rodríguez-Concepción & Boronat, 2002) (Fig. 2). 





Figure 2. Terpenoid biosynthesis in plants. Two distinct pathways for the synthesis of the 
universal precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate 
(DMAPP) exist in plants: the cytoplasm, peroxisome and endoplasmic reticulum (ER) 
localized mevalonate (MVA) pathway (purple) and the plastid localized methyl erythritol 
phosphate (MEP) pathway (blue). The prenyltransferaes (orange) generate the 
immediate precursors to the different terpene classes (green). Dashed arrows indicate 
multiple reactions. Dotted grey boxes indicate subcellular localization of the pathway. 
Grey arrows indicate metabolites that are transported between subcellular compartments. 
AACT, acetoacetyl-CoA thiolase; CMK, 4-diphosphocytidyl-methylerythritol kinase; 
CMS, 4-diphosphocytidyl-methylerythritol synthase; DXR, deoxyxylulose 5-phosphate 
reductoisomerase; DXS, deoxyxylulose 5-phosphate synthase; FPP, farnesyl 
pyrophosphate; FPPS, FPP synthase; GGPP, geranylgeranyl pyrophosphate; GGPPS, 
GGPP synthase; GPP, geranyl pyrophosphate; GPPS, GPP synthase; HDR, 
hydroxymethylbutenyl 4-diphosphate reductase; HDS, hydroxymethylbutenyl 4-
diphosphate synthase; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; HMGS, 3-
hydroxy-3-methylglutaryl-CoA synthase; IDI, isopentenyl diphosphate isomerase; MDS, 
methylerythritol 2,4-cyclodiphosphate synthase; MVK, mevalonate kinase; PDC, 
pyruvate dehydrogenase complex; PMD, 5-diphosphomevalonate decarboxylase; PMK, 
5-phosphomevalonate kinase; PSY, phytoene synthase; SQS, squalene synthase. 




The MVA pathway begins with a two-step condensation of three acetyl-CoA molecules 
to generate HMG-CoA, which is reduced to MVA that is sequentially phosphorylated in 
an ATP-dependent manner, and finally decarboxylated to generate IPP (Fig. 2). In the 
plastidic MEP pathway, pyruvate and glyceraldehyde-3-phosphate generate the first C5 
intermediate DOXP, which is rearranged and reduced to form MEP that is subsequently 
converted to IPP (Fig. 2). The generated IPP is firt isomerized to its allylic isomer 
dimethylallyl pyrophosphate (DMAPP) at the site of IPP synthesis and in the 
mitochondria. The allylic double bond in DMAPP allows its condensation with IPP to 
yield the C10 intermediate geranyl pyrophosphate (GPP), the precursor for 
monoterpenoids. Subsequent addition of one or two IPP units yields C15 farnesyl 
pyrophosphate (FPP), the precursor for sesquiterpenoids, and C20 geranylgeranyl 
pyrophosphate (GGPP), the diterpenoid precursor, respectively. FPP is the only terpene 
synthesized in the mitochondria and is the precursor for the synthesis of the ubiquinone 
tail (Rodríguez-Concepción & Boronat, 2002). The tri- and tetraterpenoid precursors are 
generated by the fusion of two FPP and GGPP units, respectively. The condensation 
reactions are catalyzed by specific prenyltransferaes and are named according to the 
product they generate. The synthesis of terpenoid skeletons from the prenylated 
precursors and their subsequent modifications are vst and highly specific and are 
reviewed elsewhere (Croteau et al., 2000; Degenhardt et al., 2009; Augustin et al., 2011; 
Hamberger et al., 2011). 
 
Regulation of terpenoid biosynthesis in plants 
The biosynthesis of terpenoids is tightly controlled in plants, since they serve many 
functions in plant growth, development and response to biotic and abiotic environmental 
factors (Tholl, 2006; Nagegowda, 2010; Vranová et al., 2012). Terpenoid synthesis 
occurs within specific tissues or at specific plant developmental stages (Nagegowda, 
2010). For instance, many plant species have glandur trichomes, specialized structures 
for the synthesis of secreted terpenoid natural products (Markus Lange & Turner, 2012). 
Artemisia annua plants synthesize and store artemisinin in specialized glandular 




trichomes on the leaves, stems and inflorescences to prevent autotoxic effects of the 
compound (Duke et al., 1994; Maes et al., 2011). In Arabidopsis thaliana specific floral 
tissues emit volatile terpenoids at particular times of the flowering period, presumably to 
attract pollinators and to defend the flowers against microbial pathogens and herbivores 
(Tholl et al., 2005; Tholl, 2006). Such specific terpenoid synthesis is mainly regulated at 
the transcriptional level (Nagegowda, 2010). For example, the two terpenoid synthase 
genes responsible for the production of the complex mixture of volatile sesquiterpenoids 
in A. thaliana flowers are expressed exclusively in specific flower tissues (Tholl et al., 
2005), and all specialized genes responsible for artemisinin biosynthesis in A. annua are 
highly expressed in the glandular trichomes (Maes et al., 2011). 
Besides this spatiotemporal regulation, induced terpenoid biosynthesis is often observed 
in response to herbivore feeding, pathogen attack or various abiotic stresses (Nagegowda, 
2010; Vranová et al., 2012). For instance, when plants are damaged by herbivorous 
insects, volatile terpenoids that attract carnivorous enemies of the herbivores are 
produced de novo, thereby providing indirect defense to the plants (Paré & Tumlinson, 
1999; Pichersky & Gershenzon, 2002; Degenhardt et al., 2003). Likewise, when white 
pine weevils attack Sitka spruce (Picea sitchensis), the plants respond by forming 
traumatic resin ducts and by increasing the expression of terpene synthase genes, leading 
to the accumulation of oleoresin terpenoids that give direct protection against the weevils 
(McKay et al., 2003; Miller et al., 2005). The increased accumulation or release of 
terpenoids in response to various (a)biotic stresses i  often mediated by an increased 
transcriptional activity of the specific terpenoid biosynthetic genes (Tholl, 2006; 
Nagegowda, 2010). This transcriptional response is controlled by a complex signaling 
cascade in which jasmonate hormones (JAs) play a crucial role. Hence, treatment of 
plants with JAs often causes transcriptional and metabolic changes comparable to 
pathogen or herbivore attack. Similar to the white pine weevil attack, the expression of 
terpenoid synthase genes strongly increases and traumatic resin ducts accumulate when 
Sitka spruce plants are treated with methyl jasmonate (MeJA) (Miller et al., 2005). 
The concerted transcriptional activation of entire secondary metabolic pathways by JAs is 
conserved across the plant kingdom. However, downstream of the conserved JA 




perception and initial signaling cascade, species-sp cific transcriptional machineries that 
regulate the transcriptional activity of the specific biosynthetic genes exist (Pauwels t 
al., 2009; Pauwels & Goossens, 2011; De Geyter e  al., 2012). Several transcription 
factors regulated by the JA signaling cascade that activate the transcription of terpenoid 
biosynthetic genes have already been characterized (D  Geyter et al., 2012). The JA–
inducible cotton (Gossypium arboreum) WRKY1 transcription factor activates the 
promoter of the CAD1-A gene, which encodes the sesquiterpene (+)-δ-cadinene synthase, 
that catalyzes the first committed step of gossypol bi synthesis (Xu et al., 2004). 
Similarly, the AP2/ERF transcription factors AaERF1 and AaERF2 are JA-responsive 
and induce the transcription of genes encoding amorpha-4,11-diene synthase (ADS) and 
CYP71AV1, 2 key enzymes of the artemisinin biosynthetic pathw y (Yu et al., 2012). 
Jasmonates are important, but definitely not the only regulators of terpenoid metabolism 
in plants. For instance, when white pine weevils attack Sitka spruce, there is a higher 
accumulation of traumatic resin ducts and a more complex terpenoid emission profile, as 
compared to MeJA-treated plants (Miller et al., 2005). Indeed, the plant’s defense is often 
regulated by a complex cross-talk between various signaling cascades in which next to 
JAs, abscisic acid, salicylic acid and ethylene play important roles (De Vos et al., 2005). 
As such, together with specific attacker-induced signals, plants can generate defense 
responses that are adapted to the different attackers th y have to face (De Geyter et al., 
2012). 
Many terpenoids also play an essential role in plant growth and development as 
phytohormones, accessory pigments and building blocks f cellular components. Hence, 
also their biosynthesis is strictly regulated. For instance, the high expression of 
gibberellin biosynthetic genes in plant tissues is correlated with a strong accumulation of 
active gibberellins, and several transcription factors involved in the developmental 
regulation of gibberellin biosynthesis have been characterized (Hedden & Thomas, 
2012). 
Besides the transcriptional, developmental and spatiotemporal modulation of terpenoid 
biosynthetic genes, post-translational regulatory mechanisms also exist in terpenoid 




biosynthesis. For instance, in addition to the transcriptional control of a key gibberellin 
biosynthetic enzyme, the gibberellin levels in developing A. thaliana embryos are 
maintained at low levels by the oxidative inactivation of the hormone by the enzyme 
gibberellin 2-oxidase, the transcription of which is stimulated by the MADS domain 
transcription factor AGL15 (Wang et al., 2004). The activity of HMGR, the enzyme that 
catalyzes the key regulatory step of the MVA pathway, is controlled at the protein level 
via dephosphorylation of the enzyme through the action of protein phosphatase 2A 
(Leivar et al., 2011). 
 
Bioengineering of terpenoids in planta 
Because of their strict regulation, most terpenoids are produced in very low amounts in 
their natural sources. The low yield makes extraction expensive, which is eventually 
reflected in their market value. Taxol, for instance, osts $300,000/kg (Expósito et al., 
2009). Consequently, there is a wide gap between demand and supply of terpenoids, 
which hampers their widespread application. The classic l approach to ensure a constant 
or improved yield is by selecting and propagating hi h-producing cultivars or by 
producing (transgenic) plant (cell) cultures (Georgiev et al., 2009; Lim & Bowles, 2012; 
Wilson & Roberts, 2012). Additionally, the use of elicitors (Zhao et al., 2005; 
Khosroushahi et al., 2006; Lambert et al., 2011), optimization of culturing conditions 
(Cusidó et al., 2002) and addition of precursors (Lee-Parsons & Royce, 2006) has been 
implemented to increase productivity. Our growing understanding of terpenoid 
biosynthesis, regulation and accumulation, together with the development of functional 
genomics and systems biology toolkits, has enabled m tabolic engineering of whole 
plants and plant cell cultures to enhance productivity and also alter terpenoid distribution 
in planta (Aharoni et al., 2006; Roberts, 2007; Dudareva & Pichersky, 2008). 
Since terpenoid biosynthesis is strictly regulated and often controlled by specific 
transcription factors, one way of increasing productivity is by modulating the expression 
of such or other regulatory factors (Broun, 2004; De Geyter et al., 2012). For example, 




overexpression of the transcription factors AaERF1 and AaERF2 leads to an increased 
accumulation of artemisinin in transgenic A. annua plants (Yu et al., 2012). However, in 
spite of the identification of transcription factors that steer the biosynthesis of terpenoids, 
overexpression of a single transcription factor often does not lead to a higher production 
of the compounds. For instance, overexpression of ORCA3, an AP2/ERF transcription 
factor that controls the expression of several TIA biosynthetic genes, is not sufficient to 
induce TIA production in C. roseus cell cultures, indicating that only a part of TIA 
biosynthesis is under the control of this transcription factor (van der Fits & Memelink, 
2000). Hence, further elucidation of the complex signaling cascades that lead to an 
increased accumulation of terpenoids is mandatory for large-scale metabolic engineering 
of terpenoid production by using transcription factors. 
A second way to increase productivity is by specifically overexpressing the rate-limiting 
enzymes in the pathway. Overexpression of genes encoding such enzymes, like HMGR, 
deoxyxylulose 5-phosphate synthase (DXS) and prenyltransferases, has been used to 
elevate terpenoid levels in plant tissue cultures (Degenhardt et al., 2003). For instance, 
expression of a C. roseus HMGR and the native ADS gene in A. annua plants enhanced 
artemisinin production by over 7.5-fold to 1.73 mg/g of dry weight (Alam & Abdin, 
2011). Enhanced terpenoid production has also been observed upon alteration of the 
subcellular localization of enzymes, presumably resulting from the uncoupling of 
biosynthesis and regulation (Bouwmeester, 2006; Kumar et al., 2012). For instance, 
expression of an avian farnesyl pyrophosphate synthase (FPPS) gene and A. annua ADS 
in plastids of tobacco (Nicotiana tabacum) resulted in a 1000-fold increase in amorpha-
4,11-diene production than when the same enzymes were targeted to the cytosol (Wu et 
al., 2006). Similarly, eight times more artemisinin accumulated in transgenic N. tabacum 
plants expressing truncated yeast HMGR and A. annua ADS, CYP71AV1, cytochrome 
P450 monooxygenase (CytP450) reductase (CPR) and artemisinic aldehyde reductase 
(DBR2) when the A. annua ADS was targeted to the mitochondria rather than to the 
cytosol (Farhi et al., 2011). 
Besides enhancing terpenoid production, in planta engineering has also been used as a 
tool to modulate the terpenoid composition of plants. By employing heterologous gene 




expression and native gene knock down strategies, staple crops like rice, maize, potato, 
carrot, tomato and canola have been engineered for β-ca otene accumulation to increase 
their nutritional value (Farré et al., 2011). Similarly, potato tubers have been engineered 
to accumulate high levels of the sesquiterpene flavor volatile α-copaene (Morris et al., 
2011). The different strategies and tools available for in planta engineering and 
production of biomolecules with respect to their cost-effectiveness have been 
summarized elsewhere (Wilson & Roberts, 2012). 
Contrary to sesqui-, tetra- and meroterpenoids, in planta triterpenoid (particularly 
saponin) engineering has been hampered by the lack of knowledge about regulatory 
mechanisms controlling gene expression and the tissue- or organ-specific nature of its 
accumulation (Sawai & Saito, 2011). Hence, a challenge for future saponin research will 
be to identify the transcription or other regulatory factors that steer their biosynthesis. 
Only a single study reports on an attempt to engineer g triterpene synthesis in tobacco 
by the heterologous expression of an avian FPPS and a yeast squalene synthase (SQS) 
gene targeted to the cytoplasm or plastid. No differences in squalene accumulation 
caused by specific targeting of the enzymes have been observed but comparison of 
transgenic tobacco plants expressing the same genes driven by a constitutive viral 
promoter or a trichome-specific promoter revealed higher squalene accumulation, 
accompanied by negative effects on plant growth and physiology, in case the enzymes 
were directed to the trichomes (Wu et al., 2012). Nonetheless, this study underscored the 
potential of engineering triterpenoids in planta by relocation of the biosynthetic pathway 
and enhancement of the precursor flux, and encourages future research on this terpenoid 
class. 
 
Heterologous biosynthesis and engineering of plant erpenoids in 
microbial hosts 
Compared to plant production systems, microorganisms are attractive alternatives as 
heterologous hosts because of their rapid doubling t me, robustness under process 




conditions, ease of scalability, simplicity of product purification due to the absence of 
competing contaminants and cost-effectiveness resulting from the conversion of 
inexpensive feedstock to valuable compounds (Zhang et al., 2011). The choice of a 
suitable host (or “chassis”) is critical and should be based on multiple factors, including 
the chemical nature and complexity of the product to be synthesized, the genetic 
amenability of the host, the intrinsic availability of precursors for product biosynthesis, 
the codon usage bias of the host, the need for post-translational modifications and the 
feasibility to metabolically engineer the host to bost productivity (Keasling, 2010). 
Microbial synthesis of any plant natural product can be achieved by ‘precursor-mediated 
product synthesis’, where an existing host pathway is altered to incorporate a 
heterologous pathway, or by ‘de novo synthesis’, where new-to-host biosynthetic routes 
are imported, thereby avoiding feedback regulation (Chang & Keasling, 2006). After 
establishing heterologous synthesis, it is usually imperative to metabolically engineer the 
host to optimize production yield and rate (Chemler & Koffas, 2008). 
The colloquial hosts Escherichia coli and Saccharomyces cerevisiae have been employed 
for both precursor-mediated and de novo synthesis of mono-, di-, sesqui-, tri- and 
tetraterpenes (Misawa, 2011). The prokaryotic E. oli has an inherent MEP pathway and 
the eukaryotic S. cerevisiae has the MVA pathway to produce IPP and its isomer 
DMAPP. Theoretically, terpenoid biosynthesis can be incorporated into these hosts by 
expressing the corresponding genes, but low yields may be obtained because of the 
limited intracellular IPP pool (Carter et al., 2003). The rate-limiting nature of the 
reactions catalyzed by dxs and dxr in E. coli (Rodríguez-Concepción & Boronat, 2002) 
and HMGR in S. cerevisiae (Gardner & Hampton, 1999) controls the IPP production. The 
IPP and subsequent precursor levels have been supplemented by metabolic engineering 
of (1) the MVA pathway in E. coli (Campos et al., 2001), (2) the MEP pathway and 
prenyltransferases in E. coli (Kajiwara et al., 1997), (3) the MVA pathway by a feedback-
regulation deficient HMGR in S. cerevisiae (Ro et al., 2006), (4) the MVA pathway by 
decreasing downstream enzymes to accumulate precursors in S. cerevisiae (Paradise et 
al., 2008), (5) the global transcription factor regulating sterol biosynthesis in S. cerevisiae 




(Davies et al., 2005) and (6) protein scaffolds for the MVA pathway in S. cerevisiae 
(Dueber et al., 2009) (Fig. 3). 
 
 
Figure 3. Strategies employed to enhance the production of IPP and terpenoids thereof, 
in E. coli and S. cerevisiae. (a) Expression of the S. cerevisiae MVA pathway in E. coli. 
(b) Expression of rate-limiting MEP enzymes in E. coli. (c) Expression of a truncated 
copy of HMGR in S. cerevisiae. (d) Downregulation of endogenous sterol biosynthesis to 
accumulate terpenoid precursors in S. cerevisiae. (e) Expression of a mutant version 
(upc2-1) of the global transcription factor (UPC2) regulating sterol biosynthesis in S.
cerevisiae upregulates expression of native sterol biosynthesis. (f) Protein scaffolding to 
prevent rate-limitation in S. cerevisiae by spatially organizing rate-limiting sterol 
biosynthetic enzymes in a modulated ratio. 
 




Alongside targeted engineering, global approaches have been applied to improve the 
terpenoid pathway flux in microbial hosts. A ‘chromsomal promoter engineering’ 
strategy was used to express some of the endogenous MEP genes from a strong 
bacteriophage T5 promoter in an E. coli strain harboring β-carotene biosynthetic genes, 
resulting in the enhanced production of β-carotene compared to the parental strain (Yuan 
et al., 2006). Similarly, a ‘global transcription machinery engineering’ (gTME) on the 
rpoD gene encoding σ70, the primary sigma factor, resulted in an increased lycopene 
production in E. coli (Alper & Stephanopoulos, 2007). In this case, a single gTME 
perturbation outperformed the traditional engineering strategies. Furthermore, the order 
of gene assembly in a synthetic zeaxanthin operon in E. coli influenced the expression of 
each gene based on its distance from the promoter (Nishizaki et al., 2007). 
Once precursor synthesis has been optimized, another major hurdle to overcome is to 
achieve functional expression of the pathway genes downstream of the precursor, 
particularly CytP450s. Plant CytP450s are ER membrane localized enzymes with a 
prerequisite for a CPR partner for efficient functioning (Podust & Sherman, 2012). The 
CPRs are also ER membrane localized electron donor proteins that mediate electron 
transfer from a cofactor, like NADPH, to the CytP450. In this regard, S. cerevisiae, with 
its native CytP450s and CPR, has an advantage over E. coli for the expression of 
complex terpenoid pathways (Hamann & Møller, 2007). Nevertheless, plant CytP450s 
supplemented with a plant CPR have been successfully expressed in both E. coli and S. 
cerevisiae (Arsenault et al., 2008). 
Two pioneering examples of microbial metabolic engineering for the production of 
terpenoids are artemisinin (Fig. 4a) and taxol (Fig. 4b). Artemisinin-based combination 
therapy (ACT) has been recommended by the World Health Organisation (WHO) as the 
first line therapy for the treatment of malaria. Artemisinin (Fig. 5a) kills the majority of 
the parasites at the beginning of infection and the slowly released partner drugs kill the 
remaining parasites, thus preventing the emergence of artemisinin-resistant Plasmodium 
falciparum. The global procurement of ACT increased by 14.5% in 2010 as compared to 
2009 (WHO, 2011), reflecting the constant demand for higher amounts of the drug, 
which is still extracted from a plant source and hence is prone to fluctuations in yearly 




harvest and market price. Microbial production is considered as a valid alternative to 
stabilize the price of artemisinin and to meet its clinical demand. Furthermore, semi-
synthesis of microbially produced intermediates is po sible. In precursor engineered S. 
cerevisiae, production of 153 mg/l amorpha-4,11-diene (Ro et al., 2006) and 2.5 g/l 
artemisinic acid under optimized fermentation conditions has been achieved (Lenihan et 
al., 2008). The amount of artemisinic acid produced by engineered S. cerevisiae in 4-
5 day fermentations is comparable to that obtained from several month-old A. annua 
plants. Additionally, S. cerevisiae secretes artemisinic acid into the growth medium, 
facilitating purification and economizing the production pipeline (Zeng et al., 2008). In 
an isoprenoid-optimized E. coli strain, under carbon- and nitrogen-depleted fermentative 
conditions, 27.4 g/l of amorpha-4,11-diene has been produced (Tsuruta et al., 2009). The 
highest titer of amorpha-4,11-diene observed thus far, 41 g/l, was produced in S. 
cerevisiae CEN.PK2 by upregulating the MVA pathway and downregulating ergosterol 
synthesis (Westfall et al., 2012). Hence, these two microbial-based cell factories are 
promising alternatives to meet the market demand for artemisinin. 
 
 
Figure 4 Chemical structures of (a) artemisinin, (b) taxol and (c) bisabolane. 
 
Production of the diterpenoid taxol (paclitaxel) has also been extensively engineered in E. 
coli and S. cerevisiae. Taking advantage of the characterization of a fewbiosynthetic 
genes (Fig. 5b) (Heinig & Jennewein, 2009), taxol production employing metabolically 
engineered E. coli (Liu & Khosla, 2010) and S. cerevisiae (Engels et al., 2008) was 
attempted. In the first endeavor, eight biosynthetic genes were expressed in S. cerevisiae, 




resulting in the production of 1 mg/l taxadiene and 25 µg/l taxadien-5α-ol. The low yields 
and failure to detect taxadien-5α-yl acetate or taxadien-5α,10β-diol monoacetate 
indicated a pathway restriction (Dejong et al., 2006). Expression of a codon-optimized 
taxadiene synthase (TS) in a precursor-optimized S. cerevisiae, resulted in the 
accumulation of 8.7 mg/l taxadiene and 33.1 mg/l geranylgeraniol, suggesting room for 
further improvement (Engels et al., 2008). Simultaneously, E. coli was engineered using 
a ‘multivariate-modular pathway engineering’ approach resulting in the production of 
300 mg/l taxadiene (Ajikumar et al., 2010). Here, the taxol biosynthetic pathway was 
first subdivided into modules and the expression of genes in each module was varied 
simultaneously to obtain an optimal expression balance or maximal taxadiene output. In a 
controlled fed-batch fermentation, this strain produced 1 g/l taxadiene, leaving room for 
further improvement by optimizing fermentation conditions. Additionally, 
overexpression of a codon-optimized translational fusion chimeric enzyme of taxadiene 
5α-hydroxylase and the CPR partner from T. cuspidata in this E. coli strain resulted in the 
conversion of 98% of the taxadiene to 58 mg/l taxadien-5α-ol and the byproduct 
5(12)-oxa-3(11)-cyclotaxane. However, taxadiene production in this strain was much 
lower than that of the parental strain, emphasizing the need for further engineering to 
boost productivity (Ajikumar et al., 2010). 
A more recent example of microbial biosynthesis of plant terpenoids is bisabolane 
(Fig. 4c), an alternative to D2 diesel fuel. Through a combination of enzyme screening 
and metabolic engineering of FPP-overproducing E. coli and S. cerevisiae, strains 
producing over 900 mg/l of the sesquiterpene bisabolene were engineered. The 
biosynthesized precursor bisabolene is then chemically hydrogenated to the advanced 
biofuel bisabolane (Peralta-Yahya et al., 2011). 
S. cerevisiae has also been employed for the expression of triterpenoid saponin 
biosynthetic genes. Although triterpenoids constitute a diverse class of compounds, their 
biosynthesis is generally catalyzed by three sets of enzymes, the oxidosqualene cyclases 
(OSCs), CytP450s and UDP-dependent glycosyltransfera es (UGTs). Through its native 
ergosterol biosynthesis, S. cerevisiae produces oxidosqualene, the precursor of saponins. 
In engineered strains optimized to accumulate oxidosqualene, different OSCs and 




CytP450s have been expressed, mainly for their functional characterization (Augustin et 
al., 2011) (Fig. 6). 
 
 
Figure 5. Biosynthetic pathway for, (a) Artemisinin and (b) Taxol. Dashed arrows 
indicate multiple steps. Highlighted enzymes (red) and compounds (blue) have been 
expressed and detected, respectively in E. coli and/or S. cerevisiae. ADS, amorpha-4,11-
diene synthase; ALDH1, aldehyde dehydrogenase 1; CPR, cytochrome P450 reductase; 
CYP71AV1, amorpha-4,11-diene monooxygenase; BAPT, C-13-phenylpropanoyl-CoA 
transferase; DBAT, 10-deacetylbaccatin III-10-O-acetyltransferase; DBR2, artemisinic 
aldehyde ∆11(13) double-bond reductase; DBTNBT, 3’-N-debenzoyl-2’-deoxytaxol N-
benzoyl transferase; DMAPP, dimethylallyl pyrophosphate; FPP, farnesyl 
pyrophosphate; FPPS, FPP synthase; GGPP, geranylgeranyl pyrophosphate; GGPPS, 
GGPP synthase; IPP, isopentenyl pyrophosphate; IDI, isopentenyl isomerase; TAT, 
taxadiene-5α-O-acetyltransferase; TBT, taxane-2α-O-benzoyltransferase; THY5α, 
taxadiene-5α-hydroxylase; THY10β, taxane-10β-hydroxylase; THY13α, taxane-13α-
hydroxylase; TS, taxadiene synthase. 




However, engineering efforts have been limited to the production of β-amyrin only. 
Through a conventional pathway engineering approach,  50% improvement in the 
production of β-amyrin with a final titer of 6 mg/l was demonstrated in a S. cerevisiae 
strain expressing a β-amyrin synthase (bAS) from A. annua (Kirby et al., 2008). 
Subsequent to a genotype-to-phenotype linking study, a 500% improvement in β-amyrin 
production was achieved by overexpressing three native genes in a S. cerevisiae strain 
expressing a Pisum sativum bAS, resulting in a final titer of 3.93 mg/l (Madsen t al., 
2011). The β-amyrin levels produced by the parent strains in the above reports reflect the 
cyclization efficiency of the enzymes employed. Therefore, by employing a more 
efficient bAS (or any other saponin biosynthetic gene), followed by targeted and/or global 
engineering, it should be possible to further enhance β-amyrin (or triterpenoid) levels. 
 
Combinatorial biosynthesis of terpenoids 
Plants are a rich source of structurally diverse biomolecules with therapeutic potential. 
Many of these therapeutics, particularly those used in the treatment of infectious diseases, 
are susceptible to development of acquired resistance. For instance, resistance against 
artemisinin easily develops when used as the sole treatment (WHO, 2011). Similarly, 
many anti-bacterials are rapidly losing their therap utic value because of the emergence 
of single and multi-drug resistant bacterial strains (Levy & Marshall, 2004). Likewise, 
many cancers are prone to acquire resistance to commonly used anti-cancer drugs 
(Gottesman, 2002). Additionally, there are still many clinical targets for which effective 
drugs have not been developed, such as influenza, polio and many types of cancers. 
Hence, despite the chemical diversity of biologically ctive compounds from plants and 
other organisms, there is a great demand for novel molecules. One way of fulfilling this 
demand is by generating ‘natural product analogs’, in which the majority of the biological 
functionality of the starting molecule is retained. 





Figure 6. A simplified scheme of triterpenoid saponin biosynthesis as expressed in S. 
cerevisiae. Dashed arrows indicate multiple steps. Highlighted nzymes (red) and 
compounds (blue) were expressed and detected, respectively. aAS, α-amyrin synthase; 
As, Avena strigosa; bAS, β-amyrin synthase; CAS, cycloartenol synthase; Cr, 
Catharanthus roseus; DDS, dammarenediol synthase; Gm, Glycine max; Gu, Glycyrrhiza 
uralensis; LAS, lanosterol synthase; LUP, lupeol synthase; Mt, Medicago truncatula; Pg, 
Panax ginseng; SHC, squalene-hopane cyclase; SQE, squalene epoxidase; Vv, Vitis 
vinifera. 




Natural product scaffolds exhibit a broad diversity in chemical space (Grabowski et al., 
2008). Hence, the generation of ‘lead-like’ natural products (or analogs), inspired by 
existing privileged scaffolds in the bioactive chemical space, is encouraging because of 
the predictive knowledge about their absorption, distribution, metabolism, excretion and 
toxicity (ADMET) properties (Norinder & Bergström, 2006; Hong, 2011). 
Combinatorial biosynthesis-based reconstitution of pathways is a useful tool to generate 
known and novel natural products, which can be further modified by semi-synthesis. In 
its simplest form, combinatorial biosynthesis is the process of generating different but 
structurally related molecules, in a short span of time, through the assembly of genes 
from different organisms in a single host (Kirschning et al., 2007) (Fig. 7a). Plants 
possess an immense potential for combinatorial biosynthesis (Pollier et al., 2011). For 
instance, expression of a bacterial halogenase in C. roseus resulted in the generation of 
novel chlorinated TIAs in the plant (Runguphan et al., 2010). However, to date there 
have been no reports on the combinatorial biosynthesis of any other terpenoid (or any 
secondary metabolite) in plants. Nonetheless, the existing chemical diversity together 
with our growing understanding of their biosynthesis, renders terpenoids appealing 
compounds for the combinatorial generation of novel analogs. For instance, the screening 
of a synthetic triterpenoid combinatorial library derived from betulinic and ursolic acid, 
led to the identification of compounds with an enhanced anti-malarial activity compared 
to the parent compounds (Pathak et al., 2002). 
Combinatorial biosynthesis of triterpenoid saponins holds great potential, as they exhibit 
a plethora of biological activities. For instance, the soluble Quillaja saponin fraction QS-
21 is a potent vaccine adjuvant (Sun et al., 2009) and the semi-synthetic derivative of 
oleanolic acid, bardoxolone methyl, has been subject of linical trials for the treatment of 
chronic kidney disease. The synthesis of bardoxolone methyl occurs through chemical 
modifications of the three active portions of oleanolic acid. These modifications render 
the derivative biologically more potent than the starter molecule (Sporn et al., 2011). The 
enzymatic addition of extra functionalities on the riterpene backbone could increase the 
number of sites that can be accessed for further synthetic modifications (Pollier & 
Goossens, 2012). These reactive moieties could be rationally engineered on the triterpene 




backbones to generate unnatural compounds using combinatorial biosynthesis in S. 
cerevisiae, to ensure the efficient expression of CytP450s. 
A major drawback of generating novel molecules in planta lays in the complexity of 
plant metabolite extracts and the complications of purifying a compound of interest from 
a large pool of different molecules, including compounds with similar structure and 
physicochemical properties. Therefore, combinatorial b osynthesis of plant secondary 
metabolites has also been performed in microorganisms, which lack the production of 
compounds similar to the target compound (Julsing et al., 2006) (Fig. 7b). Novel 
carotenoid structures with an enhanced antioxidative activity have been generated in E. 
coli by the combinatorial expression of bacterial and plant genes (Sandmann, 2002). To 
date, this is the only report on the combinatorial b osynthesis of plant-derived terpenoids 
in microbes. A probable obstacle to the wider utilization of combinatorial biosynthesis 
could be the missing information about many pathway genes encoding the enzymes that 
catalyze the biosynthetic reactions. Ways to solve this bottleneck include programs for 
gene discovery in medicinal plants by means of the next-generation sequencing platforms 
(Fox et al., 2009) or for directed evolution of enzymes towards a particular (novel) 
function (Kwon et al., 2012). 
 
Enzyme engineering or directed evolution of terpenoid biosynthetic 
enzymes 
Small molecule drugs, considered relevant as lead molecules, often have a high degree of 
chemical complexity with multiple functional groups and defined stereochemistry 
(Nannemann et al., 2011). In their natural source these small molecules are most often 
synthesized by enzymes that have a high regio- and stereoselectivity, a high catalysis rate 
and a relaxed substrate specificity. Nonetheless, natural enzymes often cannot meet the 
requirements of industrial chemists in terms of substrate tolerance, efficiency, process 
tolerance and economical viability. 





Figure 7. Strategies to generate novel triterpenoid saponins. (a) Combinatorial 
biosynthesis in the model legume Medicago truncatula which produces 3-Glc-28-Glc-
medicagenic acid. The overexpression of CYP88D6, a cytochrome P450 monooxygenase 
from Glycyrrhiza uralensis roots which produces glycyrrhizin, in M. truncatula could 
lead to the formation of a combinatorial product 3-Glc 28-Glc-11-oxo-medicagenic acid 
along with the naturally occuring saponins. (b) Combinatorial biosynthesis of saponins in 
a sterol reduced S. cerevisiae by the heterologous expression of saponin biosynthetic 
genes from M. truncatula and G. uralensis. (c) The process of directed enzyme evolution 
involves mutagenesis and selection for desired enzyme properties. Here, the evolution of 
a multifunctional enzyme to increase its reaction specificity is depicted. Glc, glucose; 
GlcUA, glucuronic acid. MtbAS, M. truncatula β-amyrin synthase, MtCytP450s, M. 
truncatula cytochrome P450 monooxygenases; UGT, UDP-glucosyltransferase. 
 




Hence, enzymes have been engineered by directed evolution to improve one or more of 
their properties under defined conditions (Dalby, 2011). In the last few years, directed 
enzyme evolution has progressed tremendously, and it is now feasible to engineer 
enzymes to accept unnatural substrates and catalyze regio- and stereospecific reactions 
with an efficiency comparable to that of the natural enzymes (Goldsmith & Tawfik, 
2012). Directed evolution mimics the process of natural evolution and employs a set of 
methodologies to enhance or modify the function of a progenitor enzyme to accept an 
unnatural substrate or to catalyze a new biosynthetic r action (Dalby, 2011; Nannemann 
et al., 2011) (Fig. 7c). 
The promiscuous nature of proteins gives them an inherent ability to generate novel or 
altered functions with a small number of amino acid substitutions (Aharoni et al., 2005), 
and computational methods like computational methods like catalytic active site 
prediction (CLASP, (Chakraborty et al., 2011)) and directed evolution using CLASP: an 
automated flow (DECAAF, (Chakraborty, 2012)) utilize virtual screening for spatial, 
electrostatic and scaffold matching to identify target progenitor proteins. Enzymes 
catalyzing branch-point reactions in multi-branched pathways, in which a substrate is 
converted to multiple products, have a high evolvabi ity. Additionally, evolvable 
enzymes exhibit multiple mutational residues and are ‘locally-specific’ as they recognize 
a common motif on structurally diverse substrates (Umeno et al., 2005). 
In terpenoid biosynthesis, carotenoid biosynthetic genes have been evolved to generate 
novel natural product analogs. Random mutagenesis of carotenoid desaturases and 
subsequent expression in E. coli resulted in their acceptance of an unnatural C35
carotenoid backbone to generate colonies with a spectrum of colors (Umeno & Arnold, 
2003). Following a site-saturation mutagenesis to generate a library of all possible 
mutations at given sites, the specificity of a caroten id synthase was altered to generate 
unnatural C45 and C50 backbones in E. coli (Umeno & Arnold, 2004). Directed evolution 
also served as a tool to define the product specificity of a sesquiterpene synthase 
expressed in E. coli. A γ-humulene synthase from Abies grandis that cyclizes FPP to 52 
different sesquiterpenes was evolved by site-saturation mutagenesis of its promiscuous 
active site, to generate seven independent synthases, each producing one or a few 




products derived from a predominant reaction pathway. Four of the seven generated 
synthases were new-to-nature, emphasizing the possibility of exploring novel structures 
from highly promiscuous natural enzymes (Yoshikuni et al., 2006). 
Oxidosqualene, the immediate precursor of triterpenoid biosynthesis is a versatile 
molecule that is cyclized into multiple products by different OSCs. Several of these OSCs 
are multifunctional in nature and generate multiple products in a single reaction (Phillips 
et al., 2006), highlighting the promiscuity, thus evolvability of the enzymes. Through 
directed evolution, the major cyclization product of a multifunctional OSC could be 
redefined to a specific or novel product. This evoluti n approach could also be extended 
to downstream enzymes, in particular the CytP450s. Triterpene saponin backbones 
constitute of 30 carbons, of which approximately 20 are accessible for CytP450-mediated 
modifications, as deduced from known saponins (Dinda et al., 2010). Additionally, 
diverse functional groups are observed at the modifiable carbons pointing to the existence 
of specific CytP450s that catalyze these highly specific reactions. For instance, the C-11 
position of many triterpene backbones can be oxidized with either an α- or β-hydroxyl 
group. The CytP450 specifically catalyzing the α-hydroxylation at C-11 (CYP88D6) has 
already been characterized (Seki t al., 2008). This implies that CytP450s that attack the 
C-11 position have naturally evolved to target the same substrate, but catalyze distinct 
reactions. To date, only seven CytP450 families involved in triterpene modifications have 
been identified (Fig. 6). Through directed evolution it should be possible to (a) broaden 
their substrate acceptance to divergent backbones, (b) target specific carbon positions and 
(c) specify the functional group to be added to the trit rpene skeleton. Understanding the 
sequence-to-structure-to-function relationships is key for directed evolution studies. 
Integrated databases of triterpene cyclases (TTCED, Racolta et al. (2012)) and CytP450s 
(CYPED, Sirim et al. (2009)) facilitate the identification of functionally relevant and 
selectivity-determining amino acid residues, within members of a protein family by 
extensive sequence analysis. 
Next to the generation of novel molecules, directed evolution of enzymes can also be 
applied to enhance enzyme efficiency or to abolish feedback regulation on enzymes. For 
instance, adaptive evolution was employed to engineer two enzymes, HMGR and γ-




humulene synthase, by minimizing their unfavorable in vivo properties for optimal 
functioning in E. coli and thereby improving the product flux (Yoshikuni et al., 2008). In 
another report, the expression of a Solanum lycopersicum 4-coumarate:CoA ligase, which 
had been directly evolved to remove allosteric feedback inhibition by naringenin, resulted 
in an enhanced flux through the phenylpropanoid pathw y in S. cerevisiae (Alberstein et 
al., 2012). A similar approach could be applied to triterpenoid biosynthetic genes to 
increase the exogenous production of desired compounds. 
 
Engineering of terpenoid production via in vivo synthetic biology 
Synthetic biology (SB) is the redesigning of complex natural living systems in a rational 
and systematic way to simplified, predictable and controllable modules that can be 
modeled and manipulated to generate industrially scalable systems with a defined 
purpose. A simplified SB framework constitutes of computational designing and 
modeling, followed by experimental synthesis and analysis of a microbial host (Fig. 8a). 
SB aims at making metabolic engineering uniform for any goal and eliminates multiple 
cycles of trial and error for the generation of robust producers in a short time and cost 
effective manner (McArthur & Fong, 2010). To complement metabolic engineering, SB 
offers a plethora of tools through the generation of minimal hosts, standard biological 
parts, regulatory elements, vectors, assembly methods and in silico computer-aided 
design tools. 
The first and main requirement for the production of any natural product is the 
availability of a robust host. SB facilitates the gneration of ‘minimal hosts’ that contain 
only genes essential for their growth to synthesize macromolecules from simple and 
inexpensive feedstock. Minimal hosts of E. coli have been generated with about 15% 
genome reduction by the deletion of non-essential genes (Pósfai et al., 2006). Similarly, 
for S. cerevisiae, the synthetic yeast genome project Sc2.0 aims at designing fully 
synthetic minimized hosts without transposable elemnts and telomeric sequences, with 
relocated tRNAs and with site-specific recombination sites incorporated in the genome. 




Two partially synthetic S. cerevisiae chromosomes synIXR and semi-synVIL with 
genome reductions of 20.3% and 15.7%, respectively, were generated and successfully 
incorporated into the yeast (Dymond et al., 2011). Likewise, the Streptomyces avermitilis 
linear chromosome was reduced to 81.46% of the wild-type chromosome by stepwise 
deletion of a region of >1.4 Mb, including genes coding for the synthesis of all 
endogenous secondary metabolites. This minimized strain produced 10-30 µg/ml of 
amorpha-4,11-diene upon expression of a synthetic codon-optimized A. annua ADS 
(Komatsu et al., 2010). Additionally, the feasibility of generating completely artificial 
synthetic hosts with a desired set of genes has been d monstrated by the cloning of a 
chemically synthesized and assembled Mycoplasma genitalium genome in S. cerevisiae 
(Gibson et al., 2008). 
Most often metabolic engineering focuses on maximizing the production of a final 
compound with less attention to the behavior of intermediates. This approach makes 
engineering time-consuming, laborious and unextendable to other products. SB on the 
other hand begins with the deconvolution of metabolic pathways to independent parts that 
are optimized for host-specific expression, and are subsequently incorporated in a rational 
bottom-up approach to build elegant production modules. The repositories of functional 
parts (promoters, ribosomal binding sites, protein domains, terminators, etc.) generated 
within SB initiatives facilitate the assembly of metabolic pathways (Boyle & Silver, 
2012). Two depositories with codon-optimized parts for pathway engineering in E. coli 
(The Registry of Standard Biological Parts, partsregistry.org/Main_Page) and terpene 
engineering in S. cerevisiae (Serber et al., 2012) have been described. SB also promotes 
variable expression of related biosynthetic genes to avoid metabolic bottlenecks. Robust 
synthetic promoter libraries with defined promoter st engths enable modular gene 
expression in bacteria and yeast (Hammer et al., 2006; Nevoigt et al., 2006; Hartner et 
al., 2008; Blazeck et al., 2011). Tunable intergenic regions that generate mRNA 
secondary structures and RNase recognition sites have also been employed for 
differential stabilization of segments of mRNA encoding multiple enzymes in the form of 
operons (Pfleger et al., 2006). Alternatively, synthetic protein scaffolds that are 
particularly efficient in overcoming rate-limiting steps, have been generated to increase 




flux through metabolic pathways by tethering enzymes together (Dueber et al., 2009). 
Several of these SB approaches resulted in an enhanced amorpha-4,11-diene production 
by over a million-fold in E. coli (Keasling, 2012). 
Natural product biosynthesis typically involves multigene pathways, thus implementing 
the necessity for simultaneous expression of multiple genes in a microbial chassis in an 
SB program. Both in vitro and in vivo methods facilitate multigene assembly in E. coli 
and S. cerevisiae (Ellis et al., 2011; Wang et al., 2012), some of which have been 
employed to assemble terpenoid biosynthetic pathways. For instance, using the λ-Red 
recombinase-based recombineering technique eight astaxanthin synthetic genes were 
successfully integrated in E. coli (Lemuth et al., 2011). In S. cerevisiae, the DNA 
assembler method, based on in vivo homologous recombination, was used to integrate an 
eight-gene zeaxanthin pathway (Shao et al., 2009). In parallel, viral mechanisms, such as 
internal ribosome entry site (IRES) and 2A oligopeptide sequences have been adapted for 
polycistronic gene expression (de Felipe, 2002). IRES are ≥500 bp elements which allow 
initiation of translation in the middle of the mRNA in a 5’ cap-independent manner 
(Hellen & Sarnow, 2001). When this sequence is inserted between protein coding 
elements, the genes are translated independently, facilitating the expression of multiple 
genes from a single promoter. However, the size of the IRES and the lower yield from the 
downstream elements make them less attractive than t e 2A peptides that are self-
cleavable 19-33 amino acid peptides possessing a ribosome skipping mechanism. When 
the 2A peptide is inserted between concatenated genes, the ribosome skips at the glycine-
proline residue of the 2A without forming a peptide bond and continues to translate the 
next gene, resulting in discrete proteins that are produced at similar levels (de Felipe, 
2004). 
Computational tools are an indispensable part of SB and make use of mathematical 
models for in silico predictions and analysis of alternative design strategies that guide 
biologists in choosing optimal translatable approaches (Marchisio & Stelling, 2009). 
Model-guided designing limits system variability, increases predictability and decreases 
the time spent on combinatorial assembly, validation and optimization. Optimization 
algorithms like Optknock (Burgard et al., 2003), OptGene (Patil et al., 2005), OptORF 




(Kim & Reed, 2010), OptFlux (Rocha et al., 2010) and OptForce (Ranganathan et al., 
2010) have been developed for identifying gene deletion and overexpression strategies. 
Genome-scale metabolic network reconstructions likeflux balance analysis (FBA, 
Gianchandani et al. (2010)), minimization of metabolic adjustments (MOA, Segrè et 
al. (2002)), dynamic flux balance analysis (DFBA, Mahadevan et al. (2002)) and 
integrated DFBA (idFBA, Lee t al. (2008)) have been developed to effectively calculate 
steady-state flux distribution and enables in silico characterization of growth yield, 
culture conditions and robustness upon gene manipulat ons. In silico driven metabolic 
engineering based on OptGene and MOMA has been applied in yeast to significantly 
increase cubebol (sesquiterpenoid) production (Asadoll hi et al., 2009). Additionally, 
computational networks like the biochemical network integrated computational explorer 
(BNICE) algorithm have been employed to design novel m tabolic routes by starting 
from a specific substrate and reaction rules to result in a defined product (Hatzimanikatis 
et al., 2005). 
Lastly, it is essential to combine metabolomics with transcriptomic approaches for the 
engineering of secondary metabolism, as metabolic profiling permits the characterization 
of novel metabolic networks and the identification of metabolic bottlenecks, and plays a 
pivotal role in model-based engineering (Nguyen et al., 2012). For instance, by applying 
targeted metabolomics, the bottlenecks in the synthesis of coenzyme Q10 in E. coli were 
determined by looking for accumulating pathway interm diates. Subsequently, the 
pathway limitations were overcome by the overexpression of the corresponding genes, 
resulting in three-fold more production (Cluis et al., 2011). 
 
In vitro synthetic biology: an evolving tool 
Contrary to cell-based SB, in which the cell’s growth and survival objectives might 
interfere with the engineering objective, i.e. the production of a compound, cell-free in 
vitro SB provides a platform where all available resources are concentrated on the user-
defined objective, which eventually might result in improved production systems (Harris 




& Jewett, 2012). A cell-free environment is highly flexible and devoid of genetic 
regulation or transport barriers, facilitating substrate addition and product purification. In 
vitro SB systems can comprise ‘synthetic enzymatic pathwys’ (SEPs), in which purified 
enzymes are combined in an aqueous environment to convert a substrate to a product 
through a series of reactions. Alternatively, ‘crude extract cell-free’ (CECF) systems, in 
which cells are grown, harvested and lyzed to obtain a crude extract, can be utilized for 
the conversion of a substrate to a product (Hodgman & Jewett, 2012) (Fig. 8b). 
The choice between SEP and CECF is influenced by time, cost and the need for cellular 
reinforcement to support the desired network. A CECF approach, for instance, is more 
suited for a reaction requiring a constant supply of energy such as protein synthesis 
(Carlson et al., 2012), however, unlike SEP, CECF reactions can exhibit undesirable 
activities due to the crude nature of the cellular ext act. 
The multireaction nature of biochemical networks, low protein concentrations, enhanced 
substrate diffusion, low enzyme proximity and low reaction rates due to unbalanced 
enzyme activity still hamper the efficiency of cell-free SB. In vitro compartmentalization 
(IVC) is one way of achieving proximity of reaction components. In IVC, genes are 
coupled to a substrate and encapsulated in water-in-oil emulsions together with 
transcription and translation machineries to facilitate enzyme synthesis and consequent 
product formation (Fig. 8c). Novel enzymes have been uncovered by linking product 
formation to genes in a confined micro-environment through IVC (Rothe et al., 2006). 
IVC is also being employed as a screening approach for the directed evolution of 
enzymes (Arnold & Volkov, 1999; Forster & Church, 2007). Besides enclosing reaction 
components in a defined environment through IVC, metabolic channeling has been 
employed as an alternative to reduce substrate diffusion lengths. Protein scaffolding 
(Fig. 8d), surface tethering of enzymes (Fig. 8e), covalently linked enzyme aggregates 
(Fig. 8f) and foam dispersion of enzymes with liposomes using surfactants (Fig. 8g) have 
been employed to facilitate the spatial organization of pathway components (Hodgman & 
Jewett, 2012). 





Figure 8. Synthetic biology platforms. (a) In vivo synthetic biology where standard 
biological parts are mathematically modeled to obtain optimal expression networks which 
are expressed in microbial hosts like E. coli. (b) In vitro synthetic biology consists of 
synthetic enzymatic pathways where purified enzymes are combined with reaction 
components in an aqueous environment to convert a substrate to a product through a 
series of reactions, and crude-extract cell-free systems where resources from the cell 
convert an externally provided substrate to a product. (c) In vitro compartmentalization 
using water-in-oil emulsions. The encapsulated water phase consists of a substrate 
coupled to a gene which is transcribed and translated in vitro to generate an enzyme that 
can convert the substrate to the product. Metabolic channeling allows bringing enzymes 
in close proximity with their substrate by (d) protein scaffolding, (e) tethering enzymes to 
a surface, (f) covalently linking related enzymes into aggregates nd (g) foam dispersion 
techniques in which the enzymes are encapsulated using surfactants. a,b,c,d,e,f,g,h, native 
enzymes; b*,d*,g*, synthetically modified enzymes; B,C,D,E,F,G,H, intermediates; P, 
product; S, substrate. 
 




Current applications of in vitro SB are limited to proteins, nucleic acids and small 
molecule ligands. Nonetheless, these tools can undoubtedly be extended to natural 
product (or terpenoid) engineering in the future. For instance, IVC could be employed as 
a tool for the directed evolution of CytP450s. A potential hurdle is the membranous 
nature of CytP450s, which prevents their solubilization in the aqueous reaction 
environment, but which may be overcome by the utilization of nanodisc membranes 
(Denisov & Sligar, 2011). A great advantage of using  vitro SB in terpenoid 
engineering would be the simplicity and ease of catalyzing precise regio- and 
stereospecific reactions with a high efficiency in a relatively pure form, which may 
overcome the drawbacks of chemical synthesis, metabolic engineering and product 
purification. 
 
Conclusions and perspectives 
Terpenoids, the largest class of structurally and biologically diverse molecules, play a 
pivotal role in the plant’s growth and survival. Since time immemorial they have also 
been exploited by mankind for their overall health promoting and therapeutic potential. 
Presently, mono-, di- and tetraterpenoids are valued as natural colorants, flavors and 
fragrances. Although many plant terpenoids have exploitable properties, they are not 
utilized excessively due to their limiting availability. Like all secondary metabolites, the 
biosynthesis of terpenoids is strictly regulated in plants, which is often reflected by a very 
low accumulation in planta. Numerous efforts to enhance the production of valuable 
terpenoids in endogenous plants through the application of elicitors, the external supply 
of precursors and the optimization of culture conditions, concurrent with the selection for 
high-producing cultivars, have resulted in limited success. Metabolic engineering of 
plants to produce desired endogenous and heterologous terpenoids has thus far also been 
uneconomical due e.g. to the high costs associated with the cultivation of plant cell 
cultures, the time and effort required to obtain competitive or sustainable yields, the 
challenges in purifying compounds from complex mixtures and the failure or limited 
success of the engineering itself. 




Microorganisms, particularly E. coli and S. cerevisiae, have emerged as industrially 
effective biological factories for the production of terpenoids, not only because of their 
scalability, but primarily due to their amenability to metabolic engineering for enhanced 
productivity. The advances in engineering strategies further support the potential of 
heterologous microbial production of secondary metabolites in general, by providing an 
ever-growing toolkit for the rational engineering of rganisms to produce profitable 
compounds in a short time span. The combinatorial biosynthesis of novel compounds, the 
evolution of enzymes to carry out defined functions and SB approaches are being 
increasingly used for tetra- and sesquiterpene engin ering, which in turn is generating a 
knowledge base for the future engineering of other terpenoid classes that have hardly 
been touched so far. For instance, the triterpene saponins with their grandeur of chemical 
diversity and biological activity, constitute one of the least engineered terpenoid classes 
with regard to heterologous production in microbes. The vast structural diversity and 
distribution of triterpene saponins in plants, highli ts the capacity for combinatorial 
synthesis of novel molecules using existing natural enzyme resources. The spectrum of 
saponins seen in nature is generated predominantly from a single squalene precursor 
through specific enzyme-driven chemical reactions, underscoring the promiscuity of the 
involved enzymes and therefore their amenability toward engineering programs. Hence, 
through the combined application of directed evoluti n strategies and synthetic biology 
toolboxes, triterpene saponin engineering could become the epitome in the near future. 
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Gas chromatography – mass spectrometry has been widely applied for the separation, 
detection and identification of a wide range of non-polar compounds, including sterols. 
The saponin building blocks or the sapogenins, akinsterols are extremely hydrophobic in 
nature. Based on sterol analysis using GC-MS, methods for the separation and 
identification of sapogenins using electron impact ionization have been established. Here, 
we give a short summary on the general principles of GC-MS and expand on the 
application of this technique for triterpenoid sapogenin analysis. In addition, the 
principles of sample preparation, gas chromatographic separation and interpretation of 
derived mass spectra for both tetra- and pentacyclic triterpenoid sapogenins is 
summarized. 








Introduction to GC-MS 
Gas chromatography – mass spectrometry (GC-MS) is a synergistic combination of two 
analytical techniques, where the gas chromatograph separates the components of a 
mixture in time and the mass spectrometer provides nformation to aid the structural 
identification of the components. The basic operating principle of the GC-MS involves 
the volatilization of the sample mixture in a heated inlet port (the injector), separation of 




Figure 1. Functional diagram of Gas chromatography – mass spectrometry (GC-MS) 
instrumentation. 
 
The carrier gas (mobile phase) is an integral part of the technique and allows the transfer 
of the sample from the injector, through the column into the detector. Gases like 
hydrogen and helium are the most commonly used carrier gases. The column and its 




packing material correspond to the stationary phase. Th  separation of components in a 
mixture is determined by the distribution of each component between the mobile and the 
stationary phase. A component that sticks less to the s ationary phase elutes quickly from 
the column and will therefore have a short retention me on the column. 
The GC column contains a thin layer of a non-volatile chemical that is either, coated onto 
the wall of the column (capillary column), or coated on an inert solid that is added to the 
column (packed column). The components of an injected sample are carried onto the 
column by the carrier gas and selectively retained on the stationary phase. The most 
commonly used general purpose stationary phases which are less prone to column bleed 
are the highly non-polar dimethylsiloxanes (DB-1 or equivalent) and 5% phenyl/95% 
dimethylsiloxane (DB-5 or equivalent). During a GC run, the temperature of the oven 
where the GC column is placed is increased gradually (r mped) at 4-20°C/min so that the 
higher boiling and more strongly retained components are successively released from the 
column. Therefore, GC is limited to compounds that are volatile or can be made volatile 
and are sufficiently stable to flow through the column. Sample derivatization is 
frequently employed to increase the volatility and stability of acids, amines, amides, 
sterols and many other compound classes for GC analysis. 
The chromatogram produced during a GC run is a graphic l representation of the signal 
generated from a compound eluting from the GC column into the detector. The X-axis 
represents the retention time (tR) of the compound on the column and the Y-axis shows 
the intensity or abundance of the signal. Each peak r presents an individual compound 
that was separated from a sample mixture. If the GC conditions (oven temperature ramp, 
column type, etc.) are the same, a given compound will al ays elute from the column at 
nearly the same tR. Therefore, by knowing the tR of a compound, some assumptions about 
its identity can be made. However, compounds with similar properties often have similar 
tR and more information is usually required for the id ntification of a compound in a 
sample containing unknown components. 
The MS allows the identification of components that elute from the GC column. An 
interface in the GC-MS allows transporting the effluent from the GC to the MS without 




condensing nor decomposing the components during the transfer. The MS measures the 
mass-to-charge ratio (m/z) of gas phase ions and the abundance of each ionic species. 
The measurement is calibrated against ions of known m/z. However, the charge of ions in 
a GC-MS is almost always 1 and therefore the m/z corresponds to the mass of the ion in 
Daltons (Da) or atomic mass units. 
The MS separates the ions in a low pressure environment or vacuum by the interaction of 
a magnetic and electrical field on the charged particles. The electron impact ionization 
(EI) is the most commonly used ionization method for GC-MS, although chemical 
ionization (CI) is also employed. During EI, electrons from a hot wire or ribbon (the 
filament) are accelerated by 70V (70eV) before enteri g the ion source through a small 
aperture. The effluent from the GC also enters this partially enclosed ion source. When 
electrons pass near neutral molecules they impart sufficient energy to remove the outer 
shell of electrons from these molecules, thereby producing additional free electrons and 
positive molecular ions. The electron-electron interactions cause molecules to lose both 
the incoming electron and a bound electron. Owing to the high energy imparted by EI, 
and the absence of other compounds as is the case in vacuum, the molecular ions break 
up or ‘fragment’ into other ions, radicals and neutral atoms (Fig. 2). 
 
 
Figure 2. Electron impact ionization (EI) of a compound (M). e-, electron; F+, fragment 
ion; N., neutral atom. 
 
The mass spectrum is a graphical representation of the ions observed by the MS over a 
range of m/z values, where the X-axis is the m/z scale and the Y-axis corresponds to the 
intensity scale. The mass spectrum produced by a compound is essentially the same every 




time and therefore, a fingerprint for the molecule, that can be used for the identification 
of compounds in sample mixtures. When all the components of a mixture eluting from 
the GC column are analyzed on the MS, the total ion current (TIC) corresponds to a full 
MS scan, and both the intensity and the m/z of a component are important for interpreting 
the mass spectrum. Full MS scans are typically used for untargeted component analysis 
and consists of a compilation of mass spectral information from all the components in the 
mixture. However, most mass spectra usually have seral peaks that correspond to 
background and not to the specific component. These background peaks occur due to the 
presence of contamination in the ion source, the transfer line, the GC column, and due to 
column bleed. 
The MS can also be used for recording the ion current at selected masses for targeted 
component analysis, by scanning for characteristic m/z corresponding to a compound. 
This is referred to as selected ion monitoring (SIM), where the MS does not spend time 
scanning the entire mass range, but rapidly changes between m/z values for which 
characteristic ions are expected. The SIM method all ws quantitative analysis at parts per 
billion (ppb) level and is advantageous because of its high specificity and sensitivity. 
 
Sample preparation for GC-MS analysis of triterpenoid sapogenins 
Triterpenoid sapogenins are composed of 30 carbon atoms that are arranged in 4 or 5 ring 
structures with or without a side chain to form tetra- and pentacyclic triterpenoids, 
respectively. For the analysis of triterpenoid sapogenins various chromatography based 
analytical techniques, like thin layer chromatography (TLC, (Oleszek, 2002)), liquid 
chromatography (LC, (Burnouf-Radosevich and Delfel, 1984)), capillary electrophoresis 
(CE, (Unger, 2009)) and gas chromatography (GC) with flame ionization (Janicsák et al., 
2003) or mass spectrometry (MS, (Burnouf-Radosevich et al., 1985)) detection are 
described. Among these, GC-MS is the most powerful technique for the separation, 
quantification and structural determination of trite penoid sapogenins, including position 
isomers with very similar structures, such as α-amyrin (Fig. 3a) and β-amyrin (Fig. 3b). 




Some of the sapogenin backbones, like α-amyrin, β-amyrin, lupeol, etc., are sufficiently 
volatile at high temperatures and can be detected by GC-MS without compound 
derivatization. However, sapogenins derived from these backbones have high molecular 
weights and are apolar, which considerably lowers their volatility. Therefore, detection of 
underivatized sapogenins by GC-MS is laborious. 
 
 
Figure 3. Chemical structure of (a) α-amyrin, (b) β-amyrin. 
 
Derivatization of sapogenins by silylation, acetylation or methylation prior to GC-MS 
enhances their volatility and hence, detectability. Silylation is the most prevalent 
derivatization method applied to tetra- and pentacycli  triterpenoid sapogenins. Silylation 
produces silyl derivatives by replacing active hydrogens through nucleophilic attack with 
a trimethylsilyl (TMSi) group. The better the leaving group, the better the silylation 
reaction. Silylation reagents readily react with water. Therefore, samples and solvents 
used for derivatization should be water-free. Pyridine is the most commonly employed 
solvent, which is also an acid scavenger that can positively influence the reaction. The 
ease of reactivity of a functional group with an active hydrogen for silylation follows the 
order; hydroxyl of alcohol (-OH) > hydroxyl of phenol (-OH) > carboxyl (-COOH) > 
amine (-NH2) > amide (-CONH2). The silylation reaction is driven by a good leaving 
group which has low basicity and therefore the ability to stabilize a negative charge in the 
transitional state, and has negligible or no π bonding between the leaving group and 




silicon atom. There are multiple silylating reagents that can be used in combination with 
pyridine for silylation reactions. We utilized the N-methyl-N-
(trimethylsilyl)trifluoroacetamide (MSTFA) silylating reagent, which contains TFA as 
the strong leaving group, and reacts completely with the sample in a short time. 
 
GC separation of derivatized triterpenoid sapogenins 
The retention of sapogenins and sapogenin backbones in a GC column is influenced by 
the number and type of functional groups they possess. We utilized a VF-5ms capillary 
column, which is equivalent to the DB-5 column, forthe separation of sapogenins. The 
retention time of sapogenins on this column generally increased with increasing 
molecular weight of the derivatized triterpenoid. Among the pentacyclic triterpenoids, the 
ursane-type sapogenins α-amyrin and uvaol, were retained longer on the column than 
their respective oleanane-type isomers β-amyrin and erythrodiol (Fig. 4). This might be a 
result of the increasing planarity of the molecule due to the shifting of the methyl (-CH3) 
group from the axial conformation on C-20 in β-amyrin to the equatorial conformation on 
C-19 in α-amyrin, thereby increasing its retention on the column. 
 
Interpretation of EI fragmentation pattern of trite rpenoid sapogenins 
In general the triterpenoid sapogenins can be divided nto three categories based on their 
EI fragmentation pattern, (a) the pentacyclic triterpenoids containing a C-12 – C-13 
double bond, like α- or β-amyrin and their derivatives, (b) the pentacyclic tr terpenoids 
without a double bond, like lupeol and its derivaties, and (c) the tetracyclic triterpenoids 
with a side chain, like dammarenediol and its derivatives. In this section, the 
interpretation of the EI fragmentation pattern of these main categories of sapogenins 
derivatized with TMS will be illustrated with examples. 
 





Figure 4. GC chromatogram showing the longer retention of the ursane-type sapogenins 
(α-amyrin and uvaol) on the GC column, as compared to the oleanane-type sapogenins 
(β-amyrin and erythrodiol). 
 
The pentacyclic triterpenoids with a C-12 – C-13 double bond undergo a characteristic 
retro Diels-Alder (rDA) cleavage of the C-ring to frm fragments consisting of the 
ABC*-rings (dienophile) and the C*DE-rings (diene), where C* represents only a portion 
of the C-ring (Fig. 5a). The charge is retained on the diene which undergoes further 
fragmentation mostly generating an ion with the m/z203, as seen in the mass spectrum of 
β-amyrin (Fig. 5b) and oleanolic acid (Fig. 5c). Similarly, the dienophile looses the 
silylated hydroxyl (TMSiOH) on C-3 to form the fragment ion with m/z 189. Together 
with the abundant intensities of the fragment ions generated by the rDA fragmentation, 
also signals corresponding to m/z of the trimethylsilylated molecular (parent, M+) ion, 
loss of methyl group (M+-CH3, 15 Da), loss of trimethylsilylated hydroxyl group (M
+-
TMSiOH, 90 Da), loss of trimethylsilylated carboxyl group (M+-TMSiCOOH, 118 Da), 
combinations of different above mentioned losses, and the m/z 73 corresponding to 
TMSiH can be observed (Fig. 5b-c). In addition, theloss of hydroxyl- and carboxyl 
groups on ring-carbons can also be distinguished from loss of hydroxyl groups from 
methyl-carbons (Burnouf-Radosevich et al., 1985). 





Figure 5. (a) EI pattern of trimethylsilylated β-amyrin, a pentacyclic triterpenoid with C-
12 – C-13 double bond. (b) Mass spectra of a β-amyrin standard. (c) Mass spectra of an 
oleanolic acid standard. The X-axis of the mass spectra correspond to m/z values. 
 
In the pentacyclic triterpenoids, like lupeol, that do not have a double bond the EI 
fragmentation is initiated by a C-14 – C-27 cleavage nd consequent methyl elimination 
(Fig. 6a). The fragment ions so generated are not observed as they readily decompose to 
fragment ions with lower m/z. The fragment ions with m/z 279 and 189 are formed, like 
in lupeol (Fig. 6b), as a result of two competitive pathways, which can be used to detect 
the presence of substituents on A, B, C, D or E rings of the pentacyclic triterpenoids (de 
Carvalho et al., 2010). Also the m/z corresponding to the M+ and M+-CH3 ions can be 
detected in the EI spectrum. 
 
 





Figure 6. (a) EI pattern of trimethylsilylated lupeol, a pentacyclic triterpenoid without 
double bond. (b) Mass spectra of a lupeol standard. The X-axis of the mass spectra 
correspond to m/z values. 
 
The tetracyclic triterpenoids, like dammarenediol have characteristic side chains attached 
to the D ring. The m/z corresponding to the trimethylsilylated parent M+ ion, is often hard 
to detect. However, the m/z of M+-CH3 and M
+-TMSiOH fragment ions, corresponding 
to the loss of 15 Da and 90 Da, respectively can be readily observed. The characteristic 
cleavage on either side of the silyloxy group at C-20 gives a m/z of 505 and 199, the 









Figure 7. (a) EI pattern of trimethylsilylated dammarenediol, a tetracyclic triterpenoid. 
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Saikosaponins are triterpenoid saponins abundantly present in the roots of the genus 
Bupleurum, the species of which are widely used in Asian tradi ional medicine. The 
saikosapogenins are the aglycosylated forms of the saponin and constitute of oleanane- 
and ursane-type backbones with multiple oxygenations mainly in the D and E rings of the 
backbone. In this study we have identified a cytochr me P450 (BF567) from Bupleurum 
falcatum that is involved in the hydroxylation of triterpenes during the biosynthesis of 
saikosapogenins. We engineered a yeast strain that endogenously produces 36.2 mg/L β-
amyrin and used it for the ectopic expression of BF567. Additionally, by varying the ratio 
of the cytochrome P450 reductase to BF567 we demonstrate improvements in the 
endogenous β-amyrin hydroxylation efficiency of BF567 and thereby the relevance of 
this ratio for the production of triterpene sapogenins. We also establish a novel approach 
for the extraction of hydrophobic triterpene sapogenins from yeast cells into the medium, 
using methylated cyclodextrin to increase productivity and facilitate downstream 
processing. Finally, we present proof of concept for c mbinatorial triterpene sapogenin 
biosynthesis in S. cerevisiae and apply it for the characterization of BF567. 









Triterpenoid saponins are a class of secondary metabolites exhibiting a wide range of 
structural diversity and biological activities among many plant species (Suzuki et al., 
2002; Sparg et al., 2004). Saponins can be structurally defined as, glycosides of 
“sapogenins” composed of 30 carbon cyclic isoprenoids arranged in 4 or 5 ring 
structures, that are decorated by additional functio al groups (hydroxy-, carboxy-, oxo-, 
etc). Saponins are synthesized by multiple glycosylations of the sapogenin building 
blocks, which in turn are produced by multiple cytochrome P450 monooxygenase 
(CytP450) or oxido-reductase mediated modifications f basic sapogenin backbones like 
β-amyrin (oleanane-type), α-amyrin (ursane-type), lupeol and dammarenediol (Fig. 1a). 
These diverse backbones are generated by specific oxidosqualene cyclase (OSC) 
mediated cyclization of 2,3-oxidosqualene, which is also an intermediate in the synthesis 
of membrane sterols in plants, mammals and yeast. Sapogenins are valuable as 
biologically active compounds and can also serve as important starter molecules for 
further synthetic modifications. For instance, the naturally occurring triterpenoid 
sapogenin oleanolic acid and its derivatives possess veral promising pharmacological 
activities, such as hepato-protective effects, anti-inflammatory, antioxidant and 
anticancer activities (Pollier and Goossens, 2012), of which bardoxolone methyl, a 
semisynthetic derivative of oleanolic acid, is currently in a late-stage clinical 
development for the treatment of advanced chronic kidney disease in type 2 diabetes 
mellitus patients. 
The genus Bupleurum constitutes of perennial herbs and forms an integral part of Asian 
traditional medicine in which it is used either alone, or in combination with other 
ingredients for the treatment of common colds, fever and inflammatory disorders in the 
form of over the counter herbal teas. Bupleurum species are also enlisted in the Chinese 
and Japanese Pharmacopoeias and the WHO monographs on selected medicinal plants. 
Saikosaponins constitute the largest class of secondary metabolites in Bupleurum and 
account for ~7% of the total dry weight of roots. More than 120 closely related 
glycosylated oleanane- and ursane-type saikosaponins have been identified from this 
genus that can be distinguished only by the position and number of double bonds in rings 




C and D and oxygenation patterns on C-16, C-23, C-28 and C-30 (Fig. 1b) (Ashour and 
Wink, 2011). The presence of oxygenations at various positions on saikosapogenins 
suggest the presence of specific enzymes, generally CytP450s, capable of catalyzing 
these modifications on the β-amyrin and/or α-amyrin backbone in the genus Bupleurum. 
However, to date not a single CytP450 or oxido-reductase involved in triterpene 
sapogenin biosynthesis has been identified from Bupleurum species. 
In general the triterpene sapogenin biosynthesis is not well elucidated and only a handful 
of CytP450s have been characterized from different plants, which include a C-11 oxidase 
(CYP88D6 (Seki et al., 2008)), C-24 hydroxylases (CYP93E1 (Shibuya et al., 2006), 
CYP93E2 (Fukushima et al., 2011) and CYP93E3 (Seki et al., 2008)), C-28 oxidases 
(CYP716A12 (Carelli et al., 2011), CYP716A15, CYP716A17 (Fukushima et al., 2011) 
and CYP716AL1 (Huang et al., 2012)) and C-30 hydroxylases (CYP72A154 and 
CYP72A63 (Seki et al., 2011)) that modify the β-amyrin backbone (indicated by asterisk, 
Fig. 1b). Additionally, a C-6 (CYP716A53v2 (Han et al., 2012)) and C-12 (CYP716A47 
(Han et al., 2011)) hydroxylase that modify the dammarenediol-II backbone have also 
been identified. To characterize these CytP450s, yeast strains either producing β-amyrin 
or externally fed with the substrate have been employed for ectopic expression of the 
CytP450 and identification of modified products. From these studies it is naturally 
evident that yeast cells can be employed, not only for the characterization of novel 
enzymes, but also as a heterologous host for the production of triterpenoid sapogenins. 
From the perspective of a production host, in spite of several OSCs having been 
expressed in S. cerevisiae, little effort has been made towards engineering the host to 
enhance production of triterpenes. For instance, Kirby and coworkers could produce 
6 mg/L of β-amyrin in S. cerevisiae by expressing a β-amyrin synthase (bAS) from 
Artemisia annua and manipulating two enzymes, 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGR) and lanosterol synthase (ERG7), of the ergosterol biosynthetic 
pathway. In this strain they observed a 12-fold increase in squalene levels indicating 
scope for further improvements in β-amyrin production (Kirby et al., 2008). 
 





Figure 1. (a) A simplified overview of saponin biosynthesis in plants depicting the 
different branches of enzymes involved. DMAPP, dimethylallyl pyrophosphate; FPP, 
farnesyl pyrophosphate; GPP, geranyl pyrophosphate; IPP, isopentenyl pyrophosphate. 
(b) Chemical structure of oleanane-type sapogenin backbone. Asterisk (*) indicate the 
carbon positions for which a CytP450 has already been characterized. (c) Schematic 
representation of the modified yeast ergosterol biosynthetic pathway. Multiple steps are 
indicated by dashed lines. 
 
Here we describe the identification and characterization of a novel plant cytochrome 
P450 (BF567), from B. falcatum involved in the biosynthesis of saikosaponins. BF567 
was identified through a genome wide cDNA-AFLP based transcript profiling and 




ectopically expressed in a β-amyrin producing S. cerevisiae strain with modified sterol 
biosynthesis (Fig. 1c), where it was identified as a novel hydroxylase from B. falcatum. 
Further, using BF567 we established a combinatorial pipeline for the production of 
triterpene sapogenins. Additionally, we propose a novel approach for the extraction of 
triterpene sapogenins from yeast cells into the medium to facilitate downstream 
purification by utilizing cyclodextrins. 
 
Results 
Transcript profiling of MeJA-treated B. falcatum roots reveals BF567. 
To identify new saponin biosynthetic genes, we performed a genome-wide cDNA-AFLP 
based transcript profiling on the roots of hydroponically grown B. falcatum plants. Using 
the complete set of 128 BstYI+1/MseI+2 primer combinations, the expression of a total 
of 18,800 transcript tags was monitored over time. In total, 1,771 MeJA-responsive 
transcript tags were isolated (hereafter referred to as BF tags). Direct sequencing of the 
reamplified BF tags gave good quality sequences for 1217 (68.7%) of the fragments. To 
the remaining 554 tags (31.3%), no unique sequence could be attributed unambiguously, 
indicating that they might not represent unique gene tags and hence were not considered 
for further analysis. A BLAST search with the nucleotide sequences of the 1217 unique 
cDNA-AFLP tags led to the annotation of 776 (63.7%) of the BF tags. 
Average linkage hierarchical clustering analysis of the expression profiles of the 776 
annotated BF tags showed that, upon MeJA treatment the selected genes are either 
transcriptionally activated (Clusters I-V, Fig. 2a) or transcriptionally repressed (Cluster 
VI, Fig. 2a). The activated gene tags can be divided into five subclusters, based on the 
timing of the MeJA response. A first cluster consists of genes with a response 
immediately after (≤ 1 h) MeJA treatment (cluster II). In a second and third cluster 
(Clusters III and IV, respectively), genes reach maxi um expression between 2-4 h and 
4-8 h after MeJA treatment, respectively. In a fourth cluster (Cluster I), genes are 




activated 24 h after MeJA treatment, and in a fifth cluster (Cluster V), genes are activated 
within 2 h after the MeJA treatment, and their exprssion remains high thereafter. In the 
latter group, tags corresponding to genes encoding enzymes that catalyze early steps in 
the triterpene saponin biosynthesis, including squalene synthase (SQS) and bAS can be 
found. These tags displayed an almost identical expression pattern, suggesting a tight co-
regulation, and reached maximum levels of expression 8-24 h post-elicitation (Fig. 2b). 
The gene tag BF567 is tightly co-regulated with these genes (Fig. 2b), and shows 
homology to the M. truncatula gene encoding the cytochrome P450 enzyme CYP716A12, 
characterized to oxidize β-amyrin in a sequential three-step oxidation on C-28 to yield 
oleanolic acid through erythrodiol (Carelli et al., 2011; Fukushima et al., 2011). The full-
length open reading frame (BF567) corresponding to the gene tag BF567 was picked up 
from a B. falcatum Uncut Nanoquantity cDNA library (Pollier et al., 2011b). 
Additionally, a phylogenetic analysis (Fig. 2c) confirmed that BF567 groups together 
with the CYP716 family of CytP450s involved in triterpene sapogenin biosynthesis. 
 
Saccharomyces cerevisiae strain TM1 with modified sterol biosynthesis. 
The ergosterol biosynthetic pathway of a S288c BY4742 strain of S. cerevisiae was 
modified as described (Kirby et al., 2008) with adaptations, to facilitate accumulation of 
2,3-oxidosqualene (Fig. 1c), a common intermediate of sterol biosynthesis between plants 
and yeast. First, the S. cerevisiae lanosterol synthase (ERG7) responsible for the 
cyclization of 2,3-oxidosqualene to lanosterol was made conditionally down-regulatable, 
by replacing the native ERG7 promoter with a methionine-repressible MET3 promoter to 
generate strain TM1. The amount of ergosterol produced by TM1 in the presence of 
different concentrations of methionine was quantified using the sterol quantification 
method (Arthington-Skaggs et al., 1999) and a 60% reduction in ergosterol accumulation 
was observed with 1.5 mM methionine, when compared to wild type cells. This 
concentration of methionine was thus used for all following experiments. An overview of 
all yeast strains derived from TM1 is given in Table 1. 





Figure 2. Transcript profiling of jasmonate elicited B. falcatum roots. (a) General view 
on the average linkage hierarchical cluster and tree of all 776 unique BF tags. (b) 
Subcluster of the B. falcatum transcriptome, comprising tags corresponding to genes 
reported to be involved in triterpene biosynthesis, or with high sequence similarity to 
such genes. Treatments and time points (in h) are indicated on top. Blue and yellow 
boxes reflect transcriptional activation and repression relative to the average expression 
level, respectively. Gray boxes correspond to missing time points. (c) Phylogenetic 
relationship among the CYP716 proteins. Arrowhead indicates the CytP450 functionally 
defined in this study. Scale bar indicates the number of amino acid substitutions per site. 
 
Further, a truncated feedback uncoupled copy of isoform 1 of the rate limiting enzyme 3-
hydroxy-3-methylglutaryl-CoA reductase (tHMG1) was generated and cloned into the 
multiple cloning site (MCS) 1 of the high copy number plasmid pESC-URA behind the 




galactose inducible GAL10 promoter to generate pESC-URA[GAL10/tHMG1], which 
was transformed into TM1 to generate a control strain TM5. 
 
β-amyrin producing strains TM2 and TM3. 
Two β-amyrin producing strains TM2 and TM3 were generated from TM1 by expressing 
bAS of M. truncatula (GenBank accession number AJ430607; (Suzuki et al., 2002)) or G. 
glabra (GenBank accession number AB037203; (Hayashi et al., 2001)), respectively 
from the plasmid pESC-URA[GAL10/tHMG1; GAL1/bAS]. The in vivo activity of the 
bAS in TM2 and TM3 was compared by quantifying levels of β-amyrin produced by 72 h 
cultures, using GC-MS. The strains were grown in galactose medium for 24 h, to 
accumulate bASp and increase flux through ergosterol pathway, prior to repression of 
ERG7 with 1.5 mM methionine for 48 h, to accumulate 2,3-oxidosqualene and 
simultaneously convert it to β-amyrin. Analysis of cell pellets showed the presence of a 
single peak at 27.2 min with an electron ionization (EI) pattern corresponding to a β-
amyrin standard (Fig. 3d), in the GC chromatograms of TM2 (Fig. 3a) and TM3 (Fig. 3b), 
but not the control strain TM5 (Fig. 3c). Further, we observed higher accumulation of β-
amyrin in strain TM3 (36.2 mg/L) compared to TM2 (19 mg/L) and hence continued with 
TM3 for further experiments. 
 
In vivo activity of BF567 in strain TM7. 
Strain TM7 was generated by super-transforming strain TM3 with plasmids 
pAG423[GAL1/BF567] and pAG425[GAL1/AtATR1], expressing BF567 and the A. 
thaliana CytP450 reductase (CPR), AtATR1 (At4g24520), respectively from the galactose 
inducible GAL1 promoter. In parallel, a control strain TM26 harboring only 
pAG425[GAL1/AtATR1] in TM3 was also generated. Cell pellets analyzed by GC-MS 
showed the presence of a unique new peak eluting at 31.8 min in TM7 (Fig. 4a), but not 




TM26 (Fig. 4c). The EI pattern of this peak corresponded to a hydroxylated derivative of 
β-amyrin, with the alcohol function on either the D or E ring of β-amyrin (Fig. 4d). 
 
Figure 3. GC chromatograms showing β-amyrin at 27.2 min, where the X- and Y-axis 
correspond to time in minutes and total ion current, respectively. (a) Extraction from cells 
of strain TM2, expressing tHMG1 and MtbAS. (b) Extraction from cells of strain TM3, 
expressing tHMG1 and GgbAS. (c) Extraction from cells of control strain TM5, 
expressing tHMG1. (d) A β-amyrin standard. Right panel shows the mass spectra 
extracted from the indicated (*) peak, where X-axis corresponds to m/z values. 




Since BF567 was tentatively annotated as a homolog of the M. truncatula CYP716A12 
(GenBank accession number FN995113; (Carelli et al., 2011)), we compared the GC 
elution time and EI pattern of the new peak in TM7 with a standard of erythrodiol (28-
hydroxy-β-amyrin). We also generated strain TM10 by transforming plasmid 
pAG423[GAL1/CYP716A12] along with pAG425[GAL1/AtATR1] in TM3, and compared 
its GC-MS profile with TM7, TM26 and an erythrodiol standard. A peak corresponding to 
the elution time and EI of standard erythrodiol (Fig. 4e) was observed at 32.5 min in the 
GC chromatogram of TM10 (Fig. 4b) but not TM7 and TM26, indicating that BF567 
hydroxylates β-amyrin at a position different than CYP716A12. Therefore, we looked at 
the oleanane-type triterpenoid sapogenins found in Bupleurum (Ashour and Wink, 2011) 
and narrowed down the possible hydroxylation positins of BF567 on rings D and E of β-
amyrin to C-16β, C-21β and C-29 (Fig. 4d), which are positions for which a CytP450 has 
not been characterized to date. 
 
Effect of CPR:CytP450 ratio on in vivo activity of BF567. 
The endoplasmic reticulum (ER) localized CPRs are flavoproteins, containing both a 
redox cofactor flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), that 
serve as electron donor proteins for several ER oxygenases, including CytP450s. 
Therefore, optimal interaction between CPR and CytP450 is essential to allow the 
reducing equivalents from NADPH to pass from the CPR to the CytP450 (Reed and 
Backes, 2012). In an attempt to increase the efficincy of hydroxylation of β-amyrin by 
BF567, we determined the effect of the ratio of CPR to CytP450, by varying the 
expression level of AtATR1 while keeping the expression of BF567 constant. 





Figure 4. GC chromatograms corresponding to, (a) Extraction from cells of strain TM7, 
expressing tHMG1, GgbAS, AtATR1 and BF567. (b) Extraction from cells of strain 
TM10, expressing tHMG1, GgbAS, AtATR1 and CYP716A12. Right panels show the mass 
spectra extracted from the indicated (*) peaks. (c) Extraction from cells of control strain 
TM26, expressing tHMG1, GgbAS and AtATR1. (d) Mass spectra extracted from the peak 
indicated (*) at 31.8 min of strain TM7. The possible hydroxylation positions on β-
amyrin are indicated by arrow heads. (e) Mass spectra of an erythrodiol standard. The X- 
and Y-axis of the GC chromatograms correspond to time in minutes and total ion current, 
respectively. The X-axis of the mass spectra correspond to m/z values. 




The CPR:CytP450 ratios between 1:5 and 1:30 have been r ported to be ideal for the 
efficient functioning of yeast and mammalian CytP450s (Reed and Backes, 2012), 
therefore we expressed the AtATR1 from either an integrated (pAG305, 1 copy per cell), 
low-copy number (pAG415, 3-5 copies per cell), or high-copy number (pAG425, 10-40 
copies per cell) vector, in combination with BF567 always expressed from the high-copy 
number plasmid (pAG423, 10-40 copies per cell). Thus, we generated two strains TM8 
and TM9, overexpressing pAG423[GAL1/BF567] along with pAG305[GAL1/AtATR1] or 
pAG415[GAL1/AtATR1], respectively and compared the amount of hydroxylated β-
amyrin produced by these strains with that of TM7. In accordance with this assumption, 
strain TM9, accumulated higher levels of hydroxylated β-amyrin compared to TM8 and 
TM7, with the lowest accumulation in the strain expressing the integrated copy of CPR 
(Fig. 5a). Therefore, we expressed AtATR1 from the low-copy number vector pAG415, 
for further experiments. 
 
Cyclodextrin facilitates production and release of triterpene sapogenins from yeast 
cells. 
Cyclodextrins (CDs) are cyclic oligosaccharides comp sed of α-D-glucopyranoside units, 
that can be represented by a toroidal topology and re extensively employed for 
solubilizing and stabilizing pharmaceuticals (Stella and He, 2008). Owing to their 
toroidal arrangement, the interior of the CD is considerably more hydrophobic than the 
exterior aqueous environment enabling them to host hydrophobic moieties, like 
cholesterol (Christian et al., 1997). Therefore, considering the hydrophobic nature of 
sapogenins and their common biosynthetic origin with sterols, sapogenins could also be 
sequestered by CD and transported from within the yeast cells to the external growth 
medium. 
First the concentration of methyl β-cyclodextrin (MβCD) to be applied to the yeast 
culture, to facilitate the extraction of ergosterol and β-amyrin from yeast cells to the spent 
medium was determined. We compared the GC chromatograms of extracts from cell 




pellet and spent medium of strain TM3 treated with 5 mM or 25 mM MβCD and 
compared it with an untreated control. Both ergoster l and β-amyrin were detected in the 
cell pellet of all the samples, but only in the spent medium of MβCD treated samples, 
suggesting the ability of MβCD to sequester not only yeast sterols but also triterpene 
sapogenin backbones into the medium (Fig. 5b). Since both 5 mM and 25 mM MβCD 
could extract the hydrophobic compounds from the yeast cells, we decided to continue 
further experiments with the lower concentration of MβCD. 
Using 5 mM MβCD we examined the amount of β-amyrin extracted from the yeast cells 
by culturing strain TM3 in the presence and absence of the CD and quantified he amount 
of β-amyrin in the cell pellet and spent medium by GC-MS. GC chromatograms 
confirmed the presence of β-amyrin in both the cell pellet (20.4 mg/L) and spent medium 
(37.3 mg/L) upon MβCD treatment, with higher concentrations of β-amyrin quantified 
from the extracts of spent medium (Fig. 5c). Additionally, the total concentration of β-
amyrin was found to be 1.6-fold higher in cultures treated with MβCD, when compared 
to untreated controls. 
Next, we determined if MβCD facilitates the extraction of β-amyrin from strain TM3 in a 
dose dependent manner. For this we applied MβCD at different times during culturing 
and generated a total of 7 culturing conditions which included, an untreated control (C, 
Fig. 5d) and 6 treated samples, with MβCD added to a concentration of 5 mM each time. 
To samples I1, I2 and I3 (Fig. 5d) MβCD was added on Day 1 after inoculation into 
galactose medium. To samples I2 and I3 an additional dose of MβCD was added on Day 
2 together with addition of methionine, and additionally to sample I3 a third dose of 
MβCD was added on Day 3. Further, to samples R1, R2, and AR1 (Fig. 5d) MβCD was 
added on Day 2 only, Day 2 and Day 3, and Day 3 only, respectively. Extractions were 
performed on the spent medium of all the samples on Day 4 and quantified for β-amyrin 
using GC-MS. We observed a direct corelation between the amount of β-amyrin 
quantified from the spent medium and the number of times cyclodextrin was added to the 
sample, thereby suggesting the dose dependent nature of this extraction (Fig. 5d). 





Figure 5. (a) Effect of CPR:CytP450 ratio on the in vivo activity of BF567 in strains 
TM8, TM9 and TM7, where AtATR1 is expressed from vectors having integrative (INT), 
centromeric (CEN) and 2 micron (2µ) origin of replication. (b) GC chromatograms 
showing ergosterol and β-amyrin in spent medium of strain TM3 treated with 5 mM or 
25 mM MβCD and untreated control. The X- and Y-axis correspond to time in minutes 
and total ion current, respectively. (c) Quantification of β-amyrin from the cells and spent 
medium of strain TM3, where 100% corresponds to 36.2 mg/L of β-amyrin. (d) Dose 
dependent extraction of β-amyrin quantified for strain TM3, where cyclodextrin was 
added on Day 1 (I1), Day 1 and 2 (I2), Day 1, 2 and3 (I3), Day 2 (R1), Day 2 and 3 (R2), 
Day 3 (AR) and untreated control (C). (e) Relative amounts of hydroxylated β-amyrin 
quantified from the cells and spent medium of strain TM9. (f) Relative amounts of 
hydroxylated β-amyrin quantified from spent medium of strain TM9 treated with different 
variants of CD. 




For the following experiments with strain TM9, we employed condition R2 to avoid the 
excessive release and hence loss of β-amyrin, the precursor for BF567, from the cells into 
the medium. Surprisingly, the hydroxylated β-amyrin eluting at 31.8 min was only 
observed in the GC chromatograms of the spent mediu and not cell pellets of TM9 upon 
MβCD treatment (Fig. 5e), suggesting the complete relase of the hydroxylated product 
from the yeast cells into the medium. 
We also determined the specificity of the type of CD used, on the sequestering of 
hydroxylated β-amyrin from the cells into the spent medium of strain TM9. The most 
abundant variants of CD are α, β and γCD which have 6, 7 and 8 glucose units, 
respectively. Therefore, we applied αCD, βCD, γCD, Random MβCD (RMβCD) or 
MβCD to a final concentration of 5 mM as in condition R2 and analyzed the spent 
medium on Day 4, for quantification of the amount of hydroxylated β-amyrin released 
into the medium. Sequestering was only observed with the βCD and its methylated 
versions and the highest amount of hydroxylated β-amyrin was detected upon RMβCD 
and MβCD treatment, suggesting a strong specificity of the methylated forms of CD over 
the unmethylated forms, for sequestering of triterpenoid sapogenins from yeast cells 
(Fig. 5f). 
 
Combinatorial biosynthesis using BF567 and CYP716A12. 
Combinatorial biosynthesis also known as combinatori l biochemistry involves the 
combination of genes from different organisms, in a heterologous host to produce 
bioactive compounds by establishing novel enzyme-substrate combinations in vivo, 
which in turn could lead to the biosynthesis of novel natural products (Pollier et al., 
2011a). Although BF567 is tentatively annotated as a homolog of CYP716A12, the GC 
elution time and EI pattern of the β-amyrin hydroxylation product of BF567 is different 
from erythrodiol (Fig. 4). We reasoned that if the two enzymes hydroxylate β-amyrin at 
two different carbon positions, it should be possible to combine the enzymes in the yeast 
strain TM3 and produce a combinatorial compound not produced by either of the 




enzymes alone. Therefore, we generated strain TM30 from TM3 by overexpressing the 
plasmids pAG415[GAL1/AtATR1] and pAG423[GAL1/BF567-T2A-CYP716A12], where 
BF567 and CYP716A12 are stitched together into a self-processing polypr tein via the 
2A oligopeptide (de Felipe et al., 2006) which is expr ssed from a single galactose 
inducible GAL1 promoter. The spent medium of strain TM30 cultured in the presence of 
MβCD was analyzed by GC-MS and compared to the GC chromatograms of spent 
medium from strains TM9, and TM17 overexpressing pAG423[GAL1/CYP716A12] and 
pAG415[GAL1/AtATR1] in TM3. 
We observed a unique peak at 40.5 min in strain TM30 (Fig. 6a) but not TM9 (Fig. 6b) 
and TM17 (Fig. 6c), strongly supporting the fact that BF567 and CYP716A12 catalyze 
hydroxylations of two different carbons on β-amyrin. Additionally, the EI pattern of this 
peak suggested the presence of carboxyl and alcohol functions on β-amyrin, indicating 
the C-28 carboxylation by CYP716A12 and the C-16, C-21 or C-29 hydroxylation by 
BF567. Considering the close proximity of C-16 and C-28 on the β-amyrin molecule 
(Fig. 1b) and the tentative annotation of BF567 as a homolog of CYP716A12 we reasoned 
that BF567 might hydroxylate C-16 of β-amyrin. Therefore, we compared the GC 
chromatogram and EI pattern of an echinocystic acidstandard (Fig. 6d) with that of the 
new peak at 40.5 min in TM30 (Fig. 6a). However, the GC elution time and 
fragmentation of the new peak at 40.5 min did not match that of echinocystic acid 
(3β,16α-dihydroxyolean-28-oic acid) ruling out the possibility of a C-16 α-hydroxylation 
by BF567. Due to the absence of authentic 3β,16β-dihydroxyolean-28-oic acid, 3β,21β-
dihydroxyolean-28-oic acid and 3β,29α-dihydroxyolean-28-oic acid standards we could 












Figure 6. GC chromatograms corresponding to, (a) Extraction from spent medium of 
strain TM30, expressing tHMG1, GgbAS, AtATR1, CYP716A12 and BF567. (b) 
Extraction from spent medium of strain TM9, expressing tHMG1, GgbAS, AtATR1 and 
BF567. (c) Extraction from spent medium of strain TM17, expressing tHMG1, GgbAS, 
AtATR1 and CYP716A12. (d) An echinocystic acid standard. The X- and Y-axis of the 
GC chromatograms correspond to time in minutes and total ion current, respectively. (e) 
Mass spectra extracted from the peak indicated (*) at 40.5 min. Parts of the structure in 
blue depict the possible unknown hydroxylation positi n. (f) Mass spectra extracted from 
echinocystic acid standard. The X-axis of the mass spectra correspond to m/z values. (g) 
Oxidation of β-amyrin by BF567 and CYP716A12. 
 




Table 1. List of yeast strains generated and used in this sudy. 
Name Construct 
S288c BY4742 MATa; his3∆1; leu2∆0; ura3∆0; lys2∆0 
TM1 S288c BY4742; Perg7::PMET3-ERG7 
TM2 TM1; pESC-URA[GAL10/tHMG1; GAL1/MtbAS] (19.03 mg/L β-amyrin)  
TM3 TM1; pESC-URA[GAL10/tHMG1; GAL1/GgbAS] (36.2 mg/L β-amyrin)  
TM5 TM1; pESC-URA[GAL10/tHMG1] 
TM7 TM3; pAG423[GAL1/BF567], pAG425[GAL1/AtATR1] 
TM8 TM3; pAG423[GAL1/BF567], pAG305[GAL1/AtATR1] 
TM9 TM3; pAG423[GAL1/BF567], pAG415[GAL1/AtATR1] 
TM10 TM3; pAG423[GAL1/CYP716A12], pAG425[GAL1/AtATR1] 
TM17 TM3; pAG423[GAL1/CYP716A12], pAG415[GAL1/AtATR1] 
TM26 TM3; pAG423, pAG425[GAL1/AtATR1] 
TM30 TM3; pAG423[GAL1/BF567-T2A-CYP716A12], pAG415[GAL1/AtATR1] 
 
Discussion 
Saikosaponins constitute the most abundant secondary metabolites produced by the genus 
Bupleurum, an integral plant in Asian traditional medicine. The biological activity of the 
genus Bupleurum is generally attributed to the saikosaponins, which are glycosylated 
oleanane- and ursane-type sapogenins. The saikosapogenins are very closely related in 
their structure and contain oxygenations on C-11, C- 6, C-21, C-23, C-28, C-29 or C-30 
(Fujioka et al., 2003; Ashour and Wink, 2011; Nakahar  et al., 2011). However, not a 
single CytP450 involved in the oxygenation of any of these carbon positions has been 
described so far from Bupleurum. We identified BF567, a CytP450 that was tightly co-
regulated with known triterpene saponin biosynthetic genes, through a cDNA-AFLP 
based transcript profiling of MeJA-treated B. falcatum roots. The BF567 was tentatively 
annotated as a homolog of the M. truncatula CYP716A12 and thought to oxygenate C-28 
of the oleanane- and ursane-type sapogenin backbones. I  this study, using a 
combinatorial approach in S. cerevisiae we revealed that BF567 is not a C-28 oxygenase 




but, a novel cytochrome P450 that encodes a β- myrin 16β/21β/29α-hydroxylase 
involved in the synthesis of saikosaponins in Bupleurum. 
For the purpose of this study we generated a highly efficient β-amyrin producing S. 
cerevisiae strain TM3 by expressing an already characterized bAS from G. glabra. By 
employing the same strategy as (Kirby et al., 2008), but utilizing an efficient bAS we 
could generate a yeast strain capable of accumulating 36.2 mg/L β-amyrin in 72 h from 
synthetic medium. This is a considerable (6-fold) improvement over the 6 mg/L of β-
amyrin produced by expressing an A. annua bAS (Kirby et al., 2008). Our lesser efficient 
strain TM2 expressing a M. truncatula bAS was also able to produce 3.2-fold more β-
amyrin (19 mg/L) than (Kirby et al., 2008). However, we have not looked at the levels of 
the other intermediates in sterol biosynthesis of yeast, like squalene and ergosterol among 
others, that can provide vital clues for pathway engineering to further improve the 
amounts of β-amyrin produced by S. cerevisiae, which might be relevant to achieve our 
ultimate goal of creating an industrially compatible triterpene sapogenin producing yeast 
platform. 
We subsequently utilized strain TM3 for the ectopic expression of BF567 and identified a 
hydroxylated product of β-amyrin, that was produced in considerably low amounts in the 
strain TM7 that was used for this analysis. Therefore, we tried to improve the efficiency 
of this reaction by manipulating the relative expression level of the redox partner AtATR1 
we employed, the isoform 1 of cytochrome P450 reductase from A. thaliana, whilst 
keeping the expression of BF567 constant. In this study we have shown for the first t me 
in heterologous triterpene sapogenin (or plant secondary metabolite) biosynthesis that, 
the ratio of CPR to CytP450 plays a key role in the efficient functioning of CytP450s, and 
should be considered while engineering cytochrome P450 mediated reactions in non-
native hosts. On gene expression level we have demonstrated the generally accepted ratio 
of CPR:CytP450 between 1:5 and 1:30 to also hold true for the expression of plant 
CytP450s in heterologous systems. Nonetheless, these ratios are yet to be confirmed on 
protein expression and enzyme activity levels. 




We also addressed the concern of the terpene research community, which has 
reverberated around the fact that triterpene production may not be amenable to 
engineering efforts, like volatile sesquiterpenes and monoterpenes that can diffuse out of 
cells (Kirby et al., 2008), thereby enhancing productivity by disposal of toxic 
heterologous compounds from the cells internal enviro ment. Here, we have described a 
novel approach for transporting triterpenes into the culture medium from within the yeast 
cells by the use of methylated cyclodextrins. We have proven using our engineered 
triterpene yeast strains that it is possible to release hydrophobic compounds like β-amyrin 
and triterpene sapogenins into the spent medium to, a) relieve the cells from exogenous 
compounds, which in turn increases production of the compound and b) facilitate 
downstream processing for product identification and purification. Although the approach 
has been demonstrated for triterpene sapogenins, it can be extended to the extraction of 
any hydrophobic compound from living cells without damaging the integrity of the cell, 
and theoretically can be extended to continuous culture systems for the production of 
valuable hydrophobic compounds, like triterpene sapogenins. 
Lastly, in this study we have generated a combinatorial triterpene sapogenin biosynthesis 
product, using our new CytP450 from B. falcatum, BF567 and CYP716A12 from M. 
truncatula, in our yeast strain expressing a G. glabra β-amyrin synthase and a A. thaliana 
cytochrome P450 reductase. Although we did not characte ize the exact hydroxylation 
position of BF567 using nuclear magnetic resonance (NMR), we decided to combine 
BF567 with CYP716A12 in an attempt to prove the different reaction specificities of the 
two enzymes. We observed a combinatorial product in s rain TM30, the identity of which 
could not be confirmed with the use of an echinocysti  acid standard, that harbors an α-
hydroxyl-group on C-16 and a β-carboxyl-group on C-28 of β-amyrin. However, we 
could exclude a 16α-hydroxylation by BF567. We looked into literature for the other 
possible hydroxylation positions in Bupleurum species and narrowed the possibilities to a 
16β, 21β or 29α (Ashour and Wink, 2011). We still speculate the possibility of a 16β 
hydroxylation based on the EI pattern of the combinatorial product and its longer 
retention time on the column. In case of a 16β hydroxylation, its close proximity with the 
28β carboxyl group could stearically hinder the complete trimethylsilyl derivatization of 




the compound, resulting in only the 3β and 28β positions being derivatized. As a result 
the completely trimethylsilylated echinocystic acid would have a lower vaporizing 
temperature than the bimethylsilylated 3β,16β-dihydroxyolean-28-oic acid, which would 
be reflected by a longer column retention or higher elution time of the latter. 
Additionally, the EI pattern could be interpreted to a biderivatized compound further 
supporting this possibility. However, this does not exclude the possibility of 
hydroxylation at C-21 or C-29 and therefore an NMR on the hydroxylated β-amyrin is 
essential to truly characterize BF567. Nonetheless, a combinatorial approach originally 
developed to generate novel bioactive products, could be exploited for the partial 
characterization of a novel plant β-amyrin 16β/21β/29α-hydroxylase. 
 
Materials and Methods 
Chemicals. β-amyrin, Erythrodiol and Echinocystic acid were purchased from 
Extrasynthese. Hexane, Pyridine and N-Methyl-N-(trimethylsilyl)trifluoroacetamide were 
purchased from Sigma-Aldrich. Methyl-β-cyclodextrin was purchased from CAVASOL. 
α-cyclodextrin, β-cyclodextrin, γ-cyclodextrin and random methyl-β-cyclodextrin (degree 
of substitution, DS~12) were purchased from Cyclolab. 
Cultivation and elicitation of B. falcatum plants. B. falcatum seeds, obtained from a 
commercial source (www.SandMountainHerbs.com), were sown in soil, and 2 weeks 
after germination, seedlings were transferred to aerated hydroponics medium containing 
1 g/L 10-30-20 salts (Scotts, Ohio, USA), pH 6.5. Plants were grown at 16 h/8 h 
light/dark regime, at 21°C. The pH was monitored daily nd adjusted to 6.5, by adding 
KOH to the hydroponics medium. Three weeks after th plants were transferred to the 
hydroponics medium, they were treated with 50 µM methyl jasmonate (MeJA) (dissolved 
in ethanol (EtOH)) or an equivalent amount of EtOH as a control, by adding the EtOH or 
MeJA solution directly to the hydroponics medium. For transcript profiling, roots were 
harvested 0, 0.5, 1, 2, 4, 8 and 24 h after treatment, frozen in liquid nitrogen, and stored at 
-70°C. For each sample, 3 individual plants were pooled. 




Transcript profiling.  After appropriate sample preparation, cDNA-AFLP based 
transcript profiling with all 128 possible BstYI+1/MseI+2 primer combinations was 
performed as described (Vuylsteke et al., 2007). Gel images were analyzed with the 
AFLP-QUANTARPRO software (Keygene, Wageningen, The N therlands), allowing 
accurate quantification of band intensities. The intensity of all individual bands was 
determined, and the obtained raw expression data was corrected for lane variations (due 
to PCR or loading differences) by dividing the raw data by a correction factor. The 
correction factor was calculated by dividing the sum of the expression levels of all 
fragments within one lane by the highest sum of all lanes within a primer combination. 
Subsequently, the standard deviation and the average w s calculated for each individual 
band. Individual gene expression profiles were variance normalized by subtracting the 
calculated average from each individual data point, after which the obtained value was 
divided by the standard deviation. A coefficient of variation (CV) was obtained by 
dividing the standard deviation by the calculated aver ge. Gene tags displaying 
expression values with a CV ≥ 0.5 were considered as differentially expressed. Based on 
this cut-off value, together with visual inspection f cDNA-AFLP gels, differentially 
expressed gene tags were selected for further analysis. Cluster analysis, sequencing, and 
BLAST analysis in publicly available protein databases using a translated nucleotide 
query (blastx) or nucleotide database using a nucleotid  query (blastn) was performed as 
described (Rischer et al., 2006). 
Phylogenetic analysis. The protein sequences were retrieved from GenBank and aligned 
with ClustalW. The phylogenetic tree was generated in MEGA 4.0.1 software (Tamura et 
al., 2007), by the Neighbor-Joining method, and bootstrapping was performed with 1000 
replicates. The evolutionary distances were computed using the Poisson correction 
method, and all positions containing gaps and missing data were eliminated from the data 
set (complete deletion option). 
Full length cloning of BF567. Using the primers P11 + P12, the full-length coding 
sequence of BF567 was screened for in a B. falcatum Uncut Nanoquantity cDNA library 
(custom-made by Invitrogen, Carlsbad, CA, USA) as repo ted (Pollier et al., 2011b). The 




full-length open reading frame (FL-ORF) of BF567 was PCR amplified for GatewayTM 
cloning using the primer pair P21 + P22 (Table 2). 
Generation of strain TM1. The native ERG7 promoter of a wild type S288c BY4742 
strain was replaced with a MET3 promoter using a PCR based gene targeting approach 
(see addendum 2) as described previously for ERG9 in S. cerevisiae CEN.PK 113-7D 
(Asadollahi et al., 2008). First, plasmid pIP007 was created by amplifying the MET3 
promoter from the genomic DNA of BY4742 using primers P1 + P2 (Table 2) followed 
by ligation of the digested PCR fragment into the Sp I and SacII sites of plasmid pUG6, 
which harbors the KanMX selection cassette. Next, two overlapping PCR fragments a 
and b, were amplified from pIP007, using the primer pairs P3 + P4 and P5 + P6 
(Table 2), respectively. Further, fragment c, corresponding to the genomic region 500 bp 
upstream of ERG7 promoter and fragment d, corresponding to 500 bp of the start of 
ERG7 coding sequence (CDS) were amplified from the genome of BY4742 using the 
primer pairs P7 + P8 and P9 + P10 (Table 2), respectively. The gel purified PCR 
fragments were then combined in pairs, a+c and b+d to generate two fused overlapping 
fragments e and f, using the primer pairs P7 + P4 and P5 + P10, respectively. A S. 
cerevisiae BY4742 wild type strain was transformed with the gel purified fragments e 
and f, using the lithium acetate mediated transformation method, and transformants with 
the ERG7 promoter replaced by the MET3 promoter, were selected on YPD medium 
(Yeast extract Peptone Dextrose, Clontech) supplemented with 200 µg/mL G-418 
Disulfate (Geneticin, Duchefa). An overview of all the yeast strains generated from TM1 
is given in Table 1. 
Generation of plasmid vectors. The tHMG1 gene (coding amino acids 532 to 1054 of 
HMG1p (Polakowski et al., 1998)) was amplified from the chromosomal HMG1 gene 
using primers containing NotI and PacI restriction sites P13 + P14, and inserted into the 
MCS1 of pESC-URA (Agilent Technologies) to generate pESC-URA[GAL10/tHMG1]. 
The bAS was inserted into the MCS2 of the generated plasmid to create pESC-
URA[GAL10/tHMG1; GAL1/bAS]. The bAS of M. truncatula and G. glabra were 
amplified using XhoI and KpnI containing primers, P15 + P16 and P17 + P18 (Table 2), 




respectively. All constructs were first inserted into GatewayTM vector pDONR221 to 
facilitate sequence verification prior to insertion nto their respective expression vectors. 
The FL-ORF of A. thaliana CPR (AtATR1, At4g24520), B. falcatum BF567 and M. 
truncatula CYP716A12 were PCR amplified using primers P19 + P20, P21 + P22, and 
P23 + P24 (Table 2), respectively and cloned into the entry vector pDONR221 by 
GatewayTM recombination. The AtATR1 was further recombined into the integrating, low-
copy number and high-copy number yeast expression vectors pAG305GAL-ccdB 
(Addgene plasmid 14137), pAG415GAL-ccdB (Addgene plasmid 14145) and 
pAG425GAL-ccdB (Addgene plasmid 14153), respectively and all having the galactose 
inducible GAL1 promoter and LEU2 auxotrophic marker. The entry clones of BF567 and 
CYP716A12 were recombined into the high-copy number expression vector 
pAG423GAL-ccdB (Addgene plasmid 14149) with the GAL1 promoter and HIS3 
auxotrophic marker. 
The self-processing polyprotein of BF567 and CYP716A12, was generated by amplifying 
the FL-ORF of BF567 without a stop codon and having a 3’- overhang of the partial T2A 
sequence using the primer pair P21 + P25. The FL-ORF of CYP716A12 was amplified 
with a 5’- overhang of the partial T2A sequence using the primers P26 + P24 such that 
there was an overlap of 7 bp between the two amplified sequences. Since the primers P25 
and P26 contain an Uracil each, the BF567 and CYP716A12 were PCR amplified using 
the Pfu Turbo Cx polymerase (Stratagene). The purified gel fragments were used for 
Uracil-Specific Excision or USERTM Cloning (New England Biolabs) to generate two 
fragments with complementary sticky ends which were ligated in vitro using the T4 DNA 
ligase (Invitrogen). The ligated DNA product was once again gel purified and used as 
template for amplification with the primers P21 + P24. This amplicon was GatewayTM 
recombined into pDONR221, sequence verified and further recombined into 
pAG423GAL-ccdB to generate pAG423[GAL1/BF567-T2A-CYP716A12]. 
Culturing of yeast cells for metabolite analysis. Precultures were grown at 30°C, 
250 rpm for 18-20 h in 5 ml synthetic defined (SD) medium containing glucose 
(Duchefa, Clontech) and appropriate drop out (DO) supplements (Duchefa, Clontech). 




The precultures were washed twice with water to remove glucose prior to inoculating 
15 ml SD Gal/Raf medium containing galactose and raffinose as carbon source (Duchefa, 
Clontech) and appropriate DO supplements to a starting optical density of 0.25. The 
cultures were incubated as before for 24 h before ERG7 repression by adding 2.25 ml of 
10 mM methionine to a final concentration of 1.5 mM. The cultures were incubated 
further for 48 h. 
MβCD treatment was carried out by adding 300 µl or 1500 µl of, a 250 mM MβCD stock 
to a final concentration of 5 mM or 25 mM, respectively. To determine the specificity of 
CD variants, αCD, βCD, γCD, RMβCD and MβCD treatment was carried out by adding 
750 µl of a 100 mM stock to a final concentration of 5 mM. 
Metabolite extraction and GC-MS analysis. An organic extract of the yeast cells or 
spent medium was prepared for identification and quantification using GC-MS. For 
extraction from yeast cells, a 1 ml culture was pellet d by centrifugation at 10,600 x g for 
1 min, resuspended in an ethanolic potassium hydroxi e solution (250 µl 40% KOH, 
250 µl 50% ethanol), boiled at 95°C for 10 min, and allowed to cool to room temperature. 
For extraction from the spent medium, only the supernatant post centrifugation of a 1 ml 
culture was used. On both the lyzed cell pellet and spent medium, a first extraction was 
performed with 500 µl hexane by vortexing at high speed for 1 min. The p ases were 
separated by centrifugation at 10,600 x g for 1 min, and the organic phase was transferred 
to a fresh tube. The extraction was repeated two more times on the aqueous phase with 
500 µl hexane each and the organic phases pooled (~1400 µl) and vaporized to dryness. A 
trimethylsilyl derivatization was performed on the dry material, by adding 20 µl pyridine 
and 100 µl N-methyl-N-(trimethylsilyl)trifluoroacetamide directly to the tube, vortexing 
and incubating at room temperature for 15 min. The derivatized material was transferred 
to GC vials and subjected to GC-MS (GC model 6890, MS model 5973, Agilent). A 1 µl 
aliquot was injected (splitless mode) into a VF-5ms capillary column (Varian CP9013, 
Agilent) and operated at a constant helium flow of 1 ml/min. The injector temperature 
was set to 280°C and the oven temperature was held at 80°C for 1 min post injection, 
ramped to 280°C at 20°C/min, held at 280°C for 45 min, ramped to 320°C at 20°C/min, 
held at 320°C for 1 min, and finally cooled down to 80°C at 50°C/min at the end of the 




run. The MS transfer line was set to 250°C, the MS ion source to 230°C and the 
quadrupole to 150°C, throughout. For identification f metabolites a full mass spectra 
was generated by scanning the m/z range of 60-800 with a solvent delay of 7.8 min. For 
quantification of β-amyrin a select ion mode was operated detecting the ions 498, 483, 
393, 279, 218, 203 and 189. The areas of the peaks were calculated using the default 
settings of the AMDIS software (version 2.6, NIST, USA). 
Table 2. Primers used in this study. 
Primer Sequence (5’ to 3’) 









P8 CATGGCAATTCCCGGGGATCCCG AAACATCGACTTTATCGAGG 
P9 ATGACAGAATTTTATTCTGACACAATCG 
P10 CCTTCCCATTTATACAAGTTTAGTGC 


















P26 ATGCGGUGACGTCGAGGAGAATCCTGGCCCA TGGAGCCTAATTTCTATC 
The sequences in lower case represent the restriction recognition site used for restriction 
enzyme mediated cloning. The underlined sequence corresponds to T2A partial 
sequences. 
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Maesasaponins are oleanane-type saponins with diverse biological activities produced by 
the indigenous African plant Maesa lanceolata. The maesasapogenins harbor 
modifications on positions C-16, C-21, C-22 and C-28 of the oleanane backbone, the 
latter being involved in hemiacetal and ester bridge formation. In this study we have 
characterized three enzymes, a β- myrin synthase which is the first committed enzyme of 
the oleanane-type triterpene saponin biosynthesis, a C-28 oxidase involved in bridge 
formations and a putative C-21 hydroxylase, involved in the biosynthesis of 
maesasaponins. 









Triterpenoid saponins are a large class of diverse plant secondary metabolites produced 
by many plant species (Sparg et al., 2004; Vincken et al., 2007). They belong to the class 
of isoprenoid natural products and are composed of 6 isoprene units resulting in a total of 
30 carbon atoms, that are arranged in 4 or 5 ring structures to form triterpene sapogenin 
backbones like β-amyrin, α-amyrin, lupeol and dammarenediol. These diverse sapogenin 
backbones are derived from a common precursor 2,3-oxidosqualene, an intermediate of 
membrane sterol biosynthesis in eukaryotes, via specific plant oxidosqualene cyclase 
(OSC) mediated cyclizations. The triterpenoid saponin structural diversity is further 
aggravated by multiple cytochrome P450 monooxygenase (CytP450) mediated 
modifications of the sapogenin backbone, which generates “sapogenins” containing 
reactive functional groups (hydroxyl-, carboxyl-, oxo-, etc). The subsequent UDP-
glycosyltransferase mediated glycosylations of these functional groups results in the 
formation of biologically active saponin moieties (Osbourn et al., 2011). 
Maesa lanceolata, a member of the Myrsinaceae family, is a shrub or small tree 
indigenous to Africa. African traditional healers ue extracts and/or parts of the plant for 
the treatment of a wide range of diseases including infectious hepatitis, bacillary 
dysentery, impetigo, ozena, dermatoses and neuropathies. Methanol extracts of M. 
lanceolata leaves are rich in maesasaponins and have been shown to possess virucidal, 
molluscicidal, fungistatic and antimutagenic activities (Sindambiwe et al., 1998). The 
maesasaponins identified so far are derived from an oleanane skeleton via modifications 
of the β-amyrin backbone, resulting in a characteristic C-13,28 hemiacetal or ester bridge 
and oxidations on C-16, C-21 and C-22 (Fig. 1) (Foubert et al., 2010; Manguro et al., 
2011). The hemiacetal or ester bridge between C-13 and C-28 is thought to occur through 
the reaction between a C-13 hydroxyl and C-28 aldehy  or carboxyl group, respectively 
(Vincken et al., 2007). The presence of these diverse oleanane maesasaponins suggests 
the presence of a β-amyrin specific OSC (or β-amyrin synthase) along with specific 
CytP450s catalyzing oxygenations at C-16, C-21, C-22 and C-28 in M. lanceolata. 
However, to date not a single triterpene saponin biosynthetic gene has been identified 
from Maesa. 





Figure 1. Chemical structure of maesasapogenins. 
 
In the past, several plant β-amyrin synthases have been functionally characterized in 
yeast, including from Artemisia annua (Kirby et al., 2008), Medicago truncatula (Suzuki 
et al., 2002), Glycyrrhiza glabra (Hayashi et al., 2001) and Saponaria vaccaria 
(Meesapyodsuk et al., 2007). Additionally, cytochrome P450s catalyzing the C-28 
oxidation of triterpene backbones have been identifi d from M. truncatula (Carelli et al., 
2011), Vitis vinifera (Fukushima et al., 2011) and Catharanthus roseus (Huang et al., 
2012). Furthermore, we identified a C-16β/21β/29α hydroxylase from Bupleurum 
falcatum (see chapter 4). These CytP450s have also been functionally characterized using 
yeast cells. 
The current study describes the identification of putative maesasaponin biosynthetic 
genes through cDNA-AFLP based transcript profiling, the application of degenerate PCR 
for gene cloning and the functional characterization of a β-amyrin synthase and two 
CytP450s involved in the oxidation of C-28 (ML257) and most probably, hydroxylation 
of C-21β (ML593) of the oleanane backbone using an engineered Saccharomyces 
cerevisiae strain. 
 





Transcript profiling of MeJA treated M. lanceolata shoots reveals ML257 and 
ML593. 
To identify new saponin biosynthetic genes, we performed a transcript profiling on 
methyl jasmonate (MeJA) treated M. lanceolata axenic shoot cultures. Using the 
complete set of 128 BstYI+1/MseI+2 primer combinations, a genome-wide cDNA-AFLP 
transcript profiling analysis (Vuylsteke et al., 2007) was carried out to monitor the 
expression of a total of 13,558 transcript tags over time. In total, 733 MeJA-responsive 
transcript tags were isolated (hereafter referred to as ML tags). Direct sequencing of the 
reamplified ML tags gave good quality sequences for 545 (74.4%) of the fragments. To 
the remaining 188 tags (25.6%), no unique sequence could be attributed unambiguously, 
indicating that they might not represent unique gene tags and hence, these were not 
considered for further analysis. A BLAST search with the nucleotide sequences of the 
545 unique cDNA-AFLP tags led to the annotation of 312 (57.2%) of the ML tags. 
Average linkage hierarchical clustering analysis of the expression profiles of the ML tags 
showed that, upon MeJA treatment the genes are either transcriptionally activated 
(Clusters I-V, Fig. 2a) or transcriptionally repress d (Cluster VI, Fig. 2a). The activated 
gene tags can be divided into 5 subclusters, based on their MeJA response time. A first 
cluster consists of genes with a response immediately fter (≤ 2 h) MeJA treatment 
(cluster V). In a second cluster (Cluster IV), genes r ach maximum expression 4-8 h after 
MeJA treatment. In a third cluster (Cluster II), genes are activated 2 h after MeJA 
treatment and their expression remains high thereafter. In a fourth and fifth cluster 
(Clusters III and I, respectively), genes are activated 24 h after MeJA treatment. In cluster 
III a gene tag that reached maximum levels of expression 24-48 h post-elicitation and 
corresponding to squalene epoxidase (SQE) can be found (Fig. 2b). 
The gene tags ML257 and ML593, corresponding to CytP450s are tightly co-regulated 
with this gene (Fig. 2b). The gene tag ML257 shows homology to the M. truncatula 
CYP716A12 that was shown to oxidize β-amyrin in a sequential three-step oxidation on  





Figure 2. Transcript profiling of jasmonate elicited M. lanceolata plants. (a) General 
view on the average linkage hierarchical cluster and tree of all 545 unique ML tags. (b) 
Subcluster of the M. lanceolata transcriptome, comprising all tags corresponding to enes 
reported to be involved in terpene biosynthesis, or with high sequence similarity to such 
genes, and all gene tags corresponding to CytP450s. Treatments and time points (in h) are 
indicated on top. Blue and yellow boxes reflect transcriptional activation and repression 
relative to the average expression level, respectivly. Gray boxes correspond to missing 
time points. (c) Phylogenetic relationship between CytP450 proteins i volved in 
triterpene saponin biosynthesis. Arrowheads indicate the CytP450s functionally defined 
in this study. Scale bar indicates the number of amino acid substitutions per site. 
 
C-28 to yield oleanolic acid through erythrodiol (Carelli et al., 2011; Fukushima et al., 
2011), and the gene tag ML593 shows homology to the A. thaliana steroid 22α-
hydroxylase gene encoding a CytP450 enzyme that catlyzes the oxidation of sterols on 
the C-22 position (Fujita et al., 2006). The full-length open reading frame of ML257 and 
ML593 corresponding to the respective gene tags was picked up from a M. lanceolata 
Uncut Nanoquantity cDNA library (Pollier et al., 2011). Phylogenetic analysis of all the 
CytP450s characterized to be involved in triterpene saponin biosynthesis (Fig. 2c) 
showed that ML257 groups together with the CYP716 family of CytP450s and ML593 




formed an isolated branch. The ML257 encodes a polypeptide of 485 amino acids 
showing 76% identity with CYP716AL1 from Catharanthus roseus (AEX07773), 73% 
identify with CYP716A15 from Vitis vinifera (BAJ84106) and 69% identity with 
CYP716A12 from Medicago truncatula (ABC59076). 
 
Cloning and in vivo characterization of M. lanceolata β-amyrin synthase. 
Since no cDNA-AFLP tag corresponding to β-amyrin synthase (bAS) was encountered in 
the cDNA-AFLP transcript profiling analysis, we amplified a gene tag corresponding to 
bAS from a M. lanceolata cDNA template using degenerate oligonucleotide prime s. The 
obtained sequence allowed us to generate a gene tag that was used to screen for the full-
length open reading frame of M. lanceolata β-amyrin synthase (MlbAS) in a cDNA 
library (Pollier et al., 2011). The MlbAS encodes a polypeptide of 760 amino acids 
showing 75% identity with GgbAS from Glycyrrhiza glabra (BAA89815) and 74% 
identity with MtbAS from Medicago truncatula (AES86318). 
Using our yeast strain TM1 (Table 1) with the modified ergosterol biosynthesis (see 
chapter 4), we generated a strain TM4 harboring the plasmid pESC-
URA[GAL10/tHMG1; GAL1/MlbAS]. We cultured TM4 and the control strain TM5 
(Table 1) in galactose medium for 24 h, prior to repression of ERG7 with 1.5 mM 
methionine for 48 h. The cell pellets of 72 h cultures were used for metabolite extraction 
and analyzed by GC-MS. The GC chromatogram of TM4 showed a single peak at 
27.2 min (Fig. 3a) with electron ionization (EI) pattern corresponding to a β-amyrin 
standard (Fig. 3c). This peak was absent in the control strain TM5 (Fig. 3b). However, the 
β-amyrin peak in TM4 could only be confirmed on the mass spectrometer (MS) with 
select ion monitoring, indicating the low concentration of β-amyrin produced by the 
strain, which in turn suggests the poor 2,3-oxidosqualene cyclization efficiency of 
MlbAS, to generate β-amyrin. Therefore, we decided to continue further experiments with 
the high β-amyrin producing strain TM3 (Table 1, chapter 4). 





Figure 3. GC chromatograms corresponding to, (a) Extraction from cells of strain TM4, 
expressing tHMG1 and MlbAS. (b) Extraction from cells of control strain TM5, 
expressing tHMG1. (c) A β-amyrin standard. Right panels show the mass spectra 
extracted from the indicated (*) peak, where the X-axis corresponds to m/z values. The 
X- and Y-axis of the GC chromatograms correspond to time in minutes and total ion 
current, respectively. 
 
In vivo characterization of ML257 as a C-28 oxidase. 
We generated strain TM20 by super-transforming the β-amyrin producing strain TM3 
(Table 1) with the plasmids pAG415[GAL1/AtATR1] and pAG423[GAL1/ML257], where 
the cytochrome P450 reductase (CPR, AtATR1) was expressed from a low-copy number 
plasmid (pAG415) and the CytP450 from a high-copy number plasmid (pAG423), to 
maintain a CPR:CytP450 ratio between 1:5 and 1:30 (see chapter 4). In parallel, we 
generated a control strain TM27 not expressing any CytP450, but harboring the plasmid  




pAG415[GAL1/AtATR1] and pAG423GAL-ccdB in the strain TM3. The strains were 
cultured in the presence of methyl-β-cyclodextrin (MβCD), to facilitate extraction of 
hydrophobic metabolites from the yeast cells (see chapter 4), and the spent medium was 
analyzed for the presence of β-amyrin and hydroxylated β-amyrin by GC-MS. 
Strain TM20 expressing the CytP450 ML257, annotated as a homolog of the M. 
truncatula CYP716A12, showed three new peaks eluting at 32.5 min, 35.4 min and 
36.6 min in the extracts from the spent medium (Fig. 4a). The CYP716A12 (GenBank 
accession number FN995113; (Carelli et al., 2011)) is a C-28 oxidase that catalyzes the 
conversion of β-amyrin to oleanolic acid in a three-step reaction via the intermediates 
erythrodiol and most likely an oleanolic aldehyde (Carelli et al., 2011). Therefore, we 
compared the GC chromatograms of TM20 with that obtained from the spent medium of 
strain TM17 (Table 1) expressing the M. truncatula CYP716A12 and the control strain 
TM27 (Fig. 4c). Alongside we also determined the elution time and EI pattern of 
erythrodiol (Fig. 4d) and oleanolic acid (Fig. 4e) standards. We observed the same three 
peaks eluting at 32.5 min, 35.4 min and 36.6 min in TM17 (Fig. 4b), as we observed in 
TM20 and could confirm the identity of these peaks as erythrodiol (32.5 min) and 
oleanolic acid (35.4 min). Although the EI pattern of the peak eluting at 36.6 min could 
be interpreted as oleanolic aldehyde in both strains TM20 and TM17, we could not 
confirm its elution time due to the lack of an authentic standard. 
Nonetheless, our data confirms ML257 to be a C-28 oxidase that catalyzes the three-step 
oxidation of β-amyrin to oleanolic acid. Additionally, we observed differences in the 
efficiency of the three step oxidation of β-amyrin to oleanolic acid between strains TM20 
and TM17. The M. lanceolata ML257 in strain TM20 exhibited a lower efficiency to 
produce oleanolic acid than CYP716A12. When comparing the amounts of β-amyrin, 
erythrodiol, oleanolic aldehyde and oleanolic acid between the two strains (Fig. 5), TM20 
was found to accumulate 3-fold more erythrodiol than TM17, while the relative amounts 
of β-amyrin and oleanolic aldehyde remained comparable between the two strains. 
Contrary to the substrate and the intermediates, th amount of oleanolic acid was 2-fold 
lesser in strain TM20 compared to TM17. The high efficiency of CYP716A12 to oxidize 
β-amyrin to oleanolic acid has been reported earlier for both in vitro (Carelli et al., 2011) 




and in vivo (Fukushima et al., 2011) activity of the CytP450, where either no or very low 
amounts of erythrodiol was detected, respectively. 
 
 
Figure 4. GC chromatograms (first column) corresponding to, (a) Extraction from spent 
medium of strain TM20, expressing tHMG1, GgbAS, AtATR1 and ML257. (b) Extraction 
from spent medium of strain TM17, expressing tHMG1, GgbAS, AtATR1 and 
CYP716A12. (c) Extraction from spent medium of control strain TM27, expressing 
tHMG1, GgbAS and AtATR1. (d) An erythrodiol standard. (e) An oleanolic acid standard. 
Columns two to four show the mass spectra extracted from the indicated (*) peaks, where 
the X-axis corresponds to m/z values. The X- and Y-axis of the GC chromatograms 
correspond to time in minutes and total ion current, respectively. 






Figure 5. Relative amounts of β-amyrin, erythrodiol, oleanolic aldehyde and oleanolic 
acid produced by the strains TM20 and TM17, expressing ML257 and CYP716A12, 
respectively. 
 
In vivo characterization of ML593. 
To characterize the second putative CytP450, ML593 from our transcript profiling, we 
generated strain TM21 from the β-amyrin producing strain TM3 (Table 1), by super-
transforming with the plasmids pAG415[GAL1/AtATR1] and pAG423[GAL1/ML593]. 
The strains TM21 and TM27 (Table 1) were cultured in the presence of MβCD and the 
spent medium analyzed by GC-MS. We observed a new pak eluting at 31.8 min 
corresponding to a hydroxylated β-amyrin in strain TM21 (Fig. 6a), but not in the control 
strain TM27 (Fig. 6c). The EI pattern of this peak (Fig. 6a) corresponded to a 
hydroxylation on the D or E ring of the oleanane structure and was similar to that 
observed with strain TM9 (Table 1) expressing BF567 (Fig. 6b). The strong similarity 
between the elution time and EI pattern of the hydroxylated β-amyrin in strain TM21 and 
TM9 further supports this assumption. We also observed that strain TM21 produced 8-
fold more hydroxy β-amyrin than strain TM9, highlighting the better efficiency of ML593 
for hydroxylating β-amyrin as compared to BF567. 





Figure 6. GC chromatograms corresponding to, (a) Extraction from spent medium of 
strain TM21, expressing tHMG1, GgbAS, AtATR1 and ML593. Arrow heads indicate the 
positions that could be hydroxylated by ML593 and are common with predicted positions 
of BF567. (b) Extraction from spent medium of strain TM9, expressing tHMG1, GgbAS, 
AtATR1 and BF567. (c) Extraction from spent medium of control strain TM27, expressing 
tHMG1, GgbAS and AtATR1. Right panel shows mass spectra extracted from the 
indicated (*) peaks, where the X-axis corresponds to m/z values. The X- and Y-axis of 
the GC chromatograms correspond to time in minutes and total ion current, respectively. 
 
To confirm the identity of ML593 as a functional homolog of BF567, we generated strain 
TM31, similar to strain TM30 (Table 1) (see chapter 4). Strain TM31 was created by 
supertransforming TM3 with the plasmids pAG415[GAL1/AtATR1] and 
pAG423[GAL1/ML593-T2A-CYP716A12], where ML593 and CYP716A12 form a self-
processing polyprotein stitched together by the 2A oligopeptide (de Felipe et al., 2006) 




and is expressed from a single GAL1 promoter. The strains TM31, TM17 and TM21 
(Table 1) were cultured in the presence of MβCD and the spent medium was analyzed 
using GC-MS. Similar to strain TM30 (Fig. 7d), we observed a new peak eluting at 
40.5 min in strain TM31 (Fig. 7a), but not the strains TM17 (Fig. 7b) and TM21 (Fig. 7c) 
expressing only the CytP450 CYP716A12 and ML593, respectively. From the EI pattern 
of this peak we could confirm its identity as being the same as in strain TM30. Maesa 
saponins with C-16α and/or C-21β hydroxylations on the rings D and E of β-amyrin have 
been reported so far. Similarly, the saikosaponins from Bupleurum have C-16β, C-21β 
and/or C-29 hydroxylations on the D and E rings of β-amyrin. The oxidation positions 
known from literature together with the lack of homology, of the peak at 40.5 min in 
strains TM30 and TM31, with echinocystic acid suggests a β-hydroxylation on C-21 by 
BF567 and ML593, the only remaining position commonly hydroxylated between 
Bupleurum and Maesa species. 
 
Table 1. List of yeast strains generated and used in this sudy. 
Name Construct 
S288c BY4742 MATa; his3∆1; leu2∆0; ura3∆0; lys2∆0 
TM1 S288c BY4742; Perg7::PMET3-ERG7 
TM3 TM1; pESC-URA[GAL10/tHMG1; GAL1/GgbAS] (36.2 mg/L β-amyrin)  
TM4 TM1; pESC-URA[GAL10/tHMG1; GAL1/MlbAS] 
TM5 TM1; pESC-URA[GAL10/tHMG1] 
TM9 TM3; pAG423[GAL1/BF567], pAG415[GAL1/AtATR1] 
TM17 TM3; pAG423[GAL1/CYP716A12], pAG415[GAL1/AtATR1] 
TM20 TM3; pAG423[GAL1/ML257], pAG415[GAL1/AtATR1] 
TM21 TM3; pAG423[GAL1/ML593], pAG415[GAL1/AtATR1] 
TM27 TM3; pAG423, pAG415[GAL1/AtATR1] 
TM30 TM3; pAG423[GAL1/BF567-T2A-CYP716A12], pAG415[GAL1/AtATR1] 
TM31 TM3; pAG423[GAL1/ML593-T2A-CYP716A12], pAG415[GAL1/AtATR1] 





Figure 7. GC chromatograms corresponding to, (a) Extraction from spent medium of 
strain TM31, expressing tHMG1, GgbAS, AtATR1, CYP716A12 and ML593. (b) 
Extraction from spent medium of strain TM17, expressing tHMG1, GgbAS, AtATR1 and 
CYP716A12. (c) Extraction from spent medium of strain TM21, expressing tHMG1, 
GgbAS, AtATR1 and ML593. (d) Extraction from spent medium of strain TM30, 
expressing tHMG1, GgbAS, AtATR1, CYP716A12 and BF567. (e) An echinocystic acid 
standard. Right panel shows the mass spectra of indicate  (*) peaks, where the X-axis 
corresponds to m/z values. The X- and Y-axis of the GC chromatograms correspond to 
time in minutes and total ion current, respectively. Parts of structure highlighted in blue 
indicate probable hydroxylation positions. 





The maesasaponins constitute a suite of oleanane derive  triterpenoid saponins 
distinguishable by their characteristic C-13,28 hemiacetal or ester bridges, which result 
from the reaction between a C-13 hydroxyl and C-28 aldehyde or carboxyl group, 
respectively. Additional oxidations also occur on C-16, C-21 and C-22 of the oleanane 
backbone. However, to date not a single enzyme involved in either, the formation of or, 
modification of the oleanane backbone had been elucidated from M. lanceolata. Here, we 
identified a β-amyrin synthase, the first committed enzyme for the production of 
oleanane-type triterpene saponins and two CytP450 monooxygenases (ML257 and 
ML593), involved in the biosynthesis of maesasaponins. 
Through a degenerate PCR approach we cloned a β-amyrin synthase from M. lanceolata 
and functionally characterized it using a sterol modified S. cerevisiae strain. However, 
only very low amounts of β-amyrin was produced, which we tentatively attribute to a bad 
‘exogenous functionality’ of the MlbAS gene. For instance, yeast expressing the β-amyrin 
synthase from Artemisia annua has been reported to produce 6 mg/L of β-amyrin (Kirby 
et al., 2008), while we have reported a 36 mg/L and  19 mg/L β-amyrin producing strain 
by expressing the bAS from Glycyrrhiza glabra or Medicago truncatula, respectively, 
even though all these yeast strains harbored the sam  modifications in their ergosterol 
biosynthesis (see chapter 4). This variability in the exogenous activity of bAS in yeast, 
might not necessarily be reflective of their in planta enzyme efficiency. The 
inconsistencies in enzyme activity can be attributed to factors including the lack of 
upstream elements for the optimal expression of plant genes in yeast, unoptimized codon 
usage, protein misfolding, protein instability, etc. 
Therefore, for the characterization of the CytP450s we employed a high β-amyrin 
producing yeast strain. We identified ML257 as a homolog of the M. truncatula C-28 
oxidase (CYP716A12) and could confirm its function in the oxidation of β-amyrin to 
oleanolic acid via the intermediates erythrodiol and oleanolic aldehyde. Although the role 
of the intermediate, oleanolic aldehyde, in this reaction is yet to be generally accepted, 
we detected its presence in our yeast strains expressing either the ML257 or the 




CYP716A12. Additionally, in our yeast strain the ML257 favored the C-28 hydroxylation 
of β-amyrin to erythrodiol over its subsequent oxidation t  oleanolic acid. The relative 
higher amounts of erythrodiol in ML257 strain, could be reflective of the presence of 
non-bridged C-28 hydroxylated saponins in M. lanceolata (Manguro et al., 2011), a 
branch of saponins never detected in M. truncatula from which the CYP716A12 
originated. The further oxidation of erythrodiol to oleanolic aldehyde and oleanolic acid 
are essential for their involvement in the hemiacetl and ester bridge formation with C-
13, in M. lanceolata. 
In our genome-wide transcript profiling we also identified a second CytP450 (ML593) 
that was annotated as a homolog of the 22α-hydroxylase of sterols (CYP90B1), but 
tightly co-regulated with other triterpene saponin b osynthetic genes. Using our yeast 
strain we could functionally characterize this gene to catalyze the same hydroxylation of 
β-amyrin (or triterpene sapogenins) as BF567 (characterized in chapter 4) and was found 
to be its functional homolog. Although the BF567 and ML593 belong to different 
CytP450 families (CYP716A and CYP90B, respectively), in our yeast strain they 
demonstrate the same catalytic activity. To the best of our knowledge this is a first report 
demonstrating the functional homology of CytP450s belonging to two different families, 
involved in triterpene saponin biosynthesis. 
The hydroxylations at C-16 and C-21 in maesasaponins occur as α and β-hydroxy groups, 
respectively. The lack of EI homology between the combinatorial product in strain TM31 
and an echinocystic acid standard suggests, that ML593 does not catalyze a 16α-
hydroxylation on the triterpene backbone and most likely is involved in the hydroxylation 
of C-21. This can only be verified by NMR of the hydroxylated β-amyrin structure 
produced by strain TM21 or TM31 due to the absence of authentic 3β,21β-
dihydroxyolean-12-ene and 3β,21β-dihydroxyolean-28-oic acid standards. 
Hence, we have in this study identified and characterized three genes involved in the 
biosynthesis of maesasaponins. These include a β-amyrin synthase which is the first 
committed enzyme involved in the cyclization of thepr cursor 2,3-oxidosqualene to the 
oleanane backbone, a putative C-21β hydroxylase and a C-28 oxidase catalyzing a) the 




hydroxylation of the oleanane backbone to 28-hydroxy sapogenins involved in the 
production of non-bridged maesasaponins, b) the C-28 aldehyde formation to generate 
the hemiacetal-bridged maesasaponins and c) the carboxylation of the oleanane backbone 
to generate the ester-bridged maesasaponins. 
 
Materials and Methods 
Chemicals. β-amyrin, Erythrodiol, Oleanolic acid and Echinocystic acid were purchased 
from Extrasynthese. Hexane, Pyridine and N-Methyl-N-(trimethylsilyl)trifluoroacetamide 
were purchased from Sigma-Aldrich. Methyl-β-cyclodextrin was purchased from 
CAVASOL. 
Cultivation and elicitation of M. lanceolata plants. M. lanceolata axenic shoot cultures 
were generated and maintained as described (Faizal et al., 2011). For elicitation, each pot 
of shoot culture was sprayed with 2 ml deionized water containing 0.05% (v/v) Tween-20 
in combination with 500 µM MeJA (10 µl of 100 mM stock dissolved in ethanol) or an 
equivalent amount of ethanol as control. For transcript profiling, samples were collected 
0, 0.5, 1, 2, 4, 8, 24 and 48 h after elicitor or mock treatments. For each sample, 3 
different plants were pooled. 
Transcript profiling.  The cDNA-AFLP based transcript profiling was performed with 
all 128 possible BstYI+1/MseI+2 primer combinations as described (Vuylsteke et al., 
2007). For accurate quantification of band intensitie  he gel images were analyzed with 
the AFLP-QUANTARPRO software (Keygene, Wageningen, The Netherlands). After 
determining the intensity of all individual bands, the raw expression data was corrected 
for lane variations by dividing with a correction factor, which was calculated by dividing 
the sum of the expression levels of all fragments wi hin one lane with the highest sum of 
all lanes within a primer combination. Next, the standard deviation and average was 
calculated for each individual band. Individual gene expression profiles were variance 
normalized by subtracting the calculated average from each individual data point, and the 




obtained value was divided by the calculated standard deviation. A coefficient of 
variation (CV) was obtained by dividing the standard deviation by the calculated average. 
Gene tags displaying expression values with a CV ≥ 0.5 were considered as differentially 
expressed. Based on this cut-off and visual inspection of the cDNA-AFLP gels, 
differentially expressed gene tags were selected for further analysis. Cluster analysis, 
sequencing, and BLAST analysis in publicly available protein databases using a 
translated nucleotide query (blastx) or nucleotide database using a nucleotide query 
(blastn) was performed as described (Rischer et al., 2006). 
Phylogenetic analysis. The protein sequences were retrieved from GenBank and aligned 
with ClustalW. The phylogenetic tree was generated in MEGA 4.0.1 software (Tamura et 
al., 2007), by the Neighbor-Joining method and bootstrapping was performed with 1000 
replicates. The evolutionary distances were computed using the Poisson correction 
method, and all positions containing gaps and missing data were eliminated from the data 
set (complete deletion option). 
Full length open reading frame (FL-ORF) cloning of ML257, ML593 and MlbAS. 
The FL-ORF of ML257 and ML593 were screened for in a M. lanceolata Uncut 
Nanoquantity cDNA library (custom-made by Invitrogen, Carlsbad, CA, USA) as 
reported (Pollier et al., 2011), using the primer pairs P27 + P28 and P29 + P30 (Table 2), 
respectively. 
Degenerate oligonucleotide primers were designed based on highly conserved amino acid 
regions of known plant bAS genes and used to amplify a fragment of the MlbAS gene. 
First a PCR was performed on M. lanceolata cDNA using the primers P31 and P32, 
corresponding to the amino acid motifs DGGWGLH and LKAARHLP, respectively. The 
amplicon was purified using the NucleoSpin Extract II kit (Macherey-Nagel) according 
to the manufacturer’s instructions and used as template for a nested PCR with the primers 
P33 and P34, corresponding to the amino acid motifs FLPMHPAKMW and 
EQAGAPEWA, respectively. The resulting PCR fragment was purified once again and 
cloned into the pGEM®-T easy vector (Promega) for sequencing. The obtained sequence 
was used to design the primers P35 and P36, which were used to generate a DNA probe 




for screening the FL-ORF of MlbAS in the M. lanceolata cDNA library as reported 
(Pollier et al., 2011). 
The FL-ORFs of MlbAS, ML257 and ML593 were PCR amplified for GatewayTM cloning 
in pDONR221 using the primer pairs P37 + P38, P39 + P40 and P41 + P42, respectively 
(Table 2). 
Generation of plasmid vectors. The MlbAS was PCR amplified using XhoI and KpnI 
containing primers, P37 + P38 (Table 2) and cloned i to GatewayTM vector pDONR221 
for sequence verification prior to insertion into the MCS2 of the plasmid pESC-
URA[GAL10/tHMG1] (described in chapter 4) to create the expression vector pESC-
URA[GAL10/tHMG1; GAL1/MlbAS]. 
The A. thaliana CPR (AtATR1, At4g24520) and CYP716A12 were cloned (described in 
chapter 4) into the low-copy number yeast expression vector pAG415GAL-ccdB 
(Addgene plasmid 14145) and high-copy number expression vector pAG423GAL-ccdB 
(Addgene plasmid 14149), respectively. The entry clones of ML257 and ML593 were 
GatewayTM recombined into the high-copy number expression vector pAG423GAL-ccdB 
behind the galactose inducible GAL1 promoter and having the HIS3 auxotrophic marker. 
The self-processing polyprotein of BF567 with CYP716A12 was generated (as described 
in chapter 4). Similarly, a self-processing polyprotein of ML593 with CYP716A12 was 
generated by amplifying the FL-ORF of ML593 without a stop codon and having a 3’- 
overhang of the partial T2A sequence using the primer pair P41 + P43. The FL-ORF of 
CYP716A12 was amplified with a 5’- overhang of the partial T2A sequence using the 
primers P26 + P24 such that there was an overlap of 7 bp between the two amplified 
sequences. Since the primers P43 and P26 contain an Ur cil each, the ML593 and 
CYP716A12 were PCR amplified using the Pfu Turbo Cx polymeras  (Stratagene). The 
purified gel fragments were used for Uracil-Specific Excision or USERTM Cloning (New 
England Biolabs) to generate two fragments with comple entary sticky ends which were 
ligated in vitro using the T4 DNA ligase (Invitrogen). The ligated DNA product was once 
again gel purified and used as template for amplification with the primers P41 + P24. 




This amplicon was GatewayTM recombined into pDONR221, sequence verified and 
further recombined into pAG423GAL-ccdB to generate pAG423[GAL1/ML593-T2A-
CYP716A12]. 
 
Table 2. Primers used in this study. 
Primer Sequence (5’ to 3’) 
P24 GGGGACCACTTTGTACAAGAAAGCTGGGTATTAAGCTTTGTGTGGATAAAG
GCG 



















P43 ACCGCAUGTTAGCAGACTTCCTCTGCCCTC TTGTTTTTCTTGGTGACCT 
The sequences in lower case represent the restriction recognition site used for restriction 
enzyme mediated cloning. The underlined sequence corresponds to T2A partial 
sequences. 
 
Culturing of yeast cells for metabolite analysis. Precultures were grown at 30°C, 
250 rpm for 18-20 h in 5 ml synthetic defined (SD) medium containing glucose 
(Duchefa, Clontech) and appropriate drop out (DO) supplements (Duchefa, Clontech). 
Cultures were induced by inoculating to a starting optical density of 0.25 in 15 ml SD 
Gal/Raf medium containing galactose and raffinose as carbon source (Duchefa, Clontech) 
and appropriate DO supplements, post washing of the preculture in water. The cultures 




were incubated at 30°C, 250 rpm for 24 h before addition of 2.25 ml of 10 mM 
methionine to a final concentration of 1.5 mM and subsequently incubated further for 
48 h. MβCD treatment was carried out by adding 300 µl of a 250 mM MβCD stock to a 
final concentration of 5 mM, twice during culturing, at the time of methionine repression 
and 24 h after methionine addition. 
Metabolite extraction and GC-MS analysis. An organic extract of the yeast cells or 
spent medium was prepared (as described in chapter 4) for identification and 
quantification of metabolites using GC-MS. In brief, first a hexane extraction was 
performed on alkali lyzed cell pellets or spent medium, which was concentrated by 
evaporation of the hexane and trimethylsilyl derivatized before GC-MS analysis. For 
identification of metabolites a full mass spectra ws generated by scanning the m/z range 
of 60-800 with a solvent delay of 7.8 min. For select ion monitoring of β-amyrin the ions 
498, 218 and 203 were screened. The areas of the peaks were calculated using the default 
settings of the AMDIS software (version 2.6, NIST, USA). 
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Combinatorial biosynthesis is the process of establi hing novel enzyme-substrate 
combinations in vivo, leading to the synthesis of new natural product derived compounds 
that can be used in drug discovery programs. Plants are a rich source of bioactive natural 
products and continue to possess huge potential for drug discovery. However, these 
valuable natural products cannot always be isolated from the plant source in 
commercially feasible quantities. Additionally, the biosynthetic pathways leading to the 
synthesis of these secondary metabolites in plants re not completely elucidated making 
the translation of pathways to heterologous hosts complicated. Therefore, we utilized a 
combinatorial approach for the synthesis of triterpenoid sapogenins in Saccharomyces 
cerevisiae by coexpression of known saponin biosynthetic enzymes. Using this approach 
we were able to synthesize both known as well as hitherto undescribed and possibly 
novel triterpene scaffolds. 









The secondary metabolites of plants are structurally diverse natural products with 
significant therapeutic applications. For instance, the anti-malarial drug artemisinin, a 
sesquiterpene, and the anti-cancer drug taxol, a diterpene were originally isolated from 
the shrub Artemisia annua and the Pacific yew tree (Taxus cuspidata), respectively. 
Together with plant cell cultures, the plants themslves remain the only source of these 
drugs to date, rendering them susceptible to fluctuations in yield and market price. 
Although total chemical synthesis of both of these molecules has been established, their 
intricate structural complexity makes the process expensive and fairly complicated. 
Nonetheless, there are continuous efforts being made towards engineering microbes for 
the production of plant-based drugs to stabilize prices and to meet the ever increasing 
market demand. The fast growing, genetically amenabl  hosts Saccharomyces cerevisiae 
and Escherichia coli continue being the first choice for the microbial production of plant 
natural products (Ajikumar et al., 2010; Westfall et al., 2012). Additionally, the recent 
advances in metabolic engineering facilitate directed synthesis of high levels of desired 
products in heterologous hosts. 
Combinatorial biosynthesis is an extension of the metabolic engineering process, where 
genes catalyzing individual metabolic steps from different organisms are combined in a 
single host to create novel branches in metabolic pathways to synthesize products that 
were not accessible previously (Kirschning et al., 2007; Pollier et al., 2011). Synthesis of 
novel scaffolds by combinatorial biosynthesis generates structural diversification and 
broadens the spectrum of lead molecules for therapeutic applications. Structural novelty 
can be achieved either by rational redesigning of biosynthetic pathways, or by the random 
mixing of biosynthetic genes from related pathways. However, the combinatorial 
approach can also be applied for the biosynthesis of natural products, of which complete 
biosynthetic pathways are not yet elucidated (Julsing et al., 2006; Chemler and Koffas, 
2008) or even to enhance the productivity of certain desired products. For instance, in S. 
cerevisiae the production of taxadiene, the precursor of taxol, was enhanced by the 
combination of bacterial and plant genes (Engels et al., 2008). 




The triterpenoid branch of plant secondary metabolites comprises the saponins that 
display a plethora of biological activities and are widely distributed among many plant 
species in nature (Sparg et al., 2004). The triterpenoid saponins are glycosides of 
“sapogenins”, that are valuable not only as biologically active compounds but also serve 
as starting molecules for semi-synthetic modifications to enhance structural diversity. For 
instance, the naturally occuring sapogenins, oleanolic acid (Pollier and Goossens, 2012) 
and betulinic acid (Fulda, 2008) are wide spread in the plant kingdom and exhibit various 
biological activities that have been accessed for future clinical development. Chemical 
derivatives of these molecules have been generated not only for structural diversification, 
but also to reduce cytotoxicity, enhance efficacy and increase solubility of the 
sapogenins. One such semi-synthetic derivative of olean lic acid, bardoxolone methyl is 
currently in a late-stage clinical development for the treatment of advanced chronic 
kidney disease in type 2 diabetes mellitus patients (Pollier and Goossens, 2012). 
In the current study we established a combinatorial pl tform in S. cerevisiae for the 
production of triterpene sapogenins by coexpressing aponin biosynthetic genes from 
different (medicinal) plants. Through this untargeted biosynthesis approach we generated 




Oxidation of β-amyrin by a putative C-21β hydroxylase and a C-11 oxidase. 
To generate a combinatorial scaffold using β-amyrin we expressed ML593 (see chapter 5) 
and CYP88D6 in strain TM3. The CytP450 CYP88D6 (GenBank accession number 
AB433179; (Seki et al., 2008)) catalyzes a two-step oxidation of β-amyrin to 11-oxo-β-
amyrin through a 11-hydroxy-β amyrin intermediate. First, we confirmed the activity of 
CYP88D6 in our β-amyrin producing strain by generating strain TM18 (Table 1) and 
culturing it in the presence of MβCD along with the control strain TM27. GC 




chromatograms of the spent medium of strain TM18 showed the presence of four unique 
peaks (Fig. 1c) that were absent in the control strain TM27 (Fig. 1d). Two of these peaks 
eluting at 25.4 min and 37.5 min corresponded to 11-hydroxy β-amyrin and 11-oxo β-
amyrin (Seki et al., 2008), respectively. The two remaining peaks eluting at 24.4 min and 
26.6 min could not be assigned an identity despite their clear EI pattern. The highest mass 
observed in the mass spectra extracted from these paks (Fig. 1e) was lower than that of 
trimethylsilylated β-amyrin (M+=498), indicating their possibly non-triterpenoid origin. 
These additional peaks observed in our yeast strain were not reported when the CYP88D6 
was expressed in a wild type yeast strain expressing a β-amyrin synthase from Lotus 
japonicus (Seki et al., 2008). 
Further, we generated strain TM32 by supertransforming strain TM3 with the plasmids 
pAG415[GAL1/AtATR1] and pAG423[GAL1/ML593-T2A-CYP88D6], where ML593 and 
CYP88D6 are stitched together with the 2A oligopeptide resulting in the generation of a 
self-processing polypeptide (de Felipe et al., 2006). The spent medium of strain TM32 
(Fig. 1a) cultured in the presence of MβCD was compared with that of strains TM21 
(Fig. 1b), TM18 (Fig. 1c) and TM27 (Fig. 1d). Strain TM32 showed the presence of two 
unique peaks eluting at 32.1 min and 44.7 min that could correspond to 11α,21β(?)-
dihydroxy β-amyrin and 11-oxo-21β(?)-hydroxy β-amyrin based on their EI pattern, 
respectively. 
 
Oxidation of lupeol and lupanediol by C-28 oxidases. 
The Maesa lanceolata ML257 like the Medicago truncatula CYP716A12 is a C-28 
oxidase of β-amyrin (see chapter 5). We determined the substrate specificity of ML257 
for the oxidation of other triterpene sapogenin back ones, like lupeol. First, we generated 
a lupeol producing strain TM6 from the engineered strain TM1 (Table 1) by expressing 
the Arabidopsis thaliana isoform 1 of lupeol synthase (AtLUP1) (GenBank accession 
number U49919; (Herrera et al., 1998)) from the plasmid vector pESC-
URA[GAL10/tHMG1; GAL1/AtLUP1]. We cultured TM6 and the control strain TM5  





Figure 1. GC chromatograms corresponding to, (a) Extraction from spent medium of 
strain TM32, expressing tHMG1, GgbAS, AtATR1, CYP88D6 and ML593. (b) Extraction 
from spent medium of strain TM21, expressing tHMG1, GgbAS, AtATR1 and ML593. (c) 
Extraction from spent medium of strain TM18, expressing tHMG1, GgbAS, AtATR1 and 
CYP88D6. (d) Extraction from spent medium of control strain TM27, expressing tHMG1, 
GgbAS and AtATR1. (e) Mass spectra extracted from indicated (*) peaks of train TM18 
and TM32. Right panels show the mass spectra extracted fromthe indicated (*) peaks, 
where the X-axis corresponds to m/z values. The X- and Y-axis of the GC 
chromatograms correspond to time in minutes and total i n current, respectively. (f) 
Oxidation of β-amyrin by ML593 and CYP88D6. 




(Table 1) and quantified lupeol accumulation from the cell pellets using GC-MS. A peak 
eluting at 28.9 min and corresponding to 46.3 mg/L of a lupeol standard (Fig. 2c) was 
observed in the GC chromatograms of TM6 (Fig. 2a), but not the control strain TM5 
(Fig. 2b). 
 
Figure 2. GC chromatograms corresponding to, (a) Extraction from cells of strain TM6, 
expressing tHMG1 and AtLUP1. (b) Extraction from cells of control strain TM5, 
expressing tHMG1. (c) A lupeol standard. Right panels show mass spectra x cted from 
the indicated (*) peaks, where the X-axis corresponds to m/z values. The X- and Y-axis 
of the GC chromatograms correspond to time in minutes and total ion current, 
respectively. (d) Cyclization of 2,3-oxidosqualene to lupane and lupanediol. (e) 
Quantification of lupeol from the cells and spent medium of strain TM6, where 100% 
corresponds to 46.3 mg/L of lupeol. 




Additionally, in this strain we also observed a new peak eluting at 40.2 min (Fig. 2a) the 
EI pattern of which corresponded to 3β,20-dihydroxylupane (lupanediol), resulting from 
the addition of water to the lupanyl cation (Fig. 2d) in the course of its cyclization by 
AtLUP1 (Kushiro et al., 2006). Notably, the relative amount of lupanediol eluting at 
40.2 min (corresponding to the area under the curve in the GC chromatogram), was 
higher than lupeol eluting at 28.9 min. 
The AtLUP1 has been reported to cyclize oxidosqualene to multiple riterpene alcohols 
and oxacyclic triterpenoids with the major products being lupeol and lupanediol together 
with multiple minor products, including β-amyrin, germanicol, ψ-taraxasterol (Segura et 
al., 2000), and 17,24-epoxybaccharane, 20,24-epoxydammarane (Shan et al., 2005). 
However, in our strain we only detected lupeol and lupanediol and none of the minor 
products that have been reported earlier. 
When the strains TM6 and TM5 were cultured in the presence of MβCD, the same two 
peaks corresponding to lupeol and lupanediol were observed in the extracts of the spent 
medium of TM6 but not TM5 and hence, to facilitate metabolite extractions we utilized 
MβCD in all subsequent experiments. A strikingly higher concentration of lupeol was 
quantified from the extracts of spent medium (164.2 mg/L) compared to cell pellet 
(41.7 mg/L) on MβCD treatment and the total lupeol concentration was4.4-fold higher in 
treated cultures compared to non-treated controls (Fig. 2e). This pattern was also 
observed for the production and extraction of lupanediol from TM6 in the presence of 
MβCD. 
Next, we supertransformed strain TM6 with the plasmids pAG423[GAL1/ML257], 
pAG423[GAL1/CYP716A12] or pAG423GAL-ccdB in combination with 
pAG415[GAL1/AtATR1] to generate strains TM23, TM22 and TM28, respectively. These 
strains were cultured in the presence of MβCD and the spent medium analyzed by GC-
MS for the presence of lupeol, lupanediol and their ydroxylation products. We observed 
new peaks eluting at 35.2 min corresponding to betulin (Fig. 3d) and at 46.8 min most 
likely corresponding to the C-28 hydroxylation of lupanediol in strains TM23 (Fig. 3a) 
and TM22 (Fig. 3b), but not the control strain TM28 (Fig. 3c). Strain TM22 also showed 




the presence of an extra new peak at 54.7 min, the EI pattern of which could not be 
interpreted due to the very low abundance of the peak in the chromatogram, but which 
could correspond to the carboxylation of C-28 of lupanediol. However, we did not detect 
betulinic acid in either TM23 or TM22 expressing ML257 or CYP716A12, respectively, 
contrary to (Fukushima et al., 2011) where both betulin and betulinic acid were detected 




Figure 3. GC chromatograms (first column) corresponding to, (a) Extraction from spent 
medium of strain TM23, expressing tHMG1, AtLUP1, AtATR1 and ML257. (b) Extraction 
from spent medium of strain TM22, expressing tHMG1, AtLUP1, AtATR1 and 
CYP716A12. (c) Extraction from spent medium of control strain TM28, expressing 
tHMG1, AtLUP1 and AtATR1. (d) A betulin standard. Columns two and three show the 
mass spectra extracted from the indicated (*) peaks, where the X-axis corresponds to m/z 
values. The X- and Y-axis of the GC chromatograms correspond to time in minutes and 
total ion current, respectively. 




Oxidation of other triterpene sapogenin backbones by C-28 oxidases. 
In an attempt to generate a dammarenediol producing yeast strain we expressed the 
plasmid pESC-URA[GAL10/tHMG1; GAL1/CaDDS], harboring a dammarenediol 
synthase gene (CaDDS) from Centella asiatica (GenBank accession number AY520818; 
(Kim et al., 2009)), in the sterol modified yeast strain TM1, to generate strain TM33. We 
cultured strain TM33 and the control strain TM5 in medium containing MβCD and 
analyzed the GC chromatograms obtained from the spent m dium of both the strains. 
Unexpectedly, we found 3 new peaks in strain TM33 eluting at 27.2 min, 28.6 min and 
33.5 min (Fig. 4a) that were absent in the control strain TM5 (Fig. 4b). We could confirm 
the identity of the peak eluting at 27.2 min as β-amyrin (Fig. 4c) based on its elution time 
and EI pattern. The peak at 28.6 min had a similar EI pattern as β-amyrin and was 
confirmed as α-amyrin by comparing to a standard (Fig. 4d). The EI pattern of the peak at 
33.5 min could be interpreted to dammarenediol-II (Spencer, 1981), but was not 
confirmed due to the lack of an authentic standard. Although, the CaDDS was initially 
reported as a putative bAS (Kim et al., 2005) and later characterized as a damm renediol 
synthase (Kim et al., 2009), in our yeast strain the gene was capable of cyclizing 2,3-
oxidosqualene to both β-amyrin and dammarenediol in addition to a third product, α-
amyrin. In our yeast strain the relative amounts of α-amyrin, β-amyrin and 
dammarenediol-II were in the ratio of 8.8:1.1:0.1, highlighting the very low dammarene 
synthase activity of CaDDS as opposed to its current characterization. Therefore, we 
propose to characterize CaDDS as a multi-functional oxidosqualene cyclase. 
We continued with the strain TM33 expressing the multifunctional cyclase and used it for 
the generation of strains TM36, TM34 and TM38, expressing the plasmid 
pAG415[GAL1/AtATR1] with either pAG423[GAL1/ML257], 
pAG423[GAL1/CYP716A12] or pAG423GAL-ccdB, respectively. GC-MS analysis of the 
spent medium of TM36, TM34 and TM38 cultured in the presence of MβCD showed the 
presence of multiple new peaks corresponding to oxidation products in strains TM36 
(Fig. 5a) and TM34 (Fig. 5b), but not the control strain TM38 (Fig. 5c). 





Figure 4. GC chromatograms corresponding to, (a) Extraction from spent medium of 
strain TM33, expressing tHMG1 and CaDDS. (b) Extraction from spent medium of 
control strain TM5, expressing tHMG1. (c) A β-amyrin standard. (d) An α-amyrin 
standard. Right panels show the mass spectra extracted from the indicated (*) peaks, 
where the X-axis corresponds to m/z values. The X- and Y-axis of the GC 
chromatograms correspond to time in minutes and total i n current, respectively. 
 
The peak eluting at 32.5 min (Fig. 5a and 5b) could be confirmed as erythrodiol (Fig. 5d), 
confirming the β-amyrin synthase functionality of CaDDS. Next to the erythrodiol peak, 
another high intensity peak with the same EI pattern as erythrodiol but a different elution 




time of 34.2 min was observed, which could correspond t  uvaol (28-hydroxy α-amyrin), 
thereby also reaffirming the α-amyrin synthase activity of CaDDS. We also observed 
higher concentrations of uvaol in both strains TM36 and TM34 compared to erythodiol. 
 
 
Figure 5. GC chromatograms corresponding to, (a) Extraction from spent medium of 
strain TM36, expressing tHMG1, CaDDS, AtATR1 and ML257. (b) Extraction from spent 
medium of strain TM34, expressing tHMG1, CaDDS, AtATR1 and CYP716A12. (c) 
Extraction from spent medium of control strain TM38, expressing tHMG1, CaDDS and 
AtATR1. (d) An erythrodiol standard. Right panels show the mass spectra extracted from 
the indicated (*) peaks, where the X-axis corresponds to m/z values. The X- and Y-axis 
of the GC chromatograms correspond to time in minutes and total ion current, 
respectively. 
 




Oxidation of α-amyrin by a C-11 oxidase. 
We supertransformed strain TM33 with the plasmids pAG415[GAL1/AtATR1] and 
pAG423[GAL1/CYP88D6] to generate a strain TM35. GC chromatograms of extracts 
from the spent medium of TM35 (Fig. 6a) cultured in the presence of MβCD showed the 
presence of four unique peaks, that were absent in the control strain TM38 (Fig. 6b). 
 
Figure 6. GC chromatograms corresponding to, (a) Extraction from spent medium of 
strain TM35, expressing tHMG1, CaDDS, AtATR1 and CYP88D6. Right panels show the 
mass spectra extracted from the indicated (*) peaks, where the X-axis corresponds to m/z 
values. The X- and Y-axis of the GC chromatograms correspond to time in minutes and 
total ion current, respectively. (b) Extraction from spent medium of control strain TM38, 
expressing tHMG1, CaDDS and AtATR1. (c) Mass spectra extracted from indicated (*) 
peaks of strain TM35. 
 
Two of these peaks eluting at 25.4 min and 37.5 min were identified as 11-hydroxy β-
amyrin and 11-oxo-β-amyrin based on their EI pattern (Seki et al., 2008), respectively. 
The remaining two peaks eluting at 29.4 min and 39.6 min had the same EI pattern 
(Fig. 6c) as 11-hydroxy and 11-oxo-β-amyrin, repectively, but a different elution time. 
These peaks could correspond to the C-11 oxidations of α-amyrin, but could not be 
confirmed due to the lack of authentic standards. 




Oxidation of α-amyrin by a putative C-21 hydroxylase. 
Strain TM37 was generated from strain TM33 by supertransforming with the plasmids 
pAG415[GAL1/AtATR1] and pAG423[GAL1/ML593]. The ML593 was characterized as a 
putative C-21 hydroxylase of β-amyrin (see chapter 5) and we determined the substrate 
specificity of this CytP450 by expressing it together with the multifunctional cyclase 
CaDDS. We cultured strain TM37 and the control strain TM38 in the presence of MβCD 
and compared GC chromatograms for the presence of unique peaks. We identified two 
peaks eluting at 31.8 min and 33.2 min in the spent medium of TM37 (Fig. 7a), but not 
the control strain TM38 (Fig. 7b). The EI pattern of both these peaks were identical 
(Fig. 7a) and the peak at 31.8 min corresponded to (most likely) 21-hydroxy β-amyrin 
(see chapter 5). Therefore, the second peak at 33.2 min could correspond to 21-hydroxy 
α-amyrin, but was not confirmed due to the absence of an authentic standard. 
 
 
Figure 7. GC chromatograms corresponding to, (a) Extraction from spent medium of 
strain TM37, expressing tHMG1, CaDDS, AtATR1 and ML593. Right panels show the 
mass spectra extracted from the indicated (*) peaks, where the X-axis corresponds to m/z 
values. (b) Extraction from spent medium of control strain TM38, expressing tHMG1, 
CaDDS and AtATR1. The X- and Y-axis of the GC chromatograms correspond to time in 
minutes and total ion current, respectively. Parts of structure in green indicate the 
putative hydroxylation position. 




Table 1. List of yeast strains generated and used in this sudy. 
Name Construct 
S288c BY4742 MATa; his3∆1; leu2∆0; ura3∆0; lys2∆0 
TM1 S288c BY4742; Perg7::PMET3-ERG7 
TM3 TM1; pESC-URA[GAL10/tHMG1; GAL1/GgbAS] (36.2 mg/L β-amyrin)  
TM5 TM1; pESC-URA[GAL10/tHMG1] 
TM6 TM1; pESC-URA[GAL10/tHMG1; GAL1/AtLUP1] (46.3 mg/L lupeol) 
TM18 TM3; pAG423[GAL1/CYP88D6], pAG415[GAL1/AtATR1] 
TM21 TM3; pAG423[GAL1/ML593], pAG415[GAL1/AtATR1] 
TM22 TM6; pAG423[GAL1/CYP716A12], pAG415[GAL1/AtATR1] 
TM23 TM6; pAG423[GAL1/ML257], pAG415[GAL1/AtATR1] 
TM27 TM3; pAG423, pAG415[GAL1/AtATR1] 
TM28 TM6; pAG423, pAG425[GAL1/AtATR1] 
TM32 TM3; pAG423[GAL1/ML593-T2A-CYP88D6], pAG415[GAL1/AtATR1] 
TM33 TM1; pESC-URA[GAL10/tHMG1; GAL1/CaDDS] 
TM34 TM33; pAG423[GAL1/CYP716A12], pAG415[GAL1/AtATR1] 
TM35 TM33; pAG423[GAL1/CYP88D6], pAG415[GAL1/AtATR1] 
TM36 TM33; pAG423[GAL1/ML257], pAG415[GAL1/AtATR1] 
TM37 TM33; pAG423[GAL1/ML593], pAG415[GAL1/AtATR1] 
TM38 TM33; pAG423, pAG415[GAL1/AtATR1] 
 
Discussion 
The triterpenoid saponins are a vast group of glycosides, whose structural diversity arises 
from the variable oxidation patterns on the sapogenin backbones that are composed of 30 
carbon atoms arranged in ring structures. Although a lycones with oxidations on various 
positions of the 30 carbons have been described from different plants (Dinda et al., 2010), 
only 7 enzyme classes (or CytP450s) catalyzing specific modifications to C-6 (Han et al., 
2012), C-11 (Seki et al., 2008), C-12 (Han et al., 2011), putative C-21 (see chapter 5), C-
24 (Shibuya et al., 2006), C-28 (Carelli et al., 2011) and C-30 (Seki et al., 2011) have 
been identified to date. This great void in our understanding about the synthesis of 




sapogenins makes targeted biosynthesis highly complicated and sometimes impossible. 
To truly exploit the therapeutic potential of tritep nes it is essential to synthesize them in 
non-native hosts that can be engineered for high level production. Hence, we set up a 
combinatorial approach to generate triterpene sapogenins, the building blocks of saponins 
in S. cerevisiae by random coexpression of known CytP450s. 
We first attempted a targeted combinatorial biosynthesis approach by expressing 
enzymes GgbAS, ML593 and CYP88D6, from G. glabra, M. lanceolata and G. uralensis, 
respectively. The resulting compounds, 11,21(?)-dihydroxy-β-amyrin and 11-oxo-21(?)-
hydroxy-β-amyrin, are undescribed in any of the plant species from which the enzymes 
originated, but may be an intermediate in the biosynthesis of saikosapogenins produced 
by plants of the genus Bupleurum. This approach of coexpressing genes from different 
plants to generate a target molecule underscores th potential of combinatorial 
biosynthesis. 
As a next step we generated triterpene alcohol backbones lupeol and dammarenediol-II in 
yeast. Our engineered strain TM6 producing lupeol also cyclized oxidosqualene to high 
amounts of 3β,20-dihydroxylupane/lupanediol. Although unforeseen, this cyclization 
reaction catalyzed by AtLUP1 generated a triterpene diol scaffold in yeast for further 
modification by CytP450s. We performed a targeted C-28 oxidation on both the lupane 
and lupanediol backbones by overexpressing C-28 oxidases, ML257 and CYP716A12 in 
the yeast strain TM6. The resulting 3β,20-dihydroxylupan-28-oic acid generated by the 
three-step C-28 carboxylation activity of CYP716A12 on lupanediol is a known aglycone 
of the saponins Snatzkein C and D, from the plant Arenaria filicaulis (Elgamal et al., 
1998). However, the 3β,20,28-trihydroxylupane resulting from the hydroxylation of C-28 
of lupanediol is to the best of our knowledge a hither o undescribed triterpene backbone 
and could serve as an interesting backbone for further enzymatic or semi-synthetic 
modifications. Lupeol derived sapogenins like betulin (3β,28-dihydroxylupane) and 
betulinic acid (3β-hydroxylupan-28-oic acid) have been valued for their potent antitumor 
activities (Fulda, 2008; Mullauer et al., 2009). Additional favourable modifications like 
hydroxylations on the backbone increase the hydrophilicity of the molecule and generate 
promising targets for clinical testing. 




Similarly, in the course of generating a dammarenediol-II producing yeast strain TM33, 
we discovered the multifunctionality of CaDDS which was reported as being only a 
dammarenediol synthase from C. asiatica (Kim et al., 2009). In our yeast strain, CaDDS 
cyclized oxidosqualene to three products, α-amyrin, β-amyrin and dammarenediol-II, 
with α-amyrin being produced 8 times more than β-amyrin and dammarenediol-II 
produced only as a minor product. The further combinatorial expression of a C-28 
oxidase from M. lanceolata or M. truncatula resulted in the generation of erythrodiol and 
uvaol in the same strain. The higher concentration of uvaol over erythrodiol in the spent 
medium of strains TM36 and TM34 reaffirmed the preferred α-amyrin cyclization activity 
of CaDDS. This is the first report on the multifunctionality of CaDDS from C. asiatica 
and could explain its initial annotation as a putative β-amyrin synthase based on the 
presence of the conserved MWCYCR β-amyrin production motif in the enzyme (Kim et 
al., 2005). 
We further utilized strain TM33 harboring the multifunctional CaDDS as an α-amyrin 
producing yeast strain and explored possibilities for modification of the α-amyrin 
backbone by the expression of CYP88D6, a C-11 oxidase from G. uralensis or ML593, a 
putative C-21 hydroxylase from M. lanceolata. Through this combinatorial biosynthesis 
we generated 11-hydroxy-α-amyrin, 11-oxo-α-amyrin and 21(?)-hydroxy-α amyrin 
producing yeast strains, that have not be reported earlier. 
In conclusion, we established a combinatorial biosynthesis platform in S. cerevisiae for 
the generation of triterpene sapogenins and applied it for the production of both known 
compounds with documented biological activities, as well as novel scaffolds that might 








Materials and Methods 
Chemicals. α-amyrin, β-amyrin, Lupeol, Erythrodiol and Betulin were purchased from 
Extrasynthese. Hexane, Pyridine and N-Methyl-N-(trimethylsilyl)trifluoroacetamide were 
purchased from Sigma-Aldrich. Methyl-β-cyclodextrin was purchased from CAVASOL. 
Generation of plasmid vectors. The AtLUP1 was PCR amplified from a pENTR223-
AtLUP1 vector (ABRC stock number U09402) using BamHI and XhoI containing 
primers P44 + P45 (Table 2) and cloned into GatewayTM vector pDONR221 for sequence 
verification prior to insertion into the MCS2 of the plasmid pESC-URA[GAL10/tHMG1] 
(described in chapter 4) to create the expression vector pESC-URA[GAL10/tHMG1; 
GAL1/AtLUP1]. Similarly, the CaDDS was amplified with XhoI and NheI containing 
primers P46 + P47 to generate pESC-URA[G L10/tHMG1; GAL1/CaDDS]. 
The A. thaliana CPR (AtATR1, At4g24520) was cloned into the low-copy number yeast 
expression vector pAG415GAL-ccdB (Addgene plasmid 14145). The full-length open 
reading frame (FL-ORF) of CYP88D6 was PCR amplified from a pTOPO-CYP88D6 
vector (Seki et al., 2008) using the primers P48 + P49 and cloned into pDONR221. The 
CytP450s ML257, CYP716A12, ML593 and CYP88D6 were GatewayTM recombined into 
the high-copy number expression vector pAG423GAL-ccdB (Addgene plasmid 14149). 
The self-processing polyprotein of ML593 and CYP88D6, was generated by amplifying 
the FL-ORF of ML593 without a stop codon and having a 3’- overhang of the partial T2A 
sequence using the primer pair P41 + P50. The FL-ORF of CYP88D6 was amplified with 
a 5’- overhang of the partial T2A sequence using the primers P51 + P49 such that there 
was an overlap of 7 bp between the two amplified sequences. Since the primers P51 and 
P50 contain an Uracil each, the ML593 and CYP88D6 were PCR amplified using the Pfu 
Turbo Cx polymerase (Stratagene). The purified gel fragments were used for USERTM 
Cloning (New England Biolabs) to generate two fragments with complementary sticky 
ends which were ligated in vitro using the T4 DNA ligase (Invitrogen). The ligated DNA 
product was used as template for amplification with the primers P41 + P49. This 




amplicon was GatewayTM recombined into pDONR221, sequence verified and further 
recombined into pAG423GAL-ccdB to generate pAG423[GAL1/ML593-T2A-CYP88D6]. 
Culturing of yeast cells for metabolite analysis. Precultures were grown at 30°C, 
250 rpm for 18-20 h in 5 ml synthetic defined (SD) medium containing glucose 
(Duchefa, Clontech) and appropriate drop out (DO) supplements (Duchefa, Clontech). 
Cultures were induced by inoculating to a starting optical density of 0.25 in 15 ml SD 
Gal/Raf medium containing galactose and raffinose as carbon source (Duchefa, Clontech) 
and appropriate DO supplements, post washing of the preculture in water. The cultures 
were incubated at 30°C, 250 rpm for 24 h before addition of 2.25 ml of 10 mM 
methionine to a final concentration of 1.5 mM and subsequently incubated further for 
48 h. MβCD treatment was carried out by adding 300 µl of a 250 mM MβCD stock to a 
final concentration of 5 mM, twice during culturing, at the time of methionine repression 
and 24 h after methionine addition. 
Metabolite extraction and GC-MS analysis. An organic extract of the yeast cells or 
spent medium was prepared (as described in chapter 4) for identification and 
quantification of metabolites using GC-MS. In brief, first a hexane extraction was 
performed on alkali lyzed cell pellets or spent medium, which was concentrated by 
evaporation of the hexane and trimethylsilyl derivatized before GC-MS analysis. For 
identification of metabolites a full mass spectra ws generated by scanning the m/z range 
of 60-800 with a solvent delay of 7.8 min. For quantification of lupeol a select ion mode 
was operated detecting the ions 498, 483, 393, 279, 18, 203 and 189. The areas of the 










Table 2. Primers used in this study. 










P50 ACCGCAUGTTAGCAGACTTCCTCTGCCCTC TTGTTTTTCTTGGTGACCT 
P51 ATGCGGUGACGTCGAGGAGAATCCTGGCCCA TGGAAGTACATTGGGTTT 
The sequences in lower case represent the restriction recognition site used for restriction 
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In the defense against attackers, the jasmonate hormone regulates production of bioactive 
metabolites in plants. Knowledge on the conserved jasmonate perception machineries by 
plants is increasing, but the downstream mechanisms that regulate defense metabolism 
remain largely unknown. Here we show that in the model legume Medicago truncatula, 
jasmonate recruits the endoplasmic reticulum associated degradation (ERAD) quality 
control system to manage the production of triterpene saponins, widespread compounds 
that share a biogenic origin with sterols. An ERAD-type RING membrane-anchor E3 
ubiquitin ligase is co-expressed with saponin synthesis enzymes to control the levels of 
the rate-limiting 3-hydroxy-3-methylglutaryl-CoA reductase to prevent unrestrained 
bioactive saponin accumulation and secure plant integrity. The down regulation of this 
key saponin regulatory gene results in accumulation of monoglycosylated saponin 
building blocks in transgenic M. truncatula hairy roots as a consequence of deficient, 
ectopic, or de novo biosynthesis of triterpene saponins. This control apparatus is 
equivalent to the ERAD system that regulates sterol synthesis in yeasts and mammals, but 
that employs distinct E3 ubiquitin ligases. Hence, th  general principles for management 
of triterpene biosynthesis are conserved across eukaryotes but can be controlled by 
distinct regulatory cues. 









Jasmonates (JAs) are ubiquitous oxylipin-derived phytohormones essential for the 
regulation of multiple plant processes, encompassing development, growth and defense. 
Across the plant kingdom, JAs act as elicitors for the production of secondary 
metabolites, many of which serve as first-line defense against pathogen or herbivore 
attack (Wasternack, 2007; Pauwels et al., 2009; De Geyter et al., 2012). The early 
signaling machinery involved in JA-mediated secondary metabolite elicitation consists of 
a conserved module for JA perception and subsequent ‘primary’ signal transduction 
(Browse, 2009; Fonseca et al., 2009; Memelink, 2009; Pauwels and Goossens, 2011). 
Each plant, however, possesses a specific compendium of bioactive metabolites of a wide 
structural variety and different biochemical origin. During evolution, these species-
specific secondary metabolic pathways evolved under JA control, downstream of the 
conserved hormone perception machinery (Pauwels et al., 2009; De Geyter et al., 2012). 
Saponins comprise a large and very diverse group of plant natural products that serve in 
planta as anti-fungal or anti-insect agents, but also display a wide range of biological 
activities with different pharmaceutical properties (Augustin et al., 2011; Osbourn et al., 
2011; Pollier et al., 2011a). Saponins are amphipatic glycosides with triterpene or steroid 
backbones that can be synthesized constitutively or inducibly, depending on species, 
developmental stage, or environmental conditions. Saponins share a common biogenic 
origin with the sterols, molecules that are ubiquito s in eukaryotic cells. They are both 
derived from 2,3-oxidosqualene and depend on the cytosolic pathway for isopentenyl 
diphosphate (IPP) supply that involves mevalonate (MVA) as a key intermediate 
(Chappell, 2002; Augustin et al., 2011; Osbourn et al., 2011; Pollier et al., 2011a). The two 
pathways diverge after 2,3-oxidosqualene, which can be cyclized either by cycloartenol 
synthase to yield cycloartenol, the sterol precursor, or by β-amyrin synthase (bAS) to yield 
β-amyrin, the precursor of many classes of triterpene saponins (Fig. 1). Both cyclases share 
extensive sequence homology, suggesting an evolutionary recruitment of (at least some) 
triterpene saponin biosynthesis genes from sterol metabolic genes (Phillips et al., 2006). 




In yeast and mammalian cells, the sterol content is continuously adjusted by the regulation 
of the levels of key synthetic enzymes, in particular of 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGR), by means of sterol-regulated ubiquitin-mediated protein degradation. 
The endoplasmic reticulum (ER)-associated protein dgradation (ERAD) quality control 
system directs the feedback-regulated destruction of the HMGR enzyme, both in yeast 
(Saccharomyces cerevisiae) and mammals, and involves the RING E3-ligase HMGR 
DEGRADATION 1 (HRD1/DER3) in yeast or its homologs Hrd1/SYVN1 and gp78 in 
humans (Hampton and Garza, 2009; Hirsch et al., 2009; Jo and Debose-Boyd, 2010; Burg 
and Espenshade, 2011). Both yeast and humans have other, distinct, E3-ligases, such as the 
human RING-FINGER PROTEIN WITH MEMBRANE ANCHOR 1 (RMA1) that 
participate in ERAD but not in the regulation of HMGR stability (Hirsch et al., 2009). 
Triterpene saponin accumulation in plant cells is stimulated in the defense responses that 
are triggered by JAs, but as for most other plant ntural products, the underlying molecular 
mechanisms remain largely unknown. Here, we identifi d a RMA1-like E3 ubiquitin 
ligase, called MAKIBISHI1 (MKB1), that is co-induced with the triterpene saponin 
biosynthetic enzymes following JA elicitation in the model legume Medicago truncatula. 
MKB1 operates in an ERAD-like manner to regulate thriterpene saponin biosynthetic 




Co-regulation of biosynthetic and regulatory genes. 
We used genome-wide transcript profiling to identify new regulators of plant triterpene 
saponin biosynthesis. Using cDNA-AFLP, we monitored over time the methyl jasmonate 
(MeJA)-modulated transcriptome of suspension-cultured M. truncatula cells, in which 
MeJA-inducible triterpene saponin biosynthesis has been reported before (Suzuki et al., 
2002). 





Figure 1. The triterpene saponin biosynthesis pathway in M. truncatula. HMG, 3-
hydroxy-3-methylglutaryl and P450s, cytochrome P450 monooxygenases. 




The expression of a total of 8,462 transcripts was visualized and 282 MeJA-responsive tags 
were identified. Average linkage hierarchical clustering showed that gene tags 
corresponding to HMGR, geranyl pyrophosphate synthase, squalene synthase, squalene 
epoxidase, bAS and CYP93E2, which encode enzymes catalyzing steps in triterpene 
saponin biosynthesis (Fig. 1) displayed an almost ident cal, MeJA-induced, expression 
pattern, suggesting a tight co-regulation (Fig. 2a)
 
 
Figure 2. Expression of the RMA-type E3 ubiquitin ligase, MKB1 is coregulated with that 
of triterpene saponin enzymes. (a) Subcluster of the Mt transcriptome comprising tags 
corresponding to genes reported to be involved in triterpene biosynthesis or jasmonate 
signal transduction. Treatments and time points (in h) are indicated at the top. Blue and 
yellow boxes reflect transcriptional activation and repression relative to the average 
expression level, respectively. (b) Screenshot of the coexpression analysis of M. 
truncatula MKB1 (green), HMGR1 (red), HMGR4 (orange), and HRD1 (black) with the 
MtGEA software. 
 
Several tags corresponding to transcription factors, protein kinases and E3 ubiquitin ligases 
had maximal transcriptional upregulation within 30 min to 2 h after elicitation, prior to or 
concurrent with the onset of genes involved in triterpene saponin synthesis, and hence 
represent potential regulators of this metabolic pathw y. Within this gene set a MYC-like 
bHLH protein and several homologs of the JAZ repressor proteins, known elements of the 
core JA signaling module were present (Browse, 2009; Fonseca et al., 2009; Memelink, 
2009; Pauwels et al., 2010; Pauwels and Goossens, 2011), as well as a tag (MT067) 
corresponding to an RMA-like E3 ubiquitin ligase (Hirsch et al., 2009), and denominated 




MKB1 (Fig. 2a, Fig. 3a-c). The early MeJA response of MKB1 and HMGR was verified 
and confirmed in the M. truncatula Gene Expression Atlas (MtGEA; (Kushiro et al., 2006) 
http://bioinfo.noble.org/gene-atlas/ (He et al., 2009)) (Fig. 2b). 
 
 
Figure 3. Sequence and structural analysis of eukaryotic RMA and HMGR proteins. (a) 
Phylogenetic analysis of MKB1 and other RMA E3 Ub-ligases. The percentage of replicate 
trees that clustered together in the bootstrap test is shown next to the branches. The scale 
bar indicates the number of amino acid substitutions per site. Arabidopsis thaliana (At), 
Capsicum annuum (Ca), Caenorhabditis elegans (Ce) and Homo sapiens (Hs) amino acid 
sequences were retrieved from GenBank. Amino acid sequences of M. truncatula MKB1 
and homologous proteins (prefix TC) were retrieved from the Medicago truncatula Gene 
Index following BLAST searches. (b) Schematic representation of the MKB1 protein and 
its domain structure. (c) Comparison of the amino acid sequence of MKB1 with that of 
RMA proteins from A. thaliana, C. annuum, C. elegans and H. sapiens. Conserved amino 
acids that are identical in the seven proteins are indicated with an asterisk. (d) Kyte & 
Doolittle hydropathy plot of MKB1 and Arabidopsis Rma2 (At4g27470) with window size 
7. Red bars indicate the membrane anchor. 




Toxic saponins cause the ‘makibishi’ phenotype. 
To assess the potential role of MKB1 in JA signaling or the regulation of triterpene 
synthesis, we generated transgenic M. truncatula hairy roots in which MKB1 was 
overexpressed (MKB1OE lines) or silenced by means of a hairpin RNAi construct 
(MKB1KD lines) (Fig. 4a). The MKB1KD lines showed a striking phenotype, in particular 
when they were transferred to liquid medium for upscaling. In its most pronounced form, 
silencing of the MKB1 gene caused ‘dissociation’ of the hairy roots in ‘caltrop-like’ 
structures (Fig. 4b-c), hence the name ‘makibishi’, which is the Japanese term for caltrop. 
No such caltrop phenotypes were observed in MKB1OE lines or hairy root lines 
transformed with control constructs. Microscopic analysis of the MAKIBISHI phenotype 
in the MKB1KD lines revealed severe root growth and epidermal deficiencies (Fig. 4d-f). 
Notably, the MKB1KD root phenotype strongly resembled the stunted root morphology 
and epidermal defects of the oat (Avena sativa) mutants sad3 and sad4, that accumulate 
the incompletely glycosylated form of the saponin avenacin A-1 (Mylona et al., 2008). 
To verify whether the MKB1KD root phenotype was correlated with altered metabolism, 
we performed metabolite profiling by liquid chromatography electrospray ionization 
Fourier transform ion cyclotron resonance mass spectrometry (LC-ESI-FT-ICR-MS) 
(Pollier et al., 2011b). Processing of the mass spectrometry data yielded 16,278 m/z 
peaks. Principal component analysis indicated that e MKB1KD samples were clearly 
different from those of the control and MKB1OE lines, whereas no significant differences 
were detected between control and MKB1OE roots (Fig. 5a-b). These observations were 
also confirmed by pairwise comparative analysis (data not shown). 





Figure 4. The MAKIBISHI phenotype. (a) MKB1 transcript steady-state levels in 
transgenic M. truncatula control (CTR), MKB1OE (OE) and MKB1KD (KD) lines. (b) 
Roots of control (CTR), OE and KD lines grown on solid medium. (c) Fluorescent 
microscopy analysis of roots grown in liquid medium. (d) Longitudinal optical sections 
obtained by confocal microscopy of roots grown in liquid medium. (e) Scanning electron 
microscopy analysis of roots grown in liquid medium. (f) Transmission electron 
microscopy analysis of cross sections of roots from CTR and KD lines grown in liquid 
medium. Arrows indicate wavy/thickened appearance of cell margins in MKB1KD roots. 
 
A supervised partial least squares discriminant analysis model to separate the MKB1KD 
samples was created (Fig. 5c) and used to generate an S-plot to identify the peaks 
responsible for the observed differences (Fig. 5d).83 down-regulated and 37 up-
regulated m/z peaks, corresponding to 41 and 21 compounds, respectively, were 
identified as significantly different, among which were triterpene saponin and phenolic 
compounds, the two main classes of metabolites known t  accumulate in M. truncatula 
hairy roots (Dixon and Sumner, 2003). The most striking trend was observed with the 
saponins. First, they were most represented within the down- and upregulated compounds 
(15 and 7, respectively). Second, the majority of the upregulated saponins were 
monoglycosylated compounds, such as Hex-medicagenic acid, Hex-bayogenin and Hex-
hederagenin, whereas higher glycosylated forms weremor  represented among the down-
regulated peaks (Fig. 5a,d-e and Table 1). 





Figure 5. MKB1 silencing causes ectopic accumulation of monoglycos lated triterpene 
saponins. (a) Detail of the full MS scan of root extracts from a control line (black) and a 
MKB1KD line (red). The peak at tR 26.71 represents Hex-medicagenic acid. (b) Principal 
component analysis and (c) partial least squares discriminant analysis (PLS-DA) of 
samples from MKB1KD (red), MKB1OE (blue) and control (black) lines. (d) S-plot 
derived from PLS-DA. Peaks in the lower left and upper right quadrants (marked by 
dotted red lines) correspond to metabolites that are higher and lower abundant in the 
MKB1KD samples, respectively. Peaks with an absolute covariance value above 0.03 and 
an absolute correlation value above 0.6 were considered as significantly different. (e) 
Average total ion current of the peaks colored in red in the S-plot and corresponding to 
soyasaponin I (upper) and Hex-medicagenic acid (lower). Error bars indicate the standard 
error (n=4). (f) Detail of the full MS scan of the medium from a contr l line (black) and a 
MKB1KD line (red). The peak at tR 27.95 represents Hex-medicagenic acid. 
 
Remarkably, LC-ESI-FT-ICR-MS analysis of the growth medium of MKB1KD roots 
revealed the presence of tens of compounds, whereas in the chromatograms of the growth 
medium from control or MKB1OE roots, metabolites were totally absent (Fig. 5f), 
indicating release of compounds from the MKB1KD roots, including of the three 
monoglycosylated saponins. These findings suggest that silencing of MKB1 primarily 
causes deficient, ectopic, or de novo biosynthesis of triterpene saponins, which leads to 
the overaccumulation and release of incompletely glcosylated saponins, which 
correlates with the occurrence of the sad3/sad4-like makibishi phenotype. 




Table 1. LC-ESI-FT-ICR-MS analysis of MKB1KD roots. 
Downregulated compounds Upregulated compounds 
3-Rha-Gal-GlcA-soyasapogenol B 
(Soyasaponin I) 
Afrormosin + malonyl hexose 
Hex-Hex-medicagenic acid Hex-medicagenic acid 
Formononetin + malonyl hexose Hex-bayogenin 
Naringenin + hexose dHex-Hex-Hex-hederagenin 
Hex-Hex-Hex-medicagenic acid Hex-isoflavone (biochanin A?) 
Malonic acid + pentose + hexose derivate ?-Hex-isoflav ne (biochanin A?) 
Malonic acid + pentose derivate? Hex-hederagenin 
Malonyl-Hex-HexA-bayogenin Tryptophan?? 
Rha-Gal-GlcA-soyasapogenol E Afrormosin 
Malonyl-dHex-Hex-HexA-soyasapogenol B Malonyl-Hex-bayogenin 
Naringenin + hexose + malonic acid Hex-methyl hydroxy benzoic acid 
Hex-Hex-HexA-hederagenin Medicarpin 
Malonyl-Hex-HexA-aglycone A Vanillic acid conjugate 
Hex-HexA-bayogenin Malonyl-Hex-malonyl-Hex-
medicagenic acid 
Hex-Hex-HexA-aglycone A Vanillic acid conjugate 
Hex-Hex-HexA-soyasapogenol E Vanillic acid conjugate 
Hydroxymethoxybenzoic acid + 
hydroxybenzoic acid + 276 Da 
Malonyl-Hex-malonyl-Hex-
hederagenin 
Hex-Hex-bayogenin (+ 46 Da adduct)  
Hex-HexA-hederagenin  
Malonyl-Hex-dHex-medicagenic acid  
Lariciresinol + hexose + malonic acid?  
Malonyl-? + carboxybenzoic acid (phthalic acid 
or isomer) 
 
Hex-HexA-aglycone A  
Dihydroxyflavone or hydroxyflavonol derivate?  
 
To establish that the accumulation of the incompletely glycosylated saponins was the 
cause and not the consequence of the root defects, as was also the case with the sad3 and 
sad4 oat mutants (Mylona et al., 2008), we tried to ‘phenocopy’ the MKB1KD phenotype 
by adding different metabolites to the culture medium of control roots. First, aliquots of 
the culture medium of MKB1KD roots containing the incompletely glycosylated saponins 
were applied resulting in epidermal loosening of contr l roots, whereas similar or higher 
doses of medium from control roots devoid of saponins did not have an effect (Fig. 6a). 
Second, we purified 3-O-Glc-medicagenic acid and medicagenic acid from M. sativa 




roots (Oleszek et al., 1990) and applied them to control roots. A transient phenocopy was 
obtained after addition of 3-O Glc-medicagenic acid (Fig. 6b) but not of purified 
medicagenic acid (data not shown). No phenocopy was observed after treatment with 
phytohormones, such as auxins, brassinosteroids, gibberellins, cytokinins, and JAs, or 
commercially available compounds such as the flavonoid quercetin or the fully 
glycosylated soyasaponin I, the most abundant compound in control hairy roots and also 
abundantly present in the medium of MKB1KD roots, supporting that the ectopic 
biosynthesis of one or more monoglycosylated saponins accounts, at least partially, for 
the root and epidermis defects in the MKB1KD roots. 
 
 
Figure 6. Phenocopy of the MKB1KD phenotype. (a) Light and fluorescent microscopy 
analysis of control hairy roots incubated for 1 week in medium supplemented with 
medium from control (CTR) or MKB1KD root lines. (b) Light microscopy analysis of 
control hairy roots incubated for 1 day in medium supplemented with purified 3-O-Glc-
medicagenic acid (GMA) or an equivalent amount of the solvent (EtOH). 
 
 




These observations are also in agreement with structure-activity relationship studies that 
indicate that the monodesmoside derivatives of medicagenic acid possess a higher 
hemolytic activity, as well as a higher anti-fungal and allelopathic activity than the related 
bi- and tridesmosides (Oleszek, 1990; Augustin et al., 2011). Hemolytic activity is 
generally attributed to membrane bursts caused by the in eraction between the saponins and 
the sterols of the erythrocyte membrane (Augustin et al., 2011; Osbourn et al., 2011). 
 
Transcriptional feedback for plant survival. 
We assessed whether the effects of loss of MKB1 functio  on the metabolite profiles, 
were reflected in the profile of gene transcripts corresponding to enzymes involved in the 
triterpene saponin pathway. Remarkably, in the MKB1KD roots the expression of all of the 
hitherto known specific triterpene saponin biosynthetic genes (bAS, CYP93E2, 
CYP716A12, UGT73F3 and UGT73K1) was strongly downregulated (Fig. 7). A similar 
downregulation was also observed with HMGR1 and HMGR4, the two HMGRs of M. 
truncatula that are most coregulated with MKB1. In contrast, expression of none of the 
remaining M. truncatula HMGR genes, nor of the SQS, SQE genes, corresponding to 
enzymes catalyzing triterpene synthesis up to the oxidosqualene precursor, was markedly 
altered in the MKB1KD lines (Fig. 7). 
Similarly, none of the putative M. truncatula orthologs of genes corresponding to sterol 
biosynthesis enzymes from Arabidopsis, was differentially expressed in the MKB1KD 
lines (Fig. 8), indicating that alteration in the expression of MKB1 did not affect the 
transcriptional regulation of sterol biosynthesis or triterpene synthesis in general. In 
agreement with this, we did not detect any differences in sterol levels (data not shown). 
The expression of none of the tested triterpene pathway genes differed in MKB1OE lines 
either (Fig. 7 and Fig. 8), which is in accordance with the lack of any observable 
(metabolic) phenotype. These findings point towards the occurrence of a saponin specific 
feedback mechanism, caused by the absence of MKB1 activity and its requirement to 
cope with the consequent ectopic accumulation of the toxic monoglycosylated saponins. 






Figure 7. Expression of saponin synthesis genes in transgenic M. truncatula hairy roots. 
qRT-PCR analysis of saponin biosynthetic genes in control (CTR), MKB1OE (OE) and 
MKB1KD (KD) lines. 
 





Figure 8. Expression of sterol synthesis genes in transgenic M. truncatula hairy roots. 
qRT-PCR analysis of sterol biosynthetic genes in cotrol (CTR), MKB1OE (OE) and 
MKB1KD (KD) lines. A schematic overview of the sterol biosynthesis pathway and the 
qRT-PCR patterns are shown (left and right, respectively). 




The RMA-type MKB1 possesses HRD-type activity. 
A. thaliana and mammalian RMA proteins localize to the ER and possess E3 ubiquitin 
ligase activity in vitro (Matsuda et al., 2001; Lee et al., 2009). Similar to the Arabidopsis 
RMA proteins, the MKB1 protein contains a single N-terminal C3HC4-type RING 
domain and a putative membrane anchor at the C-terminus of the protein (Fig. 3d). To 
verify the activity of MKB1, a recombinant, truncated version of the MKB1 protein, 
lacking the membrane anchor domain (MKB1∆C), was shown to possess self-
ubiquitination activity in an in vitro assay (Fig. 9a), whereas a mutated version of the 
recombinant MKB1∆C protein, in which the essential amino acid residues Cys37 and 
Cys40 were substituted by Ser residues (Fig. 3b) did not. 
To verify the localization of MKB1, we produced GFP-tagged versions of both the full-
length (FL) MKB1 and the truncated MKB1∆C in bombarded onion (Allium cepa) cells. 
The GFP-MKB1 protein was visible in a network pattern, as Arabidopsis RMA1 
(Matsuda et al., 2001; Lee et al., 2009), whereas this pattern was lost and replaced by a 
cytosolic distribution pattern when the GFP-MKB1∆C protein was produced (Fig. 9b). 
The fluorescence of the FL GFP-MKB1 fusion protein was always very weak, 
presumably because of the self-ubiquitination activity, which hampered confocal 
microscopy analysis. Therefore, the localization of GFP-MKB1 was also determined in 
yeast cells, in which co-localization with a known ER protein was confirmed (Fig. 9c). 
Thus, MKB1 corresponds to an active, ER-localized, E3 ubiquitin ligase. 
Arabidopsis RMA1 protein has recently been shown to regulate aquaporin levels by 
ubiquitination and subsequent proteasomal degradation (Lee et al., 2009). Human RMA 
proteins are involved in the ERAD quality control system that ensures that only properly 
folded proteins are released to their appropriate destinations (Hirsch et al., 2009). 
Humans also have two other, non-related, HRD-type E3 ubiquitin ligases that besides 
being involved in the ERAD quality control system also play a crucial role in the control 
of sterol synthesis through the regulation of HMGR levels (Hampton and Garza, 2009; 
Hirsch et al., 2009; Jo and Debose-Boyd, 2010; Burg and Espenshade, 2011). To our 
knowledge, a role for human RMA proteins in the latter process has not been reported 




yet. Similarly, yeast does not possess RMA-type proteins and only employs HRD-type 
E3 ubiquitin ligases for sterol control. Despite this and the apparent lack of sequence 
similarity between the two types of E3 ubiquitin ligases and the different membrane 
topology of the HMGR enzymes in plants, yeasts and mammals (Fig. 10), we reasoned 




Figure 9. MKB1 is an ER-localized protein with autoubiquitination activity. (a) In vitro 
auto-ubiquitination assay of MKB1. The bacterially expressed GST-MKB1 constructs 
were incubated with ATP in the presence or absence of His-tagged Ub, E1 (rabbit 
UBE1), and E2 (human UbcH5a). Samples were resolved by 8% SDS-PAGE, followed 
by protein immunoblot analysis with anti-GST (top) or anti-HIS (bottom) antibodies. (b) 
Subcellular localization of MKB1 in bombarded onion cells. The pictures show the GFP 
signal and the GFP-bright light merged image (left and right, respectively) of GFP-
MKB1 and GFP-MKB1∆C (top and bottom, respectively). (c) Subcellular localization of 
MKB1 in yeast cells. The pictures show the signal of GFP-MKB1, SEC13-RFP, and the 
merged image, respectively. 
 





Figure 10. Topology of RMA and HMGR proteins from yeasts, plants and humans. (a) 
Schematic overview of the topology of HMGR enzymes and ERAD RMA-type E3 Ub 
ligases from yeast, M. truncatula, and human. (b) Kyte & Doolittle hydropathy plot of S. 
cerevisiae Hmg2p (left), M. truncatula HMGR1p (middle) and H. sapiens HMGCRp 
(right). (c) Kyte & Doolittle hydropathy plot of S. cerevisiae Hrd1p (left), M. truncatula 
MKB1p (middle) and H. sapiens gp78p (right). All plots were made with window size 
15. Red bars indicate the hydrophobic transmembrane domains. 
 
Two lines of indirect evidence supported this hypothesis. Besides the correlation between 
the MKB1KD root phenotype and the ectopic accumulation of products from the HMGR-
dependent triterpene saponin pathway, we observed an extraordinarily high expression 
correlation between MKB1 and two of the M. truncatula HMGR genes. Such a correlation 
in expression was not observed between these HMGR isoforms and the putative M. 
truncatula homolog of yeast HRD1 (Fig. 2b). To assess whether MKB1 functionality 
affects HMGR stability, we checked the accumulation f HMGR proteins in M. 
truncatula roots using immunoblot analysis with polyclonal antibodies raised against the 
conserved catalytic domain of Arabidopsis or melon (Cucumis melo) HMGR proteins 
(Kobayashi et al., 2002; Leivar et al., 2011). With both antibodies, a small but consistent 




increase in HMGR proteins was detected in the MKB1KD roots as compared to control 
roots (Fig. 11a-b), pointing towards a potential inverse correlation between MKB1 and 
HMGR proteins. Unexpectedly however, HMGR activity was markedly decreased in the 
MKB1KD roots as compared to control roots (Fig. 11c), indicating that higher HMGR 
protein levels did not lead to higher enzymatic activity. We speculate that this effect is 
caused by a negative feedback control system triggered by the loss of MKB1 activity, the 
resulting decreased HMGR turnover and the consequent ectopic accumulation of harmful 
triterpene saponins. A similar inverse correlation between HMGR activity and triterpene 
levels was recently observed in transgenic Taraxacum brevicorniculatum plants in which 
the synthesis of rubber (mainly a polymer of cis-1,4-isoprene) was targeted by an RNAi 
approach. Besides a significant reduction in rubber biosynthesis, a 50% increase in the 
levels of pentacyclic triterpenes was observed, accompanied by a 50% decrease in 
HMGR activity, which was postulated to reflect feedback inhibition from oxidosqualene-
derived products or precursors thereof (Post et al., 2012). Multilevel control of HMGR in 
yeast and mammals has been well documented (Hampton and Garza, 2009; Jo and 
Debose-Boyd, 2010; Burg and Espenshade, 2011), recently also reported in plants 
(Leivar et al., 2011), and may, for instance, involve phosphorylation. 
To further support that MKB1 can target HMGR proteins for degradation, we performed 
three sets of additional experiments. In the first, we assessed HMGR transcript and 
HMGR protein levels before and after MeJA application. MeJA application dramatically 
enhanced HMGR transcript steady state levels, in particular of HMGR1 (Fig. 11d), 
whereas HMGR protein levels remained stable (Fig. 11e), supporting the existence of a 
negative posttranscriptional control of HMGR levels. 
Secondly, we produced firefly luciferase (fLUC)-tagged versions of M. truncatula 
HMGR proteins in tobacco (Nicotiana tabacum) protoplasts combined or not with 
MKB1. Cotransfection with MKB1 decreased the HMGR1-fLUC and HMGR3-fLUC 
signal by almost 2-fold, whereas it did not reduce th  levels of HMGR2-fLUC or free 
fLUC activity (Fig. 11f). Hence, tagging of fLUC with particular M. truncatula HMGR 
isoforms converts it into a target of MKB1-mediated protein degradation. 





Figure 11. The RMA-like MKB1 E3 ubiquitin ligase targets the HMGR enzyme for 
degradation. Immunoblot analysis of 15µg and 10µg total protein was performed with 
polyclonal antibodies against the conserved catalytic domain of (a) melon and (b) 
Arabidopsis HMGR proteins in control (CTR) and MKB1KD lines (KD), respectively. (c) 
Specific HMGR activity in M. truncatula roots, relative to the activity in CTR1 line. (d) 
HMGR transcript steady state levels in mock or MeJA-treated M. truncatula roots. (e) 
HMGR protein levels in 15µg loading, represented as average of two biological repeats in 
mock or MeJA-treated M. truncatula roots. (f) Degradation of M. truncatula HMGR-
fLUC fusion proteins in tobacco protoplasts. Percentage stability relative to the fLUC 
value measured in the absence (-) or presence (+M) of MKB1. Error bars indicate the 
standard error (n=24). Statistical significance was determined by Student’s t-test (** 
P<0.01). (g) Complementation of HRD1 (H) or hrd1 (h) yeast cells transformed with 
MKB1 (+M) or MKB1mut (+m), spotted in a 10-fold dilution series on SD medium 
lacking URA supplemented (SD-U+LOV) or not (SD-U) with lovastatin. Empty vector 
control (-). (h) Immunoblot analysis for 6myc-tagged Hmg2p and Coomassie Blue 
staining of total protein extracts from RHY400 (H) and RHY401 (h) transformed with 
MKB1 (+M) or MKB1mut (+m). The destination vector was used as a control (-). 




Finally, we checked whether MKB1 could target yeast HMGR and thereby complement a 
yeast strain devoid of functional HRD1, despite thelack of sequence and topology 
similarity between both the E3 ubiquitin ligases and the HMGR enzymes from yeasts and 
plants (Fig. 10). Complementation was scored by determining the ability of transformed 
strains to grow on medium containing lovastatin, an inhibitor of HMGR (Fig. 1). Wild-
type yeasts with normal HRD1 activity have low HMGR levels and therefore are 
sensitive to this compound, whereas hrd1 yeasts with higher HMGR levels can overcome 
this growth inhibition (Hampton and Garza, 2009). The lovastatin tolerance of the hrd1 
strains was returned to wild-type levels after transformation with MKB1 but not with the 
ligase-dead MKB1mut version, demonstrating that the E3 ligase activity of MKB1 is 
required to overcome HRD1 deficiency (Fig. 11g). Similar results were obtained 
independent of the yeast strain used, either containi g only the native yeast HMGR 
proteins, or in which both native HMGRs had been replaced by a single 6myc-tagged 
Hmg2p copy (Fig. 11g). The latter genetic background also allowed monitoring the levels 
of yeast HMGR proteins in the strains transformed with the different MKB1 constructs. 
In the wild-type HRD1 yeast background, the tagged Hmg2p was nearly absent, whereas in 
the hrd1 strain, it could still be detected. In agreement wi h the lovastatin growth 
complementation assay, expression of wild-type MKB1, but not the ligase-dead MKB1mut, 
restored the Hmg2p levels to those of the HRD1 strain (Fig. 11h). Together, these results 
indicate that MKB1 can functionally complement the yeast HRD1 and, thereby, target the 
yeast HMGR for ubiquitin-mediated degradation. 
 
Discussion 
Plants respond to insect or pathogen attack by activating defense programs that include 
the production of bioactive secondary metabolites to eliminate the attackers. These 
compounds are often also toxic to the plants themselve  (Goossens et al., 2003; 
Sirikantaramas et al., 2009), hence their biosynthesis and accumulation should be strictly 
regulated, spatially and temporally, quantitatively and qualitatively, to optimize plant 
survival ‘in good and bad times’. Ectopic accumulation of bioactive or phytotoxic 




intermediates of the triterpene saponin and steroidal alkaloid pathways in oat and tomato 
(Solanum lycopersicum) mutants, respectively, has dramatic effects on growth 
performance (Mylona et al., 2008; Itkin et al., 2011). Our findings reveal an efficient, 
hitherto undetected, metabolite surveillance system that controls the pace of bioactive 
triterpene saponin synthesis and thereby safeguards plant integrity. In the model legume 
M. truncatula, this surveillance system has been recruited from the ERAD protein quality 
control system, which is a conserved molecular machinery in eukaryotes, but in this 
species has evolved to control the activity of the HMGR enzymes. 
Triterpene saponins share a common biogenetic origin with the sterols and are derived from 
oxidosqualene which is generated by the cytosolic MVA pathway. In yeast and mammals 
the activity of HMGR is regulated from the transcriptional to the post-translational level 
and many of the regulatory mechanisms involved have been characterized. However, in 
plants little is known about the regulatory mechanisms that control HMGR activity. 
Regulation at the transcriptional and posttranslation l level in response to environmental 
and developmental factors, or to perturbations of the metabolic flux through the sterol 
pathway has been reported (Nieto et al., 2009). Accordingly, in MeJA-elicited M. 
truncatula cells, transcriptional upregulation of the MVA pathway was reflected by the co-
activation of different isoforms of the HMGR gene with known saponin biosynthetic genes, 
such as bAS and several UGTs. Similarly, posttranslational regulation has been 
demonstrated by an increase in HMGR activity withou changes in the HMGR transcript 
level (Nieto et al., 2009). The study of plant SNF1-related protein kinases (SnRKs) that 
phosphorylate and thereby inactivate Arabidopsis HMGR reports on a possible 
posttranslational regulatory mechanism of plant HMGR (Dale et al., 1995). Here, we show 
that MeJA-modulated (transcriptional) elicitation of saponin biosynthesis in M. truncatula 
co-regulates with the transcriptional induction of a RING E3 Ub ligase, MKB1, that 
controls the stability of HMGR through a mechanism that is analogous to the ERAD 
quality control system that directs the sterol-regulated destruction of the HMGR enzyme in 
yeast and mammals. 
Remarkably, MKB1 does not belong to the HRD-type RING E3 Ub ligases known to be 
involved in the ERAD system that controls HMGR stability in both yeast and mammals but 




instead to the RMA-type of RING E3 Ub ligases. In mammalian cells, RMA1 is involved 
in the ERAD system that targets aberrant or misfolded proteins for degradation by the 26S 
proteasome. Thus far no evidence for an involvement of mammalian RMA1 in ERAD 
surveyed HMGR degradation has been reported, in contrast to the mammalian HRD-type 
E3 ligase gp78, which like its yeast counterpart HRD1 seems to be the sole determinant in 
the HMGR control system. Furthermore, no RMA-type ERAD ligase equivalents exist in 
yeast or fungi, suggesting that sterol-mediated feeback control of HMGR stability by 
HRD-type ligases is broadly conserved. Nonetheless, MKB1 can complement a yeast hrd1 
mutant, implicating that RMA-type ERAD ligases can t ke over some of the functions of 
HRD proteins in the absence of the latter, at least in yeast, and likely employ the molecular 
machinery employed by HRD1 to do so. 
There are common mechanistic principles between the yeast/mammalian HRD-type and 
the M. truncatula RMA-type ERAD ligases in the control of HMGR stability. In 
mammalian cells, coexpression of Insig proteins is needed to restore the resistance of 
overexpressed HMGR to sterol-induced ubiquitination and degradation, which suggests 
that ectopic reductase saturates the endogenous ERAD machinery. Accordingly, RNAi 
against Insigs or Gp78 abrogates sterol-mediated HMGR ubiquitination and degradation 
(Sever et al., 2003) whereas RNAi against the mammalian Hrd1, not involved in HMGR 
control, does not have any effect on HMGR ubiquitination (Jo and Debose-Boyd, 2010). 
Similarly, in M. truncatula, RNAi against MKB1, the RMA-protein shown to target at least 
one isoform of the M. truncatula HMGR proteins, is apparently capable of provoking an 
uncontrolled flux through the saponin pathway, leading to the accumulation of 
incompletely glycosylated saponins. The increased and/or ectopic accumulation of partially 
glycosylated saponins is toxic to the cells as exemplified by the dramatic phenotype of 
MKB1KD roots. Hence, co-induction of MKB1 by MeJA treatment might be considered as a 
means to prevent saturation of the ERAD system and to control or restrict the flux to the 
saponin pathway to ensure proper advance of the triterpene biosynthetic process. 
Plant SnRKs phosphorylate and inactivate HMGR e.g. Arabidopsis HMG1 at a site (Ser-
577) equivalent to that at which mammalian AMPK, a m jor metabolic regulator in 
mammalians, phosphorylates mammalian HMGR (Dale et al., 1995). Hence, conservation 




between the activity of the modifier and the primary sequence of the physiological 
substrate between plants and mammalians might occur, although the signaling molecule 
that activates plant SnRK is not AMP as it is for the mammalian AMPK. In case of the 
ERAD control of HMGR stability, it appears unlikely that such conservation of the primary 
sequence of the substrate exists. Point mutations within the HMGR membrane domain, 
which is also the sterol-sensing domain, at amino acid residues that are conserved between 
human, hamster, Xenopus, zebrafish, sea urchin and to some extent also Dr sophila, 
disrupt Insig binding and abolish sterol-accelerated d gradation of the HMGR enzyme (Lee 
et al., 2007). In mammalians, the HMGR transmembrane domain is also the site where 
ubiquitin is conjugated (Doolman et al., 2004). In contrast to the high conservation of the 
catalytic C-terminal domain, the N-terminal, membrane-spanning domain of plant HMGRs 
is highly divergent: little primary sequence conservation can be observed, the amino acid 
residues important for the sterol-sensing in animal HMGRs are not conserved, and the N-
terminal domain is truncated and lacks the complex m mbrane-spanning architecture, i.e. 
plant HMGRs only possess 2 membrane spanning domains whereas yeast and human 
HMGRs contain 7 and 8 transmembrane domains, respectively (Learned and Fink, 1989). 
Hence, recognition of the plant HMGRs by RMA-type ligases such as MKB1 might have 
evolved alternative recognition and ubiquitinylation sites. Alternatively, ERAD-regulated 
degradation of plant HMGR might depend on a ‘distributed degron’, requiring structural 
features distributed over the entire transmembrane domain, and not visible in primary 
sequence motifs, as was found for yeast Hmg2p (Gardner and Hampton, 1999; Hampton, 
2002). Though plant HMGRs have a truncated membrane domain, such structural features 
may have been conserved. The latter hypothesis is further supported by the observation that 
despite the structural resemblance, only limited prima y sequence resemblance between the 
membrane domains of yeast and mammalian HMGR proteins was observed (<20% identity 
over 340 amino acids; DeBose-Boyd, 2008). 
Remarkably, M. truncatula uses an ERAD system different from the one that directs the 
sterol-regulated destruction of the HMGR enzymes in yeast and mammals. Nonetheless, 
despite the marked differences in sequence and topology between the plant RMA and 
yeast HRD1 proteins, as well as between the respective target HMGR enzymes, the 




MKB1 RMA-type E3 ligase can take over at least some of the functions of the yeast 
HRD-type E3 ligase protein in the absence of the latt r, and thus seems compatible with 
the connected molecular machinery. In addition to sterols in mammals, both yeast and 
mammalian cells appear to use IPP-derived non-sterol  to regulate HMGR stability or 
degradation (Sever et al., 2003; Garza et al., 2009). The divergent sequences of the plant 
proteins might have allowed the evolution of a plant-specific gateway to the ERAD-
mediated control of HMGR stability, for instance regulated by specific saponin 
intermediates. Possibly MKB1 may manage the activity of more ER-localized enzymes 
that catalyze steps in triterpene saponin synthesis, such as the Cytochrome P450 
monooxygenases that hydroxylate the β-amyrin backbone, and in this way guarantee self-
protection of the plant from its own arms. 
 
Materials and Methods 
M. truncatula suspension cell culture maintenance and elicitation. M. truncatula cell 
cultures (kindly provided by Richard Dixon, Ardmore, USA), were maintained as 
described (Suzuki et al., 2002). For elicitation, 7 days after inoculation of 75 ml of a 14 day 
old suspension culture into 175 ml fresh medium, cells were treated with 100 µM MeJA 
(dissolved in EtOH) or an equivalent amount of EtOH as a control. Samples were 
harvested, vacuum filtrated, and frozen at -80°C. For transcript profiling, samples were 
taken 0, 0.5, 1, 2, 4, 8, 12, and 24 h after elicitor or mock treatments. 
Transcript profiling.  Total RNA from M. truncatula cells was prepared with TRIZol 
(Invitrogen, Carlsbad, CA) and reverse transcribed to ouble-stranded cDNA as described 
(Vuylsteke et al., 2007). After appropriate sample reparation, cDNA-AFLP based 
transcript profiling was done with all 128 possible BstYI+1/MseI+2 primer combinations. 
Gel images were analyzed with the AFLP-QUANTARPRO software (Keygene, 
Wageningen, The Netherlands), allowing accurate quantification of band intensities. The 
intensity of all individual bands was determined an the obtained raw expression data were 
corrected for lane variations (due to PCR or loading differences) by dividing the raw data 




by a correction factor. The correction factor was clculated by dividing the sum of the 
expression levels of all fragments within one lane by the highest sum of all lanes within a 
primer combination. Subsequently, the standard deviation (SD) and the average were 
calculated for each individual band. Individual gene expression profiles were variance 
normalized by subtracting the calculated average from each individual data point, after 
which the obtained value was divided by the SD. A coefficient of variation (CV) was 
obtained by dividing the SD by the calculated averag . Gene tags displaying expression 
values with a CV ≥0.5 were considered as differentially expressed. Based on this cut-off 
value, together with visual inspection of the cDNA-AFLP gels, differentially expressed 
gene tags were selected for further analysis. Cluster analysis, sequencing, and BLAST 
analysis were done as described (Rischer et al., 2006). 
For qRT-PCR total RNA was extracted with the RNeasy mini kit (Qiagen), and cDNA 
prepared with SuperScriptTM II Reverse Transcriptase (Invitrogen). Primers were designed 
with Beacon Designer version 4.0 (Premier Biosoft International, Palo Alto, CA, USA). 
qRT-PCR was carried out with a Lightcycler 480 (Roche) and SYBR Green QPCR Master 
Mix (Stratagene). For reference genes, 40S ribosomal protein S8 (40S) (TC160725 of the 
MTGI from TIGR) and translation elongation factor 1α (ELF1α) (TC148782 of the MTGI 
from TIGR) were used. Reactions were done in triplicate and for the relative quantification 
with multiple reference genes qBase was used (Hellemans et al., 2007). 
Generation of DNA constructs. For hpRNAi, the 471-bp MKB1 cDNA-AFLP fragment 
was PCR-amplified and by Gateway™ recombination cloned into the binary vector 
pK7GWIWG2D(II) (Karimi et al., 2002). The resulting expression clone was transformed 
into the Agrobacterium rhizogenes strain LBA 9402/12 for generation of hairy roots. 
To identify the FL-ORF of MKB1, the cDNA-AFLP tag sequence was used for a BLASTN 
search against the Medicago truncatula Gene Index database 
(http://compbio.dfci.harvard.edu/tgi/). The MKB1 FL-ORF consensus sequence 
(TC149901; Genbank accession JF714982) and the M. truncatula HMGR1, HMGR2 and 
HMGR3 sequences (Genbank accession EU302813, EU302814 and EU302815, 
respectively) (Kevei et al., 2007) were PCR-amplified and by Gateway™ recombination 




cloned into the entry vector pDONR221. To obtain entry clones with and without stop 
codon, Gateway primers were designed according to (Underwood et al., 2006). The MKB1 
entry vector was used as a template to amplify truncated versions of the MKB1 sequence as 
well as to create point mutations with the GeneTailor Site-Directed Mutagenesis system 
(Invitrogen). All entry constructs were sequence-verified. 
For stable MKB1 overexpression experiments, Gateway recombination was carried out 
with the pK7WG2D binary vector (Karimi et al., 2002), and the resulting clone 
transformed to A. rhizogenes. For transient MKB1 overexpression in plant protoplasts and 
for MKB1 localization experiments in onion cells, Gateway recombination was carried out 
with the p2GW7 and pK7WGF2 vectors, respectively. 
For recombinant protein production, the MKB1 sequences were recombined in pDEST15 
expression vector and the resulting clones transformed to E. coli BL21 (DE3) cells. For the 
yeast complementation and localization assays, the pAG426GPD vector (Alberti et al., 
2007) was used as the destination vector for the MKB1 gene. For the degradation assays in 
plant protoplasts, the M. truncatula HMGR ORFs were fused at their C-terminus with the 
firefly luciferase ORF by a fusion PCR and Gateway recombined in the p2GW7 vector. 
Phylogenetic analysis. The protein sequences were aligned with ClustalW and the 
resulting alignments were manually adjusted. The phylogenetic tree was generated in 
MEGA 4.0.1 software (Tamura et al., 2007), by the Nighbor-Joining method, and 
bootstrapping was done with 10,000 replicates. The evolutionary distances were 
computed with the Poisson correction method, and all positions containing gaps and 
missing data were eliminated from the data set (complete deletion option). 
Generation and cultivation of transgenic M. truncatula hairy roots. A. rhizogenes-
mediated transformation of M. truncatula (ecotype Jemalong J5) hairy roots was done 
according to (Pollier et al., 2011b). The generated hairy root lines were grown for 7 days in 
the dark at 24°C and shaking at 300 rpm. Subsequently, the roots were transferred to 
horizontal Petri dishes containing solid MS medium (pH 5.8) supplemented with 1% 




sucrose (w/v) and 100 mg/L cefotaxime, grown in the dark at 24°C, and subcultured every 
3 weeks. 
Phenotypic analysis of transgenic M. truncatula hairy roots. Samples for scanning 
electron microscopy (SEM) were prepared as described (Van Damme et al., 2006). Briefly, 
after the first fixation step in 4% paraformaldehyde, 1% glutaraldehyde in 2 mM sodium 
phosphate buffer, the root samples were fixed in 1% osmium tetroxide (OsO4) solution 
(Fluka) for 2 hours, and subsequently subjected to a dehydratation series to 100% ethanol. 
Next, the root samples were critical-point dried and sputter-coated with gold particles 
before they were examined with the SEM microscope (JEOL JSM-5600 LV) under an 
acceleration voltage of 10 kV. 
For transmission electron microscopy (TEM), root tips from 12 day old M. truncatula 
hairy roots grown in liquid medium were briefly immersed in 20% (w/v) BSA and frozen 
immediately in a high-pressure freezer (EM Pact, Leica Microsystems, Vienna, Austria). 
Freeze substitution was carried out using a Leica EM AFS in dry acetone containing 0.1% 
uranyl acetate, 1% (w/v) OsO4 and 0.2% glutaraldehyde over a 4 day period as follows: -
90°C for 26 hours, 2°C per hour increase for 15 hours, -60°C for 8 hours, 2°C per hour 
increase for 15 hours, and -30°C for 8 hours. Samples were then slowly warmed up to 4°C, 
infiltrated stepwise over 3 days at 4°C in Spurr’s e in and embedded in capsules. The 
polymerization was performed at 70°C for 16 hours. Ultrathin sections were made with an 
ultramicrotome (Leica EM UC6) and post-stained in a Leica EM AC20 for 40 min in 
uranyl acetate at 20°C and for 10 min in lead stain at 20°C. Grids were viewed with a JEM 
1010 transmission electron microscope (JEOL, Tokyo, Japan) operating at 80 kV. 
Metabolite profiling.  M. truncatula hairy roots were grown for 21 days in liquid 
medium. The hairy roots were harvested and the medium collected from five biological 
repeats of three independent transgenic lines per transgene construct. Processing and 
metabolite extraction from hairy root tissue was performed as described (Pollier et al., 
2011b). 




To remove salts from the samples of the culture medium, 1 ml of medium was brought on 
a 100 mg Extract-Clean™ SPE column (Mandel, Guelph, Ontario, Canada) 
preconditioned with 1 ml 100% MeOH and 1 ml water acidified with 0.1% (v/v) acetic 
acid. After washing with 1 ml acidified water, samples were eluted in 1 ml methanol. The 
methanol eluate was evaporated to dryness under vacuum and the residue dissolved in 
200 µl water for analysis. 
LC ESI FT-ICR MS was carried out as decribed (Pollier et al., 2011b). Elucidation of the 
MSn spectra was according to (Pollier et al., 2011b) for the saponins and (Morreel et al., 
2006; Morreel et al., 2010) for the flavonoids and ( eo-)lignans. 
The resulting chromatograms were integrated and aligned with the XCMS package 
(Smith et al., 2006) in R version 2.6.1 with the following parameter values: 
xcmsSet(fwhm=8, max=300, snthresh=5, mzdiff=0.5), group(bw=8, max=300), 
retcor(method=loess, family=symmetric). A second grouping was done with the same 
parameter values. Due to in-source fragmentation, multiple m/z peaks for each compound 
were often observed. 
Ubiquitination assay. Recombinant GST-MKB1 fusion proteins (truncated with or 
without mutation) were purified from transformed E. coli cells pretreated for 2 hours with 
isopropyl-β-D-1-thiogalactopyranoside (IPTG), with Glutathione S pharoseTM 4B resin 
columns (GE Healthcare) according to the manufacturer’s instructions. A protein 
refolding step to assure the full ion Zn charge of the GST-MKB1 fusion protein was 
included by incubation with refolding buffer (20 mM Hepes, pH 7.4, 0.02 mM ZnCl, 
1.5 mM MgCl2, 150 mM KCl, 0.2 mM EDTA, 20% glycerol, 0.05% Triton-X100) for 
1 hour at 4°C. 
Ubiquitination reactions were done in a total volume of 30 µl using 15 µl of the refolded 
GST-MKB1 in a glutathione resin. The reaction contained 300 ng of GST-MKB1 fusion 
protein as E3 ligase, 250 ng of the Ub-activating Enzyme (UBE1) from rabbit 
(BostonBiochem), 400 ng of human recombinant UbcH5a protein (BostonBiochem), and 
2 µg of His6-Ub from human (BostonBiochem) in ubiquitination buffer (50 mM Hepes, 




pH 7.4, 2 mM ATP, 5 mM MgCl2, 2 mM DTT, 0.02 mM ZnCl2). The ubiquitination 
reactions were incubated for 1 hour at 30°C and stopped by adding 2X Laemmli buffer. 
Samples were resolved on 8% SDS-PAGE followed by protein immunoblot analysis with 
RGS/penta/tetra His antibody (Qiagen) and α-GST (GE Healthcare) antibodies. 
Particle bombardment of onion epidermis cells. The constructs for localization were 
transformed into onion epidermis cells by microparticle bombardment with a PDS-1000/He 
Biolistic® Particle Delivery System (Bio-Rad Laboratories, Hercules, CA, USA). To this 
end, 1 mg of 1.6 µm Gold Microcarriers (Bio-Rad Laboratories) were coated with 5 µg 
plasmid DNA according to the manufacturer’s instructions. The coated particles were 
bombarded into onion epidermis slices of approximately 2.5×2.5 cm, placed on solid MS 
medium (pH 5.8) supplemented with 1% (w/v) sucrose, with 1100 psi rupture discs and a 
vacuum of 0.1 bar. Subsequently, the onion slices wre stored in the dark for 24 hours at 
room temperature before analysis by confocal microscopy. 
Confocal microscopy. Transformed BY4742 yeast cells (with an integrated RFP tagged 
Sec13 protein for ER and Golgi marking) (Huh et al., 2003) and bombarded onion slices 
were analyzed by confocal microscopy with the FV10 ASW Olympus Confocal with a 
water immersion 63× objective. 
Analysis of M. truncatula HMGR protein levels and activity. Protein extraction from M. 
truncatula hairy roots was carried out as described (Leivar et al., 2011). Determination of 
HMGR protein levels by immunoblot analysis with polyclonal antibodies raised against 
the conserved catalytic domain of Arabidopsis or melon (Cucumis melo) HMGR proteins 
was performed essentially as decribed (Kobayashi et al., 2002; Leivar et al., 2011). 
Determination of HMGR-specific activity was carried out as described (Leivar et al., 
2011). 
HMGR degradation assays in tobacco protoplasts. Protoplast preparation from tobacco 
Bright Yellow-2 cells, automated transfection, lysis and firefly luciferase assays were 
carried out as described (De Sutter et al., 2005). 




Yeast complementation and protein degradation assays. Two sets of S. cerevisiae 
strains were used for the complementation and protein d gradation assays, namely strains 
YWO1167 (W303 Mat α, ura3-1, his3-11,15, leu2-3,112, trp1-1, ade2-1ocre, can1-100, 
prc1-1, doa10::KanMX) and its hrd1 (∆der3/hrd1::HIS3) knock-out (YWO1528), on the 
one hand, and RHY400 (Mat a, ade2-101, his3∆200, lys2-801, met2, hmg1::LYS2, 
hmg2::HIS3, ura3-52::6MYC-HMG2) expressing 6myc-Hmg2p and its hrd1-1 mutant 
RHY401 (Hampton et al., 1996) on the other hand. Transformations were carried out with 
the high-efficiency lithium acetate/single-stranded carrier DNA/polyethylene glycol 
method. The transformed yeast strains were selected on minimal medium (2.67% minimal 
SD Base with 0.077% -Ura DO supplement; Clontech) supplemented with 30 mg/L 
adenine and methionine. 
For the hrd1 mutant phenotype complementation assays, minimal mediu  supplemented 
with 100 µg/ml or 175 µg/ml lovastatin was used for the RHY and YWO strains, 
respectively. A stock solution of 25 mg/ml lovastatin was prepared by the hydrolysis of a 
100 mg/ml solution in 95% ethanol with 1 N NaOH at 55°C for 40 min, followed by 
addition of 1 M Tris-HCl (pH 8.0) and adjustment of pH to 8.0 with 1 N HCl. 
Whole cell protein extracts were prepared from yeast cells by washing them with minimal 
medium containing 0.1% NaN3 followed by resuspension in 100 µl of SUTE buffer (8 M 
urea, 1% SDS, 10 mM Tris base, 10 mM EDTA, pH adjusted to 7.5) containing Complete 
protease inhibitors (Roche) at pH 6.8. The cells were lysed by vortexing at high speed with 
acid-washed 0.5 mm glass beads. The lysate was boiled f r 10 min at 65°C after addition of 
100 µl USB buffer (8 M urea, 4% SDS, 0.125 M Tris-HCl, pH 6.8, 10% β-
mercaptoethanol, pH adjusted to 6.8). 10 µg of the clear liquid lysate was loaded on SDS-
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A major deliverable of this PhD was the establishment of a Saccharomyces cerevisiae 
based yeast platform for the production of triterpenoid sapogenins. As a first step towards 
achieving this goal, yeast strains producing five different triterpene sapogenin backbones, 
namely β-amyrin, α-amyrin, lupeol, lupanediol and dammarenediol were generated. 
These starter strains served as tools for the charaterization of novel CytP450s involved 
in triterpene saponin biosynthesis, resulting in the identification of three new enzymes. 
Additionally, a combinatorial biosynthesis platform was established for the synthesis of 
both known and potentially novel sapogenins in yeast. Although the main goals of this 
PhD were achieved, several problems were encountered hat need to be addressed to 
improve the existing platform and allow the full exploitation of its potential. In the 
following discussion several of these issues are pinpointed with possible ways of 
overcoming them. 
 
Can the production of sapogenins be enhanced further in the present yeast strains? 
Our S. cerevisiae strain was rationally engineered to express a feedback-free cytosolic 
version of HMGR and down regulate the expression of ERG7, to accumulate 2,3-
oxidosqualene. In addition, flux through the ergosterol pathway could be further 
enhanced (a) by overexpressing every single gene of the pathway upto the production of 
2,3-oxidosqualene, or (b) by expressing a mutant version of the transcription factor 
(upc2-1) to globally deregulate sterol biosynthesis or alternatively (c) by employing both 
(a) and (b). These approaches have been engineered in S. cerevisiae to increase 
amorphadiene and taxadiene titers substantially. 
In addition to conventional pathway specific engineering, the modulation of distant 
and/or non rate-limiting genes can also influence metabolic phenotypes. For instance, a 
genotype-to-phenotype linking study led to the identification of two sterol biosynthetic 
genes and one fatty acid metabolic gene with non-sile t single-nucleotide polymorphisms 
(SNPs), to be responsible for increased ergosterol and fatty acid levels in S. cerevisiae 





tremendously improved its heterologous triterpene production (Madsen et al., 2011). 
Similarly, using a carotenoid-based screening, gene del tions that improved isoprenoid 
production were identified. By combining these gene deletions with other mevalonate 
pathway modifications the production of the terpene-based biofuel bisabolene was 
increased by over 20-fold (Özaydın et al., 2012). Besides analyzing metabolic 
phenotypes, a genome-wide microarray analysis can help identify stress response factors 
that are activated upon heterologous pathway expression. Model-based engineering can 
further assist recognize the gene manipulations to overcome the stress response and can 
positively influence the production of the exogenous compound of interest. 
In our yeast strains expressing CytP450s, we also ob erved a great variance in the amount 
of oxygenated products generated from the substrate, β-amyrin for instance, thereby 
representing the different catalytic efficiencies of the CytP450s involved (Fig. 1). 
However, the very low amounts of product, particularly with the strain expressing 
CYP93E2, indicate a possible reaction bottleneck (compound 6, Fig. 1). Although the 
actual cause of this low efficiency is currently unknown, a plausible reason could be the 
incompatibility of the CytP450 with the reductase partner employed. This could be 
addressed by either coupling the CytP450 with its native CPR or by employing an 
ubiquitous electron transporter like cytochrome b5 as the redox partner. Additionally, 
protein misfolding, protein instability and enzyme half-life could be other factors 
attributing to the low product concentration. Amino acid substitutions resulting from 
SNPs can positively influence the folding, stability and catalytic activity of proteins and 
have been suggested to be key players in the process of natural evolution (Tokuriki and 
Tawfik, 2009). Hence, through modeling and thermodynamic predictions the inter-
residue changes that influence protein-folding and therefore protein stability can be 






Figure 1. An overlay of GC chromatograms obtained from the supernatant of strains 
cultured with MβCD. The black chromatogram corresponds to the β-amyrin producing 
control strain not expressing any CytP450. The colored chromatograms correspond to β-
amyrin producing strains expressing a CytP450 each s indicated in the legend. 
Compound 1, ergosterol; 2, unknown; 3, 11-hydroxy β-amyrin; 4, unknown; 5, β-amyrin; 
6, 24-hydroxy β-amyrin; 7, putative 21-hydroxy β-amyrin; 8, 28-hydroxy β-amyrin 
(erythrodiol); 9, 28-carboxy β-amyrin (oleanolic acid); 10, putative oleanolic aldehyde; 
11, 11-oxo β-amyrin. 
 
However, the physical properties of proteins are generally not known and in such cases it 
is more feasible to apply a random approach to obtain enzyme variants. Directed 
evolution of enzymes which involves mutagenesis and selection of enzyme mutants is an 
alternative way of obtaining variants of a lead enzyme with desirable changes. For 
instance, the reaction specificity of a γ-humulene synthase from Abies grandis that 
cyclizes FPP to 52 different sesquiterpenes was evolv d by site-saturation mutagenesis of 
its promiscuous active site to generate seven independent synthases (Yoshikuni et al., 
2006). Similarly, directed enzyme evolution can also serve as a tool to enhance the 
catalytic activity of a triterpene saponin biosynthetic enzyme, such as the CYP93E2. 
The yield of sapogenins reported in this thesis hasbeen estimated from batch 
fermentations that have been performed devoid of optimization of culturing conditions. 
Hence, future efforts must be focussed on developing fed-batch fermentation-based 
production processes through the optimization of medium composition and culturing 





hydrophobic nature of sapogenins it might be feasible to develop a biphasic continuous 
cultivation method in which the cyclodextrin-sequestered sapogenins released into the 
medium can be captured in the organic phase that can be continuously recycled, thereby 
reducing any existing metabolic regulation and negative phenotypic effects like toxicity 
on the producer strain. 
Next to optimizing culturing conditions strain optimization could also be performed by 
crossing our S288c BY4742 laboratory strain with an industrially robust strain to 
generate segregants that can be analyzed for enhanced sapogenin productivity. 
 
Can an industrial yeast strain be engineered for sapogenin production? 
The currently employed S. cerevisiae S288c BY4742 is a laboratory yeast strain that does 
not comply with the robust requirements of the industry. As a follow-up to this work, the 
goal of the PhD project of Philipp Arendt is to engineer the industrial yeast Yarrowia 
lipolytica for the synthesis of pharmaceutically active terpenes. Y. lipolytica is a non-
conventional GRAS yeast extensively employed for recombinant protein production. In 
addition, Y. lipolytica can utilize fatty acids as a source of carbon for its growth and 
convert them to acetyl-CoA, the precursor for terpene synthesis. Therefore, one aim of 
this follow-up project will be to establish a tritep noid sapogenin biosynthetic platform 
in Y. lipolytica for the production of known as well as novel compounds using 
combinatorial biosynthesis. Owing to the conversion of cheap feed-stock to valuable 
terpenoid products, the Yarrowia platform is more suited for industrial applications. 
Next to Y. lipolytica, a S. cerevisiae based industrial strain, like CEN.PK2, could also be 
engineered for sapogenin production. Transferring the engineering knowledge gained 
from S. cerevesiae S288c to CEN.PK2, the final titer of amorphadiene was enhanced to 






Can the sapogenins be easily purified from yeast cult res? 
We reported the establishment of a novel strategy to sequester triterpene sapogenins from 
within yeast cells to the spent culture medium using MβCD. The extraction of sapogenins 
involves the transfer of, presumably MβCD-bound compounds from the aqueous medium 
to the highly apolar organic solvents, from where th y are concentrated and separated 
using a TLC based approach. However, what is still unclear is whether the sapogenins 
once in the organic solvent still exist in a MβCD-bound form. Our initial attempts at 
NMR on the hydroxylated β-amyrin product of the CytP450 BF567, indicated the
presence of sugar contaminants, presumably arising from the MβCD. Therefore, it is 
essential to develop a method to expel the MβCD post purification of MβCD-bound 
compound to obtain high purity triterpene sapogenins. Cyclodextrin degrading enzymes 
have been described that could be utilized to break down cyclodextrins to water-soluble 
maltose and glucose units (Turner et al., 2005), which can thus be separated from the 
water insoluble sapogenins to obtain compounds with hig  level of purity. 
 
What is the future of combinatorial biosynthesis for novel sapogenins? 
Despite the wide spread ability of plants to synthesiz  saponins, their biosynthetic 
pathways are poorly characterized, with not a single complete synthetic pathway having 
been elucidated from any plant species. Although multiple OSCs have been 
characterized, there are only seven CytP450 families identified of which the exact 
function of six are known, and six UGTs partially characterized (Augustin et al., 2011). 
This limits the pool of biosynthetic genes that can be currently utilized for combinatorial 
biosynthesis and emphasizes on the great need for gene discovery to identify saponin 
biosynthetic genes. Nonetheless, combinatorial biosynthesis could be attempted by 
utilizing genes not necessarily involved in saponin biosynthesis, but involved in 
triterpene biosynthesis and rely on their promiscuous nature to perform desired 
functionalities. For instance, the S. cerevisiae ERG25 gene product is a CytP450 that has 





al., 1996). The reaction catalyzed by ERG25p results in a three step oxidation of a methyl 
group attached to C-4, to a carboxyl group (Fig. 2a) This carbon corresponds to the C-23 
of an oleanane triterpene sapogenin backbone, for which a C-23 oxidase has not been 
identified to date. In the β-amyrin producing engineered S. cerevisiae strain it should be 
possible to bring about a C-23 carboxylation by overexpressing the S. cerevisiae ERG25 
gene either in its native form or by expressing a variant of ERG25 obtained through 
directed enzyme evolution (Fig. 2b). Such an approach could be extended to other plant 




Figure 2. Hypothetical schematic for employing a yeast enzyme for triterpene sapogenin 
biosynthesis. (a) ERG25 catalyzes the conversion of 4,4-dimethylzymoster l to 4α-
carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol. (b) ERG25 catalyzes the conversion of 
β-amyrin to 23-carboxy β-amyrin. 
 
The recent progress in mining genetic information from non-culturable organisms (or 
metagenomics) has led to the discovery of novel enzymes which allow the development 
of compounds that benefit from enzyme-catalyzed chiral synthesis (Simon and Daniel, 





interest, metagenomics provides a vast pool of genetic information to screen for novel 
genes with triterpene (or any other compound) modifiable activity. 
With bardoxolone methyl in phase II clinical trials, the triterpene sapogenins and its 
derivatives continue to be interesting molecules with pharmaceutical applications. 
However, there is a great need to generate large-scal  combinatorial collections of 
sapogenins and its derivatives with high structural variability to screen for compounds 
with biological activity. The discipline of chemoinformatics which depicts the 
physicochemical properties of compounds with potential pharmaceutical properties 
emphasizes on the need for chiral centres, rotatable bonds, structural rigidity and 
aromatic rings in compounds to enhance their specificity and efficacy (Bade et al., 2010). 
These physicochemical properties are observed in natural products which are synthesized 
by enzyme catalyzed reactions, thereby emphasizing on the need for gene discovery to 
generate compounds with pharmaceutical potential. Hence, high-throughput sequencing 
of triterpene saponin producing plants and other triterpene producing organisms together 
with metagenomics will play an elementary role in the construction of large-scale 
sapogenin libraries. Furthermore, the expression of multiple genes in an easily scalable 
host like yeast will be mandatory to scale-up and obtain high amounts of relatively pure 
compounds. Additionally, applying multidisciplinary approaches including chemical 
modification of the reactive moieties on the enzyme-derived compounds will further 
increase the diversity of sapogenins. However, the possibility for chemical modifications 
is vast and therefore should be conjugated with in silico modeling to assess the feasibility 
of its synthesis. In parallel, computational structural biology predictions of the interaction 
of compound libraries with target proteins, associated with a target disease, will allow 
preliminary selection of chemical modifications that might influence the biological 
activity of the compound. Therefore, the successful generation of sapogenin libraries will 
depend on the future application of multiple disciplines including metabolic engineering 
in a heterologous host preferably yeast, genomics, in ilico modeling and computational 
biology. 
In conjunction with cell-based synthesis it is also essential to consider the application of 





sapogenins from their natural source is the complexity associated with their purification. 
Although yeast-based production allows extraction of relatively pure compounds, there 
are multiple hurdles associated with extraction from culture medium and/or yeast cells. In 
this respect, in vitro systems can be the sapogenin production platform of the future, 
when gene and enzyme functionality is more resolved. A desired compound can be 
synthesized from a substrate through a series of enzyme catalyzed reactions in an 
artificial environment, thereby facilitating purification. 
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Triterpenoid saponins are glycosides of sapogenins produced by a wide array of plants. 
They constitute a structurally diverse group of biologically active compounds with 
general health-promoting and pharmaceutical applications. In the native hosts these 
compounds are produced in very low amounts, renderig extraction from plants 
commercially unsustainable. The complications of engineering plants for enhanced 
production of desired products has led to the heterologous synthesis of many terpenoids 
in Escherichia coli and Saccharomyces cerevisiae. In addition, the application of current 
approaches, for the design and engineering of pathways using synthetic biology tools, and 
for the production of novel terpenoids by evolving enzymes and combinatorial 
biosynthesis, has also been more compatible with heerologous microbial hosts to date 
(chapter 2). 
The engineering of triterpenoid saponins in both plants and yeast has been limited, inspite 
of their potential applications. Hence, the main goal of this PhD research was to develop 
a heterologous yeast platform for triterpenoid sapogenin production. Producing high 
amounts of the precursor is an essential hurdle to overcome for establishing an efficient 
production system. Therefore, the native competing er osterol biosynthesis of a 
Saccharomyces cerevisiae strain was made conditionally down-regulatable to accumulate 
2,3-oxidosqualene and divert flux towards sapogenin backbone production. Using this 
engineered starter strain, yeast strains accumulating high amounts of the oleanane 
backbone β-amyrin, the ursane backbone α-amyrin and lupeol were generated (chapter 4 
and 6). The engineered yeast strain also served as a platform for characterizing functional 
oxidosqualene cyclases. A β-amyrin synthase from Maesa lanceolata and the 
multifunctionality of the dammarenediol synthase from Centella asiatica were identified 
(chapter 5 and 6). The co-cyclization of 2,3-oxidosqualene to lupanediol by the lupeol 
synthase from Arabidopsis thaliana in addition to lupeol, generated an additional novel 




Unlike mono- and sesquiterpenes, triterpenes are lage and plausibly more toxic 
compounds that are not readily excreted from yeast cells. This complicates compound 
purification from yeast cultures, due to the strict equirement for cell harvesting and lysis 
prior to compound extraction. By exploiting their hydrophobic nature, β-cyclodextrins 
were established as a sequestering agent for triterpen  sapogenins. For the first time the 
extraction of triterpenes from yeast cells was demonstrated using methylated β-
cyclodextrins, which also positively influenced the production of sapogenins itself, 
perhaps a consequence of the lack of intracellular feedback regulation (chapter 4). 
The engineered β-amyrin producing yeast strain served as a tool for the characterization 
of novel cytochrome P450 monooxygenases. A 28-oxidase nd two putative 21β-
hydroxylases were identified by employing this strain (chapter 4 and 5). Using the β-
amyrin, α-amyrin and lupeol producing strains a proof of concept for combinatorial 
biosynthesis of triterpene sapogenins in yeast was delivered (chapter 6). Also, a first 
proof on the functional homology of two cytochrome P450 monoxoygenases belonging 
to two different families was established in triterp ne saponin (secondary metabolite) 
biosynthesis (chapter 4 and 5). 
Finally, a triterpene saponin regulatory gene, called Makibishi 1 (MKB1), which encodes 
an RMA-type E3 ubiquitin ligase, was identified to be involved in the regulation of 
triterpene saponin biosynthesis in Medicago truncatula by targeting specific isoforms of 
3-hydroxy-3-methylglutaryl-CoA reductase, the rate-limiting enzyme of the mevalonate 
pathway. Down regulating MKB1 expression in transgenic M. truncatula hairy roots 
resulted in the accumulation of monoglycosylated saponins, thereby serving as a plant-
based tool for the accumulation of saponin building blocks (chapter 7). 
As a consequence, two in vivo production systems were established for the synthesis of 
known and novel saponin building blocks. The conventional yeast S. cerevisiae and the 
model legume M. truncatula could be engineered to accumulate unglycosylated 






List of yeast strains generated in this study and the sapogenin backbones or sapogenins 
they produce. 
Name Construct Compounds produced 
S288c BY4742 MATa; his3∆1; leu2∆0; ura3∆0; lys2∆0  
TM1 S288c BY4742; Perg7::PMET3-ERG7  
TM2 
TM1; pESC-URA[GAL10/tHMG1; GAL1/MtbAS] 




TM1; pESC-URA[GAL10/tHMG1; GAL1/GgbAS] 
(36.2 mg/L β-amyrin) 
TM4 TM1; pESC-URA[GAL10/tHMG1; GAL1/MlbAS] 











































































TM26 TM3; pAG423, pAG425[GAL1/AtATR1]  
TM27 TM3; pAG423, pAG415[GAL1/AtATR1]  













































































Cloning strategy and PCR fragments amplified for generation of strain TM1. 
 
 
Plasmid pIP007 was generated by inserting the MET3 promoter (PMET3) between the SpeI 
and SacII restriction sites of plasmid pUG6 harboring an ampicillin resistance cassette for 
bacterial selection. In vector pIP007 the PMET3 is inserted next to the kanamycin cassette 
(KanMX) which is driven by the TEF promoter (PTEF) and TEF terminator and flanked 
by loxP sites for Cre-mediated recombination. The PCR fragments a and b were 
amplified from the plasmid vector pIP007 and fragments c and d from the yeast genomic 
DNA. In a second PCR the fragments e and f were amplified using the template pairs a+c 
and b+d, respectively. The fragments e and f were then transformed into an S288c 
BY4742 strain of Saccharomyces cerevisiae to replace the native ERG7 promoter (PERG7) 







Additional publications and patents 
Jasmonate signaling involves the abscisic acid receptor PYL4 to regulate metabolic 
reprogramming in Arabidopsis and tobacco 
Petri Lackman, Miguel González-Guzmán, Sofie Tilleman, Inês Carqueijeiro, Amparo 
Cuéllar Pérez, Tessa Moses, Mitsunori Seo, Yuri Kanno, Suvi T. Häkkinen, Marc C. E. 
Van Montagu, Johan M. Thevelein, Hannu Maaheimo, Kirsi-Marja Oksman-Caldentey, 
Pedro L. Rodriguez, Heiko Rischer, and Alain Goossen  
The phytohormones jasmonates (JAs) constitute an important class of elicitors for many 
plant secondary metabolic pathways. However, JAs do not act independently but operate 
in complex networks with crosstalk to several other phytohormonal signaling pathways. 
Here, crosstalk was detected between the JA and abscisic acid (ABA) signaling pathways 
in the regulation of tobacco (Nicotiana tabacum) alkaloid biosynthesis. A tobacco gene 
from the PYR/PYL/RCAR family, NtPYL4, the expression of which is regulated by JAs, 
was found to encode a functional ABA receptor. NtPYL4 inhibited the type-2C protein 
phosphatases known to be key negative regulators of ABA signaling in an ABA-
dependent manner. Overexpression of NtPYL4 in tobacco hairy roots caused a 
reprogramming of the cellular metabolism that resulted in a decreased alkaloid 
accumulation and conferred ABA sensitivity to the production of alkaloids. In contrast, 
the alkaloid biosynthetic pathway was not responsive to ABA in control tobacco roots. 
Functional analysis of the Arabidopsis (Arabidopsis thaliana) homologs of NtPYL4, 
PYL4 and PYL5, indicated that also in Arabidopsis altered PYL expression affected the 
JA response, both in terms of biomass and anthocyanin production. These findings define 
a connection between a component of the core ABA signaling pathway and the JA 
responses and contribute to the understanding of the role of JAs in balancing tradeoffs 
between growth and defense. 
Published in: PNAS (IF 9.681), 2011, volume 108, issue 14, pages 5891-5896. 




Combinatorial biosynthesis in plants: A (p)review on its potential and future 
exploitation 
Jacob Pollier, Tessa Moses, and Alain Goossens 
Combinatorial biochemistry, also called combinatorial biosynthesis, comprises a series of 
methods that establish novel enzyme–substrate combinations in vivo and, in turn, lead to 
the biosynthesis of new, natural product-derived comp unds that can be used in drug 
discovery programs. Plants are an extremely rich source of bioactive natural products and 
continue to possess a huge potential for drug discovery. In this review, we discuss the 
state-of-the-art in combinatorial biosynthesis methods to generate novel molecules from 
plants. We debate on the progress and potential in biotransformation, mutasynthesis, 
combinatorial metabolism in hybrids, activation of silent plant metabolism and synthetic 
biology in plants to create opportunities for the combinatorial biosynthesis of plant-
derived natural products, and, ultimately, for drug discovery. The therapeutic value of 
two classes of natural products, the terpenoid indole alkaloids and the triterpene saponins, 
is particularly highlighted. 
Published in: Natural Product Reports (IF 9.79), 2011, volume 28, pages 1897-1916. 




A MultiSite GatewayTM  vector set for the functional analysis of genes in the model 
Saccharomyces cerevisiae 
Astrid Nagels Durand, Tessa Moses, Rebecca De Clercq, Alain Goossens, and Laurens 
Pauwels 
Background: Recombinatorial cloning using the GatewayTM technology has been the 
method of choice for high-throughput omics projects, resulting in the availability of 
entire ORFeomes in GatewayTM compatible vectors. The MultiSite GatewayTM system 
allows combining multiple genetic fragments such as promoter, ORF and epitope tag in 
one single reaction. To date, this technology has not been accessible in the yeast 
Saccharomyces cerevisiae, one of the most widely used experimental systems in 
molecular biology, due to the lack of appropriate destination vectors. 
Results: Here, we present a set of three-fragment MultiSite GatewayTM destination 
vectors that have been developed for gene expression in S. cerevisiae and that allow the 
assembly of any promoter, open reading frame, epitope ag arrangement in combination 
with any of four auxotrophic markers and three distinct replication mechanisms. As an 
example of its applicability, we used yeast three-hybrid to provide evidence for the 
assembly of a ternary complex of plant proteins involved in jasmonate signalling and 
consisting of the JAZ, NINJA and TOPLESS proteins. 
Conclusion: Our vectors make MultiSite GatewayTM cloning accessible in S. cerevisiae 
and implement a fast and versatile cloning method for the high-throughput functional 
analysis of (heterologous) proteins in one of the most widely used model organisms for 
molecular biology research. 
Published in: BMC Molecular Biology (IF 2.857), 2012, volume 13. 




Triterpenoid sapogenin production in plant and microbial cultures 
Assignees: VIB and UGent. 
Inventors: Alain Goossens, Tessa Moses, and Lorena Almagro Romero 
Field of invention: The current invention is situated in the fields of plant secondary 
metabolites with pharmacological or other industrial properties and metabolic 
engineering of these phytochemicals. More specifically, the invention relates to a method 
for enhancing the biosynthesis and/or secretion of sapogenins intermediates in the culture 
medium of plant and microbial cell cultures. 
Abstract:  The invention relates to a method for enhancing the biosynthesis and/or 
secretion of sapogenins in the culture medium of plant and microbial cell cultures. 
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a happy and contended girl. I will cherish my Ph. D. experience for a long time to come 
and these memories of 5 years wouldn’t have been th same without the help, support, 
patience and just the physical presence of many of you. 
I want to begin by thanking VIB and the whole team t the headquarters for not just the 
International Ph. D. program, but also the constant support in making my life fairly 
simple and straightforward in Belgium. If not for the International Ph. D. program I still 
would have been unaware of the geographical location of Belgium (oopsy daisies my 
geography is really bad!). Thank you Mark  (Mark Veugelers) for your advice and 
scientific guidance all through. Marijke  (Marijke Lein), I have not met someone more 
kind and considerate than you. You have always been th re, you are an inspiration. 
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sorting out the mess with my tax papers year after yea . 
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(Johan Thevelein) coined was fascinating. I have to thank both of you for the opportunity 
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process. Your hard working attitude is inspiring (quiet contagious actually!). I appreciate 
the independence you give me to plan my work, the list ning ear you lend in scientific 
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back, those side projects have taught me much more than yeast engineering, and I thank 
you for letting me be part of them. Thank you Alain  for the constant support, the 
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know ☺! If I ever get to writing something worth publishing someday, I promise to 
dedicate the most complicated of texts to you. 
Johan, you were my mystery promoter. I still remember the first time I got to meet you 
was during the VIB seminar of 2008. I never got to work closely with you, but you have 
always been there with your valuable suggestions and useful comments. I am always 
amazed by how you come up with the most logical and simplest solutions to the most 
complicated problems. You inspire me to become scientifically wise. Thank you for 
being inspirational. 
My Ph. D. wouldn’t have been technically as smooth without the help of the PSB 
administrative, ICT and logistic staff. Special thanks to Diane (Diane Hermie), Christine 
(Christine Tire), Delphine (Delphine Verspeel), Kristof  (Kristof Verleye), Jackie (Jackie 
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me when I landed in Belgium. You are so full of energy, you put me and many more to 
shame at the parties. Hendrik , I have enjoyed socializing with you outside the lab and 
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My dear fellow metabollers you guys are just awesome, such fun to work with. Gino, 
your ‘fulfil your dream’ attitude is inspirational. Vestrock truly rocks! Laurens, your 
broad view of science and the dedication to unraveling the mysteries of jasmonates is, in 
the deepest sense of the word, amazing. Andres, the man (I know that makes you 
happy!), please behave at my defense. Jacob, I love you and love working with you! 
Alex, I have never seen someone crack such hilarious jokes with the most innocent and 
serious look on their face. You are a cheerful little guy (pun intended). Rebecca, you are 
one person who comes smiling into the lab every morning, its such a pleasant sight. 
Sofie, trust me the diatom boys would be helpless without y . Way to go girl! Robin, 
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Michiel , thank you for the constant debate about everything u der the sun, through the 
past years. Most of the discussions are enlightening a d, although at first instance it 
doesn’t seem like, I do enjoy these conversations. Sandra, probably the best time I spent 
with you was when we were in Sweden for Terpnet, 2011. I will always remember how 
exhausted we were at the conference talks after chatting non stop in the nights. Jan and 
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with you guys will be great fun. The team buildings wouldn’t be the same without you 
all. 
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memorable of them. It has been a great experience to work with you and to know you as 
a person. You are a great kid. Assia, Saartje, Corinne and Nina it has been a learning 
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